
<html lang="en"     class="pb-page"  data-request-id="23d85dd2-6fab-46c6-8074-c7da63c67980"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b00571;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold" /></meta><meta name="dc.Creator" content="Michael  Forster" /></meta><meta name="dc.Creator" content="Apirat  Chaikuad" /></meta><meta name="dc.Creator" content="Teodor  Dimitrov" /></meta><meta name="dc.Creator" content="Eva  Döring" /></meta><meta name="dc.Creator" content="Julia  Holstein" /></meta><meta name="dc.Creator" content="Benedict-Tilman  Berger" /></meta><meta name="dc.Creator" content="Matthias  Gehringer" /></meta><meta name="dc.Creator" content="Kamran  Ghoreschi" /></meta><meta name="dc.Creator" content="Susanne  Müller" /></meta><meta name="dc.Creator" content="Stefan  Knapp" /></meta><meta name="dc.Creator" content="Stefan A.  Laufer" /></meta><meta name="dc.Description" content="Janus kinases are major drivers of immune signaling and have been the focus of anti-inflammatory drug discovery for more than a decade. Because of the invariable colocalization of JAK1 and JAK3 at ..." /></meta><meta name="Description" content="Janus kinases are major drivers of immune signaling and have been the focus of anti-inflammatory drug discovery for more than a decade. Because of the invariable colocalization of JAK1 and JAK3 at ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 31, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00571" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00571" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00571" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00571" /></link>
        
    
    

<title>Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00571" /></meta><meta property="og:title" content="Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0010.jpeg" /></meta><meta property="og:description" content="Janus kinases are major drivers of immune signaling and have been the focus of anti-inflammatory drug discovery for more than a decade. Because of the invariable colocalization of JAK1 and JAK3 at cytokine receptors, the question if selective JAK3 inhibition is sufficient to effectively block downstream signaling has been highly controversial. Recently, we discovered the covalent-reversible JAK3 inhibitor FM-381 (23) featuring high isoform and kinome selectivity. Crystallography revealed that this inhibitor induces an unprecedented binding pocket by interactions of a nitrile substituent with arginine residues in JAK3. Herein, we describe detailed structure–activity relationships necessary for induction of the arginine pocket and the impact of this structural change on potency, isoform selectivity, and efficacy in cellular models. Furthermore, we evaluated the stability of this novel inhibitor class in in vitro metabolic assays and were able to demonstrate an adequate stability of key compound 23 for in vivo use." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Janus kinases are major drivers of immune signaling and have been the focus of anti-inflammatory drug discovery for more than a decade. Because of the invariable colocalization of JAK1 and JAK3 at cytokine receptors, the question if selective JAK3 inhibition is sufficient to effectively block downstream signaling has been highly controversial. Recently, we discovered the covalent-reversible JAK3 inhibitor FM-381 (23) featuring high isoform and kinome selectivity. Crystallography revealed that this inhibitor induces an unprecedented binding pocket by interactions of a nitrile substituent with arginine residues in JAK3. Herein, we describe detailed structure–activity relationships necessary for induction of the arginine pocket and the impact of this structural change on potency, isoform selectivity, and efficacy in cellular models. Furthermore, we evaluated the stability of this novel inhibitor class in in vitro metabolic assays and were able to demonstrate an adequate stability of key compound 23 for in vivo use." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0010.jpeg" /></meta><meta name="twitter:title" content="Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00571"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00571">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00571&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00571&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00571&amp;href=/doi/10.1021/acs.jmedchem.8b00571" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5350-5366</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00549" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00576" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine Scaffold</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Michael Forster</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Forster</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Forster">Michael Forster</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Apirat Chaikuad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Apirat Chaikuad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, Johann Wolfgang Goethe University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, DE, Germany</div><div class="loa-info-affiliations-info">Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Apirat++Chaikuad">Apirat Chaikuad</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1120-2209" title="Orcid link">http://orcid.org/0000-0003-1120-2209</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Teodor Dimitrov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Teodor Dimitrov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Teodor++Dimitrov">Teodor Dimitrov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eva Döring</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eva Döring</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eva++D%C3%B6ring">Eva Döring</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julia Holstein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julia Holstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Dermatology, University Medical Center, Eberhard Karls University Tübingen, Liebermeisterstr. 25, 72076 Tübingen, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julia++Holstein">Julia Holstein</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benedict-Tilman Berger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benedict-Tilman Berger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, Johann Wolfgang Goethe University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, DE, Germany</div><div class="loa-info-affiliations-info">Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benedict-Tilman++Berger">Benedict-Tilman Berger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Gehringer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Gehringer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Gehringer">Matthias Gehringer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0163-3419" title="Orcid link">http://orcid.org/0000-0003-0163-3419</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kamran Ghoreschi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kamran Ghoreschi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Dermatology, University Medical Center, Eberhard Karls University Tübingen, Liebermeisterstr. 25, 72076 Tübingen, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kamran++Ghoreschi">Kamran Ghoreschi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susanne Müller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susanne Müller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susanne++M%C3%BCller">Susanne Müller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Knapp</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Knapp</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, Johann Wolfgang Goethe University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, DE, Germany</div><div class="loa-info-affiliations-info">Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Max-von-Laue-Str. 9, D-60438 Frankfurt am Main, DE, Germany</div><div class="loa-info-affiliations-info">German Cancer Consortium, DKTK, 60590 Site Frankfurt/Mainz, DE, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Knapp">Stefan Knapp</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5995-6494" title="Orcid link">http://orcid.org/0000-0001-5995-6494</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stefan A. Laufer</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan A. Laufer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +49 7071 2972459. E-mail: <a href="/cdn-cgi/l/email-protection#ea999e8f8c8b84c4868b9f8c8f98aa9f8483c79e9f8f8883848d8f84c48e8f"><span class="__cf_email__" data-cfemail="a2d1d6c7c4c3cc8ccec3d7c4c7d0e2d7cccb8fd6d7c7c0cbccc5c7cc8cc6c7">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+A.++Laufer">Stefan A. Laufer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6952-1486" title="Orcid link">http://orcid.org/0000-0001-6952-1486</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00571&amp;href=/doi/10.1021%2Facs.jmedchem.8b00571" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5350–5366</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 31, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 April 2018</li><li><span class="item_label"><b>Published</b> online</span>31 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00571" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00571</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5350%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BForster%252C%2BApirat%2BChaikuad%252C%2BTeodor%2BDimitrov%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b00571%26title%3DDevelopment%252C%2BOptimization%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BCovalent-Reversible%2BJAK3%2BInhibitors%2BBased%2Bon%2Ba%2BTricyclic%2BImidazo%255B5%252C4-d%255Dpyrrolo%255B2%252C3-b%255Dpyridine%2BScaffold%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5366%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00571"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2821</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00571" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Forster&quot;},{&quot;first_name&quot;:&quot;Apirat&quot;,&quot;last_name&quot;:&quot;Chaikuad&quot;},{&quot;first_name&quot;:&quot;Teodor&quot;,&quot;last_name&quot;:&quot;Dimitrov&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Döring&quot;},{&quot;first_name&quot;:&quot;Julia&quot;,&quot;last_name&quot;:&quot;Holstein&quot;},{&quot;first_name&quot;:&quot;Benedict-Tilman&quot;,&quot;last_name&quot;:&quot;Berger&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Gehringer&quot;},{&quot;first_name&quot;:&quot;Kamran&quot;,&quot;last_name&quot;:&quot;Ghoreschi&quot;},{&quot;first_name&quot;:&quot;Susanne&quot;,&quot;last_name&quot;:&quot;Müller&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Knapp&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;A. Laufer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5350-5366&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00571&quot;},&quot;abstract&quot;:&quot;Janus kinases are major drivers of immune signaling and have been the focus of anti-inflammatory drug discovery for more than a decade. Because of the invariable colocalization of JAK1 and JAK3 at cytokine receptors, the question if selective JAK3 inhibition is sufficient to effectively block downstream signaling has been highly controversial. Recently, we discovered the covalent-reversible JAK3 inhibitor FM-381 (23) featuring high isoform and kinome selectivity. Crystallography revealed that this inhibitor induces an unprecedented binding pocket by interactions of a nitrile substituent with arginine residues in JAK3. Herein, we describe detailed structure–activity relationships necessary for induction of the arginine pocket and the impact of this structural change on potency, isoform selectivity, and efficacy in cellular models. Furthermore, we evaluated the stability of this novel inhibitor class in in vitro metabolic assays and were able to demonstrate an adequate stability of key compound 23 for in vivo u&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00571&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00571" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00571&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00571" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00571&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00571" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00571&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00571&amp;href=/doi/10.1021/acs.jmedchem.8b00571" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00571" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00571" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00571%26sid%3Dliteratum%253Aachs%26pmid%3D29852068%26genre%3Darticle%26aulast%3DForster%26date%3D2018%26atitle%3DDevelopment%252C%2BOptimization%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BCovalent-Reversible%2BJAK3%2BInhibitors%2BBased%2Bon%2Ba%2BTricyclic%2BImidazo%255B5%252C4-d%255Dpyrrolo%255B2%252C3-b%255Dpyridine%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5350%26epage%3D5366%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Volume 61, Issue 12"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Volume 61, Issue 12"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Janus kinases are major drivers of immune signaling and have been the focus of anti-inflammatory drug discovery for more than a decade. Because of the invariable colocalization of JAK1 and JAK3 at cytokine receptors, the question if selective JAK3 inhibition is sufficient to effectively block downstream signaling has been highly controversial. Recently, we discovered the covalent-reversible JAK3 inhibitor FM-381 (<b>23</b>) featuring high isoform and kinome selectivity. Crystallography revealed that this inhibitor induces an unprecedented binding pocket by interactions of a nitrile substituent with arginine residues in JAK3. Herein, we describe detailed structure–activity relationships necessary for induction of the arginine pocket and the impact of this structural change on potency, isoform selectivity, and efficacy in cellular models. Furthermore, we evaluated the stability of this novel inhibitor class in <i>in vitro</i> metabolic assays and were able to demonstrate an adequate stability of key compound <b>23</b> for <i>in vivo</i> use.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The four Janus kinases JAK1, JAK2, JAK3, and TYK2 form a small subfamily of cytosolic tyrosine kinases with pivotal importance for the signal transduction of interleukins (ILs), interferons (IFNs), and other cytokines.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> As nonreceptor tyrosine kinases, JAKs bind to the activated cytokine receptors transmitting extracellular signals by phosphorylation of signal transducers and activator of transcription (STAT) proteins. The phosphorylated STAT proteins dimerize, translocate to the nucleus, and act as transcription factors affecting many cellular functions.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although each JAK fulfills important functions in hematological and immunological pathways, the JAK3 isoform features some unique properties compared to the other family members. While JAK1, JAK2, and TYK2 are found in many different cell types and tissues, the expression of JAK3 is mainly restricted to leukocytes having a key role in the development and maturation of T-cells, B-cells, and natural killer (NK) cells.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Therefore, JAK3 knockout or loss-of-function mutations in the kinase- or receptor-genes result in the phenotype of severe combined immunodeficiency (SCID), a general immunological disorder characterized by a complete absence of T- and NK-cells. Besides these serious consequences in the immune system, SCID patients are not affected by other defects highlighting the isolated role of JAK3 in immune signaling.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> This suggests that JAK3-selective inhibition may be a valuable therapeutic strategy to achieve immunosuppression with less adverse effects compared to known immunosuppressive panJAK inhibitors.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> However, none of the disease causing JAK3 mutations are localized to the catalytic domain and the invariant colocalization of JAK3 with JAK1 suggests that inhibition of JAK3 catalytic activity may not be sufficient for full inhibition of this signaling pathway.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In recent years it has been therefore fiercely discussed among medicinal chemists whether specific inhibition of JAK3 catalytic activity would be sufficient to achieve immunosuppression or if concomitant inhibition of JAK1 is required to abrogate cytokine signaling.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Mouse models largely confirmed the SCID phenotype, but catalytically inactive JAK3 variants that could shed light on the scaffolding role of JAK3 in the activated receptor–kinase complexes have not been generated in mice so far. To validate the usefulness of selective inhibition, much effort has been undertaken in the past decade by industry as well as academia to develop isoform specific inhibitors,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> and a number of inhibitors with different selectivities within the JAK family are under clinical investigation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Currently, the most prevalent inhibitors for interrogating JAK-dependent signaling are baricitinib and tofacitinib (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which are both approved as second-line treatment for rheumatoid arthritis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Contrary to initial reports claiming it to be JAK3 specific, <b>1</b> is a panJAK inhibitor making it unsuitable to address the JAK1 vs JAK3 signaling issue.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Another prominent JAK3 inhibitor is NIBR3049 (<b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which shows a more favorable isoform selectivity profile with a 130- to 1000-fold specificity for JAK3 vs JAK1, JAK2, and TYK2, respectively. However, this compound potently inhibits several off-targets within the kinome (namely, PKCα, PKCθ, and GSK3β) in the lower nanomolar range.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Due to the high structural similarity of the four JAKs, the design of isoform specific inhibitors is a demanding task. One of the few essential structural differences is a cysteine residue (C909) located in the solvent exposed front part of the ATP binding pocket, which is exclusively found in JAK3. The latter is replaced by a serine in the three other isoforms of the kinase family.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The presence of a cysteine in the proximity of the ATP binding site provides the opportunity to achieve selectivity by covalent targeting with electrophilic inhibitors.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> This concept was pursued by many groups in the last years, and the highly selective JAK3 inhibitors, which originated from these efforts, have been recently reviewed.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24 ref25 ref26">(20−26)</a> In 2016, we reported the discovery of FM-381 (<b>23</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a covalent-reversible JAK3 inhibitor with an outstanding selectivity within the JAK family and the whole kinome.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This compound has been included in the Structural Genomics Consortium’s (SGC) Chemical Probe pool<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and has been rated as a “4-Star-Probe” in the Chemical Probe Portal<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> as a selective tool for the elucidation of JAK3 dependent signaling. In this article, we provide an expanded insight into the structure–activity relationships (SARs) and further investigations of physicochemical and metabolic properties of the underlying inhibitor class.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of known reference JAK inhibitors discussed in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> JAK3 Structure–Activity Relationships</h3><div class="NLM_p">During the analysis of the X-ray structure of JAK3 in complex with compound <b>23</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWM">5LWM</a>), we discovered a new binding pocket induced by the nitrile substituent of the inhibitor’s α-cyanoacrylamide warhead (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). This cavity is located in close proximity to the covalently targeted C909 and is formed by significant rearrangement of two arginine side chains (R911 and R953). So far, this induced-fit binding pocket was only observed in the crystal structures of compound <b>23</b> and a close analogue (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWN">5LWN</a>), while it is not present in any other JAK3 structure deposited in the PDB (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To get a more detailed insight into the SARs regarding this “arginine pocket” and to evaluate its impact on potency and selectivity, we iteratively modified the electrophilic warhead of compound <b>23</b> by removal of the nitrile or the amide group from the α-cyanoacrylamide motif or by saturation of the α,β-double bond. These structural modifications were applied to different linkers (<i>para</i>-/<i>meta</i>-phenyl and 2,5-furyl) to cover all relevant angles between the hinge-binding motif and the side chain directed toward R911. The compounds were initially tested in our activity-based in-house ELISA<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> to evaluate JAK3 inhibition on the isolated enzyme (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In this assay format, both reference compounds <b>1</b> and <b>2</b> demonstrated excellent JAK3 potency in the lower nanomolar range with IC<sub>50</sub> values of 3.5 nM for <b>1</b> and 11 nM for <b>2</b>, respectively. The first investigated compound series were acrylamides and their corresponding saturated analogues. For both, the <i>meta</i>- and <i>para</i>-phenyl linkers, the corresponding acrylamide derivatives <b>3</b>, <b>4</b>, <b>6</b>, and <b>7</b> exhibited only moderate to weak inhibitory activity, ranging from micromolar to triple-digit nanomolar IC<sub>50</sub> values. However, it is worth mentioning that primary amide <b>3</b> precipitated under the assay conditions due to an insufficient aqueous solubility. Saturation of the double bond and therefore inactivation of the Michael system (compounds <b>12</b>, <b>13</b>, <b>15</b>, and <b>16</b>) gave IC<sub>50</sub> values in similar range with a maximally 3-fold decrease in activity, which was not substantial enough to assume a covalent targeting of C909 by this inhibitor class. These subtle changes are more probably caused by entropic effects due to the increased flexibility of the saturated alkyl chain. The replacement of the phenyl linker by a 2,5-disubstituted furan moiety generally resulted in better inhibitory activities. While a similar 3-fold decrease in potency was observed for the saturated dimethylamide analogue <b>17</b> (IC<sub>50</sub> = 181 nM) compared to the parent dimethylacrylamide <b>8</b> (IC<sub>50</sub> = 51 nM), the primary amides <b>5</b> and <b>14</b> surprisingly showed the reversed trend with IC<sub>50</sub> values of 129 nM for acrylamide <b>5</b> and 59 nM for the saturated derivate <b>14</b>. This somewhat better potency of <b>14</b> may be explained by the formation of an intramolecular hydrogen bond between the primary amide and the furan oxygen atom. This would result in a reduced flexibility and hydration and therefore have a positive entropic effect and less desolvation penalty.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Compound <b>23</b> bound to JAK3 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWM">5LWM</a>). (b) Compound <b>1</b> bound to JAK3 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>). Comparison of the protein surfaces surrounding C909 (illustrated as ball/stick) shows that <b>23</b> induces a distinct binding pocket by interaction of the nitrile substituent and R911. The cavity is generated by significant rearrangement of the side chains of R911 and R953.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. ELISA-Based JAK3 Inhibition Data<a class="ref internalNav" href="#t1fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0008.gif" alt="" id="GRAPHIC-d113e606-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0009.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>*</sup></sup><p class="last">IC<sub>50</sub> values are calculated from the results of an ELISA.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>a</sup></sup><p class="last">Average ± SD (<i>n</i> = 18).</p></div><div class="footnote" id="t1fn3"><sup><sup>b</sup></sup><p class="last">Average ± SEM (<i>n</i> = 3).</p></div><div class="footnote" id="t1fn4"><sup><sup>c</sup></sup><p class="last">Precipitation from aqueous assay buffer.</p></div><div class="footnote" id="t1fn5"><sup><sup>d</sup></sup><p class="last">Arylidene dinitriles show unspecific reactivity with assay buffer components.</p></div></div><div></div></div><div class="NLM_p">In a second series, the amide function was replaced by a cyano substituent leading to acrylonitriles <b>9</b>–<b>11</b> and the corresponding saturated analogues <b>18</b>–<b>20</b>. The para-substituted phenyl linker again provided only moderate inhibition levels with IC<sub>50</sub> values around 400 nM for the unsaturated and saturated derivatives <b>9</b> and <b>18</b>. In contrast, a 4-fold difference in JAK3 inhibition was determined for the corresponding <i>meta</i>-phenyl linked acrylonitrile <b>10</b> (IC<sub>50</sub> = 135 nM) and its saturated analog <b>19</b> (IC<sub>50</sub> = 505 nM). Moreover, <b>10</b> exhibited a significantly lower IC<sub>50</sub> compared to the corresponding amide derivatives <b>4</b> and <b>7</b> (IC<sub>50</sub> values of 470 and 548 nM, respectively). Again, the furyl linker yielded the most potent JAK3 inhibition within this series with IC<sub>50</sub> values of 27 nM for acrylonitrile <b>11</b> and 129 nM for alkylnitrile <b>20</b>. To elucidate the role of the nitrile substituent, X-ray structures were determined for compounds <b>10</b>, <b>11</b>, and <b>20</b> in complex with JAK3 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). All compounds showed a binding mode similar to <b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a) with two hydrogen bonds formed with the backbone of the hinge residues E903 and L905. The cyclohexyl moiety occupies the region of the ATP binding pocket. The linker is orientated toward the solvent exposed front part of the catalytic cleft, positioning the nitrile substituents in close proximity to C909, R911, and R953. The alkylnitrile side chain of <b>20</b> showed no directed interactions to these residues (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c), and the conformation of R911 and R953 was comparable to that seen in the X-ray structure of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). In sharp contrast, both acrylonitriles <b>10</b> and <b>11</b> induce the formation of the arginine pocket and interact with R911 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,b) in the same way as observed in the crystal structure of <b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). These structural models together with the assay data demonstrated that both the furan linker as well as the acrylonitrile substituent and the resulting formation of the arginine pocket are two distinct factors positively influencing JAK3 inhibitory potency.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Compound <b>10</b> bound to JAK3 (PDB: 6GL9). (b) Compound <b>11</b> bound to JAK3 (PDB: 6GLA). (c) Compound <b>20</b> bound to JAK3 (PDB: 6GLB). Acrylonitriles <b>10</b> and <b>11</b> induce the arginine pocket as observed in the JAK3 complex with compound <b>23</b>. Saturated alkylnitrile <b>20</b> was not able to induce this cavity, and R911 and R953 shared similar conformation as observed in the crystal structure of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a third series, we combined the nitrile and amide substituents resulting in cyanoacrylamides, a compound class, which was previously described as covalent-reversible Michael acceptors.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Comparison of inhibitory activities of compounds <b>21</b>, <b>22</b>, and <b>23</b> with the corresponding acrylonitriles <b>9</b>, <b>10</b>, and <b>11</b> reveals that only the furan-linked compound <b>23</b> benefits from the additional electron-withdrawing effect of the amide group. While phenyl linked compounds <b>21</b> and <b>22</b> only show low to moderate JAK3 inhibition (IC<sub>50</sub> values of 571 and 205 nM, respectively), compound <b>23</b> exhibits an IC<sub>50</sub> value of 9 nM, which is close to the lower resolution limit of the applied ELISA. Further modifications of the dimethyl amide of <b>23</b>, like truncation of a methyl group (<b>24</b>) or replacement by an <i>N</i>-methylpiperazine (<b>28</b>), were also well tolerated and resulted in low nanomolar IC<sub>50</sub> values (23 and 14 nM for <b>24</b> and <b>28</b>, respectively). The observed significant difference in the inhibitory potency of <b>23</b> compared to <b>22</b> suggested that covalent bond formation with C909 was limited to the furan-linked <b>23</b> and not possible with the phenyl bearing <b>22</b>. Although there was no covalent bond observed in the X-ray structure of <b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a), covalent bond formation was observed for a close analogue of <b>23</b> by mass spectroscopic and crystallographic data as reported earlier.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Moreover, comparison of the X-ray structures of <b>10</b>, <b>11</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,b), and <b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a) revealed significant differences in the dihedral angles along the α,β-double bond of the Michael system. While the usual trans angle of 180° (measured as 179° and 178°) was retained in the structures of <b>10</b> and <b>11</b>, the double bond of <b>23</b> was fairly distorted with a dihedral angle of 149°. This out-of-plane conformation of <b>23</b> may be due to interaction with the electrophilic β-carbon atom with the thiol group of C909 leading to bond formation.</div><div class="NLM_p">We further enhanced the electrophilicity of the Michael acceptor in the compounds <b>25</b>–<b>27</b> by replacing the amide function by a second nitrile group. With IC<sub>50</sub> values in the lower nanomolar range, these benzylidene malononitriles were remarkably potent JAK3 inhibitors, and contrary to the corresponding cyanoacrylamides <b>21</b>–<b>23</b>, the linker geometry had a significantly lower influence on potency. It should be mentioned that the structural element of arylidene dinitriles is relatively promiscuous and shows a high reactivity toward any nucleophile. Indeed, subsequent chemical incubation experiments revealed an unspecific reactivity for the highly electrophilic inhibitors <b>25</b>–<b>27</b> toward thiol nucleophiles. Dithiothreitol (DTT) is a common reductant and an important ingredient of standard kinase assay buffer systems. As an aliphatic thiol, it possesses a nucleophilicity comparable to cysteine and is therefore capable to react in a similar way via Michael addition with electrophilic inhibitors. While no decomposition was observed for inhibitors <b>25</b>–<b>27</b> in methanolic solution, the compounds degraded over time in the presence of DTT-containing kinase assay buffer. In contrast, cyanoacrylamides showed reversible addition of the thiol without any signs of further decomposition (data not shown). Because of the high and unspecific reactivity of the arylidene dinitrile moiety, the inhibitory activity of <b>25</b>–<b>27</b> may not only be attributed exclusively to the interaction with C909 and data obtained with this type of compound should be interpreted carefully. Nevertheless, compounds from this class showed remarkable JAK3 potency and selectivity even in cells or in the presence of thiol-containing buffer (<i>vide supra</i>).</div><div class="NLM_p">For covalent inhibitors, the binding of the ligand can be divided into two steps: first, a reversible binding event, and second, the formation of the covalent bond between electrophile and the cysteine side chain.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Since the initial reversible inhibitor binding is required before a covalent bond to C909 can be formed, it is important that the inhibitor shows not only a high reactivity toward sulfur nucleophiles but also successfully competes with the high intracellular ATP concentrations. In order to evaluate the contributions of reversible versus covalent binding to the overall inhibitory potency of compound <b>23</b>, we modified our lead compound with the goal of modulating the reversible binding affinity while retaining the electrophilic cyanoacrylamide warhead (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The truncation of the cyclohexyl side chain (compound <b>29</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), which fills the ATP binding pocket toward the glycine rich loop, results in an IC<sub>50</sub> value of 368 nM, corresponding to a more than 40-fold loss in potency compared to <b>23</b>. As expected, an even more drastic drop in potency resulted from the methylation of the pyrrole nitrogen atom (compound <b>30</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). This modification prevents the formation of key hydrogen bonds to the hinge region and caused a complete loss of inhibitory activity toward JAK3 even at concentrations up to the micromolar range. These data demonstrated that the high potency of <b>23</b> was not only driven by the covalent interaction with C909, but also originates from strong reversible interactions.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures and inhibition data of compounds <b>29</b> and <b>30</b>. IC<sub>50</sub> values are calculated from the results of an ELISA<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> as average ± SEM (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Kinase Selectivity Profiles</h3><div class="NLM_p">As a next step in the development process, we determined JAK family selectivity profiles of selected compounds of the furyl series in a radiometric assay format carried out at Reaction Biology Corp. (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In this more sensitive assay, reference compound <b>1</b> showed a subnanomolar JAK3 IC<sub>50</sub> value of 0.29 nM and, as expected, poor JAK isoform selectivity as reported earlier.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> While <b>1</b> inhibited JAK1, JAK2, and JAK3 with a similar potency, TYK2 was inhibited to a lower extent. Maleimide <b>2</b> showed a better JAK3 selectivity, comparable with the previously reported data.<a onclick="showRef(event, 'ref11 ref16'); return false;" href="javascript:void(0);" class="ref ref11 ref16">(11,16)</a> Meanwhile, acrylamide <b>8</b> and its saturated analogue <b>17</b> showed significantly higher IC<sub>50</sub> values compared to reference compounds <b>1</b> and <b>2</b> and did not exhibit a noteworthy JAK3 selectivity as well. In contrast, a huge difference in selectivity and potency was observed between acrylonitrile <b>11</b> and its saturated counterpart <b>20</b>. While <b>20</b> featured a similar selectivity profile and moderate potency as the amide derivatives <b>8</b> and <b>17</b>, compound <b>11</b> showed potent JAK3 inhibitory activity equal to <b>1</b> (IC<sub>50</sub> = 0.21 nM) with a 57-, 250-, and 210-fold selectivity against JAK1, JAK2, and TYK2, respectively. This remarkable leap in selectivity together with the crystallographic structural information disfavoring covalent binding of <b>11</b> and <b>20</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,c) provides strong evidence that the induction of the arginine pocket may be an additional key driver for JAK3 selectivity. Nevertheless, the excellent selectivity profile was even further improved when a covalent-reversible Michael acceptor was introduced. Compound <b>23</b> provided an extraordinarily potent JAK3 inhibition (IC<sub>50</sub> = 0.13 nM) combined with good isoform selectivity (400-, 2700-, and 3600-fold vs JAK1, JAK2, and TYK2, respectively). As mentioned before, we hypothesize that this improved isoform selectivity of <b>23</b> compared to <b>11</b> can be attributed to a synergism between the formation of the arginine pocket and a covalent-reversible interaction to C909 enabled by the additional electron withdrawing effect of the amide group of <b>23</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. JAK Isoform Selectivity for Chosen Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> [nM]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd.</th><th class="colsep0 rowsep0" align="center" char=".">JAK1</th><th class="colsep0 rowsep0" align="center" char=".">JAK2</th><th class="colsep0 rowsep0" align="center" char=".">JAK3</th><th class="colsep0 rowsep0" align="center" char=".">TYK2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">344</td><td class="colsep0 rowsep0" align="char" char=".">578</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2110<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">113</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">183</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">346</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">459</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">668<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">3460<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">2<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">11800<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">188</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">117</td><td class="colsep0 rowsep0" align="char" char=".">765</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="char" char=".">791</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values were calculated from the results of a radiometric assay. Data were obtained as five-dose singlicate IC<sub>50</sub> with 10-fold serial dilution starting at 1 μM. [ATP] = 10 μM.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Starting concentration 50 μM.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">[ATP] = 200 μM.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Arylidene dinitriles show unspecific reactivity with assay buffer components.</p></div></div></div><div class="NLM_p last">It is known that JAK3 has a higher affinity to ATP compared to the other JAK isoforms, which causes a shift in selectivity when the assays are performed at constant and higher ATP concentrations compared to the typically determined data at <i>K</i><sub>m</sub> ATP.<a onclick="showRef(event, 'ref11 ref20'); return false;" href="javascript:void(0);" class="ref ref11 ref20">(11,20)</a> To investigate the ATP dependency of the isoform selectivity of <b>23</b>, IC<sub>50</sub> values were determined at an ATP concentration of 200 μM and revealed a retention of the favorable selectivity profile at this physiologically more relevant ATP concentration. This 20-fold higher ATP concentration better reflects the typical intracellular conditions with even higher ATP levels in the low millimolar range. While under these conditions the JAK3 inhibitory potency of <b>23</b> remained single digit nanomolar (IC<sub>50</sub> = 2 nM), an at least 330-fold selectivity window over JAK1 was observed (IC<sub>50</sub> = 668 nM), and the IC<sub>50</sub> values for JAK2 and TYK2 even increased up to the micromolar range (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). As reported earlier,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> this compound was also screened against the activity based ProQinase panel of 410 kinases and proved to be highly JAK3 selective showing no off-targets at a concentration of 100 nM and only eleven hits with more than 50% inhibition at a higher 500 nM cutoff (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Table S2</a>). Moreover, there was no significant inhibition of the other ten human kinases, which are carrying a cysteine residue at a position equivalent to JAK3.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Derivatization of the amide residue of <b>23</b> maintains a good JAK3 selectivity, as shown by compound <b>28</b> carrying an <i>N</i>-methylpiperazinyl amide. While <b>28</b> shows a slightly weaker inhibition of JAK3 (IC<sub>50</sub> = 0.74 nM) compared to <b>23</b>, it still exhibits a favorable selectivity against the other isoforms with a 160-fold window over JAK1 and an at least 1000-fold selectivity toward JAK2 and TYK2. Despite showing a certain instability in thiol-containing buffer systems as described above, the arylidene dinitrile <b>27</b> also exhibits an evident JAK3 selectivity with a subnanomolar IC<sub>50</sub> of 0.39 nM and a 10- to 470-fold selectivity over the three other isoforms. The moderate isoform selectivity of <b>27</b> may be explained by a fast inactivation of JAK3 via covalent interaction before the highly reactive compound is decomposed in the DTT-containing kinase buffer. Based on these results, the compounds with the most favorable isoform selectivities (compounds <b>11</b>, <b>23</b>, <b>27</b>, and <b>28</b>) were selected for further evaluation in cellular assays and metabolic stability experiments.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cellular Activity and Target Engagement</h3><div class="NLM_p">We used different assay types to assess JAK3 inhibitory potency and selectivity of the selected compounds in a cellular setting. First, we used a NanoBRET assay system to demonstrate target engagement and to confirm isoform selectivity on full length Janus kinases in cells.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This assay system utilizes ectopically expressed nanoluciferase-tagged full-length kinases, which interact with a fluorescent-labeled tracer-molecule binding to the ATP binding site. While the tracer is bound to the kinase, the spatial proximity of the luciferase and the fluorescence dye results in a measurable optical signal via bioluminescence resonance energy transfer (BRET) upon substrate addition. The luminescence signal is diminished when the tracer is replaced from the ATP binding site by increasing concentrations of the tested inhibitor, hence allowing the determination of EC<sub>50</sub> values on full-length kinases in cellular environments. We performed these assays for JAK1, JAK2, and JAK3 to confirm isoform selectivity and additionally for Bruton’s tyrosine kinase (BTK), which is a likely off-target of covalent JAK3 inhibitors since it possesses a cysteine at an equivalent position to C909 in JAK3.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> For compounds <b>23</b> and <b>28</b>, which showed the best selectivity profiles within the JAK family (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), isoform selectivity was confirmed in the cellular environment. While JAK3 EC<sub>50</sub> values of 237 and 257 nM, respectively, were observed, the activities of the other two JAK isoforms, JAK1 and JAK2, were not influenced up to inhibitor concentrations of 10 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Inhibition of BTK was detected only at very high concentrations of <b>28</b> (above 50 μM) but not for compound <b>23</b>, which is in accordance with the kinome selectivity data reported previously. For compounds <b>11</b> and <b>27</b>, the JAK3 EC<sub>50</sub> values shifted to the higher nanomolar range in this cellular assay (745 and 670 nM, respectively, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), suggesting a lower permeability for <b>11</b> and <b>27</b> when comparing these data to the IC<sub>50</sub> values on the isolated enzyme (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). While <b>11</b> still shows no significant binding to JAK1, it only exhibits a less pronounced 10-fold selectivity over JAK2. However, the arylidene dinitrile <b>27</b> demonstrated only 10-fold selectivity over JAK1, while it hits JAK2 with a similar potency as JAK3 (EC<sub>50</sub> = 630 μM, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compared to the cyanoacrylamides <b>23</b> and <b>28</b>, these compounds show a slightly higher affinity toward BTK with EC<sub>50</sub> values of 13.3 and 5.8 μM for <b>11</b> and <b>27</b>, respectively. The observed BTK selectivity of the tested compounds may be achieved by the residue inducing the arginine pocket. As we reported earlier,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> none of the ten other human kinases with a cysteine equivalent to C909 in JAK3 possesses an arginine at the position of R911, which may be a mandatory requirement for the induction of this cavity. The slightly less pronounced selectivity of acrylonitrile <b>11</b> compared to cyanoacrylamides <b>23</b> and <b>28</b> may be explained by the missing covalent interaction to C909 as shown by the X-ray experiments described above. In summary, these data clearly demonstrated cellular target engagement along with a high selectivity for JAK3 for the cyanoacrylamide based inhibitors.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative BRET data measured on JAK3 kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cellular EC<sub>50</sub> Values Determined by nanoBRET</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">EC<sub>50</sub> [nM]<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd.</th><th class="colsep0 rowsep0" align="center" char=".">JAK1</th><th class="colsep0 rowsep0" align="center" char=".">JAK2</th><th class="colsep0 rowsep0" align="center" char=".">JAK3</th><th class="colsep0 rowsep0" align="center" char=".">BTK</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">7710</td><td class="colsep0 rowsep0" align="char" char=".">740</td><td class="colsep0 rowsep0" align="char" char=".">13300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">237</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">7660</td><td class="colsep0 rowsep0" align="char" char=".">630</td><td class="colsep0 rowsep0" align="char" char=".">678</td><td class="colsep0 rowsep0" align="char" char=".">5790</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">257</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values were calculated from a nonlinear least-square fit using BRET ratios measured at eleven different inhibitor concentrations.</p></div></div></div><div class="NLM_p">To study the effect of our compounds on the JAK/STAT pathway in a physiologically more relevant model, we measured the dose-dependent inhibition of STAT phosphorylation in primary human T-cells. Therefore, CD4<sup>+</sup> T-cells were incubated with increasing compound concentrations and stimulated with different cytokines that associate with certain JAKs. The STAT phosphorylation levels were determined by immunoblotting after cell lysis (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of cytokine-induced STAT-phosphorylation of selected compounds. Human CD4<sup>+</sup> T-cells were incubated with the indicated concentrations of <b>1</b>, <b>2</b>, <b>11</b>, <b>23</b>, <b>27</b>, or <b>28</b> for 1 h followed by 30 min stimulation with single cytokines. The cells were lysed, and the pSTAT levels were determined via immunoblotting. Actin was coblotted to ensure equal loadings. IL-2 activates JAK1/3-dependent STAT5 phosphorylation (A), IL-4 activates JAK1/3-dependent STAT6 phosphorylation (B), IL-6 activates JAK1/JAK2/TYK2-dependent STAT3 phosphorylation (C), and IFN-α activates JAK1/TYK2-dependent STAT1 phosphorylation (D). The cellular assays/immunoblots for <b>1</b> and <b>23</b> were performed in a separate experiment as published previously<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> than the tests/blots for <b>2</b>, <b>11</b>, <b>27</b>, and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We previously reported the results of <b>1</b> in this assay<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and confirmed the panJAK inhibitory activity of this reference compound.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> While <b>1</b> diminished the JAK1- and JAK3-dependent STAT phosphorylations after IL-2 or IL-4 stimulation in concentrations between 50 and 300 nM, it also decreased JAK1/JAK2/TYK2-dependent signaling at concentrations above 300 nM. Compound <b>2</b> only showed an effect on JAK-mediated signaling after stimulation with IL-2 indicated by a weak inhibition of STAT5 phosphorylation at a concentration of 300 nM, while no effect was seen at concentrations up to 1 μM after stimulation with the three other cytokines. These rather low cellular activities are consistent with the previously described data for this reference compound, which initially seeded the controversial conclusion that JAK1 has a dominant role over JAK3.<a onclick="showRef(event, 'ref9 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref16">(9,16)</a></div><div class="NLM_p">The putative reversible acrylonitrile-derived inhibitor <b>11</b> showed a moderate JAK3 selectivity significantly inhibiting the JAK3-dependent phosphorylations of STAT5 and STAT6 with concentrations from 100 to 300 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B), while IFN-α induced STAT1 phosphorylation was only weakly inhibited at 1000 nM, and IL-6 dependent pSTAT3 levels were not decreased at the same concentration (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D).</div><div class="NLM_p">The arylidene dinitrile <b>27</b> exhibited a somewhat weaker inhibition of the JAK1/3-dependent STAT phosphorylation with a significant inhibition of IL-2 signaling, but no effect on the IL-4 triggered pathway at the highest tested concentration of 300 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B). Since <b>27</b> showed significant binding to JAK2 in the BRET assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), it is not surprising that it also weakly inhibited JAK1/JAK2/TYK2-dependent STAT3 phosphorylation at the highest concentration of 1000 nM, while sparing JAK1/TYK2-dependent STAT1 phosphorylation (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). It should be noted that, despite the aforementioned unselective thiol reactivity, compound <b>27</b> is still able to achieve a weak but evident selectivity for the inhibition of JAK3-dependent signaling pathways in this functional cell assay.</div><div class="NLM_p last">A more pronounced JAK3 selectivity was demonstrated for cyanoacrylamides <b>23</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>28</b> showing significant inhibition of IL-2 induced STAT5 phosphorylation at concentrations around 50 to 100 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A) and blockade or reduction of IL-4 induced STAT6 phosphorylation at concentrations around 300 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). At the same time, the JAK3-independent IL-6 and IFN-α pathways are not influenced by <b>23</b> and <b>28</b> even at concentrations up to 1000 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). These results are in good agreement to the initially shown cellular selectivity from the BRET assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), and the outcome from these stimulation experiments demonstrates in a semiquantitative manner that highly selective JAK3 inhibition is sufficient to effectively abrogate the downstream signaling of γ<sub>c</sub> cytokines.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Solubility and Metabolic Stability</h3><div class="NLM_p">Aiming for an <i>in vivo</i> use of our new JAK3 probes, we next focused on physicochemical and metabolic properties of selected compounds. During the work on this structure class, we recognized that the developed inhibitors showed limited solubility. Indeed, the aqueous solubility of key compound <b>23</b> determined in phosphate buffered saline (PBS) at a physiological pH of 7.4 proved to be fairly low (24 mg/L or 56 μM, respectively). An improved solubility was achieved by replacing the dimethyl amide residue by a more polar <i>N</i>-methylpiperazine amide (compound <b>28</b>), which would be protonated under physiological conditions. Since this residue is not responsible for critical interactions with the kinase, this transformation maintained the good potency and selectivity as described before (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) while resulting in a 5-fold increase in aqueous solubility to 120 mg/L or 248 μM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In Vitro</i> Stability and Solubility of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd.</th><th class="colsep0 rowsep0" align="center" char="±">MLM stability<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> [%] ± SD</th><th class="colsep0 rowsep0" align="center" char="±">HWB stability<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> [%] ± SD</th><th class="colsep0 rowsep0" align="center" char=".">aqueous solubility<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> [mg/L]/[μM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">53.9 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">98.8 ± 3.6</td><td class="colsep0 rowsep0" align="center" char=".">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char="±">58.0 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">49.4 ± 1.7</td><td class="colsep0 rowsep0" align="center" char=".">24/56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char="±">11.0 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="center" char=".">n.d.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char="±">6.9 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">47.0 ± 1.2</td><td class="colsep0 rowsep0" align="center" char=".">120/248</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Percentage of residual compound after 180 min incubation with mouse liver microsomes.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Percentage of residual compound after 180 min incubation with human whole blood.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Aqueous solubility in PBS puffer pH 7.4.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">n.d. = not determined.</p></div></div></div><div class="NLM_p">The <i>in vitro</i> stability of the compounds <b>11</b>, <b>23</b>, <b>27</b>, and <b>28</b> was tested in mouse liver microsomes (MLM) as well as in human whole blood (HWB). While compounds <b>27</b> and <b>28</b> undergo fast degradation in the microsomal stability assay with only a small amount (ca. 10%) remaining intact at the 3 h end point, compounds <b>11</b> and <b>23</b> showed a favorable microsomal stability with more than 50% of the parent compound remaining after 3 h of incubation (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Mass spectrometric analysis of the metabolites suggested the main metabolic transformations to be hydroxylation, hydrolysis of the nitrile to an amide, and dealkylation of the cyclohexyl side chain or the amide residues of <b>23</b> and <b>28</b>. The fast decomposition of <b>28</b> is probably due to the cleavage of the metabolically vulnerable <i>N</i>-methylpiperazine moiety, which most probably undergoes demethylation as well as ring opening. Since this moiety is not required for critical interactions to the kinase, the metabolites originating from transformation of the piperazine ring are likely to retain JAK3 inhibitory activity. However, this remains speculative since the identification of possible metabolites of <b>28</b> and the determination of their biological activity were not within the scope of this study.</div><div class="NLM_p">To assess the general stability of the electrophilic inhibitors in a medium with a high content of endogenous nucleophiles, we incubated the compounds with human whole blood (HWB) and determined the residual amount of parent compound after 3 h via mass spectrometry. As in the microsomal stability assay, the arylidendinitrile <b>27</b> demonstrated a very low stability under these conditions with only 1.5% of the parent substance left after 3 h of incubation. This poor overall stability of <b>27</b> can be most probably attributed to the very high electrophilicity of the dinitrile Michael system and the high intrinsic reactivity of this functional group. In contrast, the simple acrylonitrile <b>11</b> showed a good stability in the HWB assay and was only marginally degraded at the 3 h end-point of the stability assay (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Cyanoacrylamides <b>23</b> and <b>28</b> both demonstrated a lower but still favorable whole blood stability with a half-life of around 3 h (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p last">Since key compound <b>23</b> exhibited favorable stability in both assays combined with an excellent JAK3 potency and selectivity, we consider it the most promising candidate for <i>in vivo</i> studies within this inhibitor class.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We previously reported the synthesis of <b>23</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which was slightly modified to allow a more convenient access to gram quantities of key intermediates and final compounds. The synthetic route to compounds <b>3</b>–<b>28</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and starts from commercially available 4-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. After tosyl protection and nitration in position 5 under mild anhydrous conditions, the cyclohexyl side chain was introduced via a nucleophilic aromatic substitution. Catalytic hydrogenation afforded key intermediate <b>34</b>, which is unsuitable for long-term storage under ambient conditions and should be used in the next step immediately. Closure of the imidazole ring was achieved by condensation with the corresponding aldehydes under oxidative conditions in wet DMF.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Benzylic alcohols <b>35</b> and <b>36</b> were initially transformed to the corresponding aryl carbaldehydes <b>38</b> and <b>39</b> via Dess–Martin oxidation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, since this reaction can be problematic on a multigram scale, it was replaced by a catalytic Stahl oxidation<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> for the conversion of furan derivative <b>37</b> to aldehyde <b>40</b>. Intermediates <b>41</b>–<b>43</b> were obtained by tosyl cleavage with methanolic KOH at ambient temperature. Acrylamides <b>3</b>–<b>8</b> were accessible via a LiCl-promoted Horner–Wadsworth–Emmons (HWE) reaction according to a protocol modified from Blanchette et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The saturated analogues were prepared from the corresponding acrylamides by catalytic hydrogenation on Pd/C. Nitriles <b>9</b>–<b>11</b> and <b>18</b>–<b>20</b> were synthesized from the corresponding primary amides by dehydration with cyanuric chloride in DMF.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Cyanoacrylamide- and malononitrile-derived inhibitors <b>21</b>–<b>28</b> were obtained from aldehydes <b>41</b>–<b>43</b> under Knoevenagel conditions with the corresponding cyanoacetamides or malononitrile. The cyanoacetamides for the synthesis of <b>24</b> and <b>28</b> were obtained via aminolysis of ethyl cyanoacetate (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Supporting Information</a>). Compound <b>29</b> was synthesized following the same procedures described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, but using aqueous methylamine solution instead of cyclohexylamine for S<sub>N</sub>Ar (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Supporting Information</a> for detailed procedures). Methylated compound <b>30</b> was prepared by reacting <b>23</b> with methyl iodide after deprotonation with NaH in DMF (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of JAK Inhibitors <b>3</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) NaH, TsCl, THF, 0 °C to rt, 93%; (ii) Me<sub>4</sub>N·NO<sub>3</sub>, TFAA, DCM, 0–5 °C, 67%; (iii) cyclohexylamine, Et<sub>3</sub>N, <i>i</i>PrOH, reflux, 94%; (iv) Pd/C, H<sub>2</sub>, MeOH/EtOAc, 50 °C, quant; (v) corresponding aldehyde, KHSO<sub>5</sub>, DMF/H<sub>2</sub>O, rt, 68–72%; (vi) DMP, DCM, rt, 80–92%; (vii) Cu(MeCN)<sub>4</sub>·OTf, TEMPO, bpy, NMI, O<sub>2</sub>, MeCN, 50 °C, 87%; (viii) KOH, MeOH, rt, 54–75%; (ix) corresponding HWE-reagent, LiCl, DBU, MeCN/CHCl<sub>3</sub>, 54–88%; (x) Pd/C, H<sub>2</sub>, MeOH/EtOAc, rt, 60–95%; (xi) corresponding cyanoacetamide or malononitrile, piperidine, MeOH, 60 °C, 20–93%; (xii) cyanuric chloride, DMF, rt, 50–81%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein, we report our efforts to elucidate the role of a ligand-induced binding pocket in JAK3 formed by interactions of arginine residues with a nitrile substituent, which was initially observed for cyanoacrylamide-based inhibitors. Our recently described covalent-reversible inhibitor <b>23</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> was iteratively modified to establish detailed SARs regarding this previously unknown “arginine pocket”, and we were able to show a correlation between inhibitor selectivity and the formation of this cavity. With compound <b>11</b>, we demonstrated via X-ray crystallography and <i>in vitro</i> profiling that a significant JAK3 selectivity can be achieved by induction of the arginine pocket even without covalent bond formation to the JAK3-specific C909. The application of nitrile-bearing covalent-reversible warheads resulted in a positive synergism of both selectivity vectors and yielded a set of JAK3 inhibitors with an extraordinarily high potency and isoform selectivity. The favorable selectivity profile of the compounds <b>11</b>, <b>23</b>, <b>27</b>, and <b>28</b> was further validated in several cellular assays demonstrating target engagement in engineered cells as well as selective inhibition of JAK3-dependent downstream signaling in functional human T-cells. Our data also indicate that a highly selective inhibition of JAK3 is sufficient to abrogate JAK1/3 dependent STAT-phosphorylation without the need of a simultaneous JAK1 inhibition. This is in good agreement with recent data from other groups, who investigated this issue and even provided some <i>in vivo</i> data.<a onclick="showRef(event, 'ref20 ref26 ref40'); return false;" href="javascript:void(0);" class="ref ref20 ref26 ref40">(20,26,40)</a> Compound <b>23</b> exhibited an acceptable stability profile in two <i>in vitro</i> metabolism assays, while bioavailability remains to be shown. These studies are ongoing and will be published in due course. In summary, our SAR study revealed that the well-characterized cyanoacrylamide <b>23</b> is currently the most optimized candidate from this series. This compound is a promising tool, complementing the existing irreversible acrylamide-based inhibitors by a covalent-reversible mode of action and may be suitable to investigate the effects of highly selective JAK3 inhibition <i>in vivo</i>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Protein Expression and Structure Determination</h3><div class="NLM_p last">Recombinant JAK3 was purified as previously described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The protein was mixed with 1 mM inhibitors and 0.26% <i>N</i>-phenylurea. Crystallization was performed using sitting-drop vapor diffusion method at 4 °C and the reservoir solution containing 24–30% PEG 3350, 0.1 M MES, pH 5.5–6.0 and 0.1–0.2 M MgCl<sub>2</sub>. Diffraction data were collected at Diamond Light Source, beamline i03, using X-ray at wavelength of 0.97623 Å, and were processed and scaled with XDS and Scala, respectively.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> Structure solutions were obtained by molecular replacement method using Phaser<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and the published JAK3 coordinates.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Manual Model rebuilding alternated with refinement were performed in COOT and REFMAC.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Geometric correctness was verified using MOLPROBITY.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The data collection and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Supplemental Table S1</a>. Visualization of X-ray crystallographic data and preparation of images was performed with PyMol.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> JAK1/2/3 and BTK NanoBRET Assays</h3><div class="NLM_p last">Assays were performed essentially as described previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In brief: Full-length JAK1, JAK2, JAK3, and BTK ORF (Promega) cloned in frame with a C-terminal NanoLuc-fusion were transfected into HEK cells, and proteins were allowed to express for 20 h. Serially diluted inhibitor and NanoBRET Kinase Tracer-04 (Promega) at 1 μM for JAK1, Tracer-05 (Promega) at 2 μM for JAK2/JAK3, and at 1 μM for BTK, respectively, were pipetted into white 384-well plates (Greiner 781 207). The corresponding JAK1/JAK2/JAK3 or BTK-transfected cells were added and reseeded at a density of 2 × 10<sup>5</sup> cells per well after trypsinization and resuspending in Opti-MEM without phenol red (Life Technologies). The system was allowed to equilibrate for 2 h at 37 °C/5% CO<sub>2</sub> prior to BRET measurements. To measure BRET, NanoBRET NanoGlo Substrate + Extracellular NanoLuc Inhibitor (Promega) was added as per the manufacturer’s protocol, and filtered luminescence was measured on a CLARIOstar plate reader (BMG Labtech) equipped with 450 nm BP filter (donor) and 610 nm LP filter (acceptor). Competitive displacement data were then graphed using GraphPad Prism software using a four-parameter curve fit with the following equation:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_m001.gif" alt="" id="_i18" /></img></span></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> CD4<sup>+</sup> T-cell Stimulations</h3><div class="NLM_p last">The stimulation experiments were carried out following the same procedure reported previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> CD4<sup>+</sup> T cells were purified from human PBMCs using magnetic cell separation technology (Miltenyi Biotec) followed by activation with plate-bound anti-CD3 (clone UCHT1) and anti-CD28 (clone CD28.2) antibodies (each 5 μg/mL, Biolegend) in XVIVO 15 medium (Lonza) for 3 days and expanded with rhIL-2 for another 6 days. After expansion, T cells were washed and rested in fresh medium overnight. Equal numbers of T cells were incubated with the indicated concentrations of compounds <b>1</b>, <b>2</b>, <b>11</b>, <b>23</b>, <b>27</b>, and <b>28</b> in DMSO or DMSO alone (control) for 1 h and then stimulated with rhIL-2 (50 ng/mL; Proleukin, Novartis), rhIL-6 (50 ng/mL; Peprotech), rhIL-4 (50 ng/mL, Peprotech), or IFN-α (1000 U/ml, Roche) for 30 min. After stimulation, cells were lysed in Triton X-100 lysis buffer containing protease and phosphatase inhibitors. Equal amounts of total protein were separated by PAGE, transferred to PVDF membrane, and blotted with Abs recognizing actin (Merck Millipore), specific phospho-STAT antibodies (antiphospho-Stat5 Tyr694, antiphospho-Stat3 Tyr705, both Cell Signaling), and IRDye-labeled secondary antibodies (680RD, 800CW, both LI-COR Biosciences) for detection. Specific bands were visualized using an Odyssey infrared imaging system (LI-COR Biosciences).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> MLM Stability</h3><div class="NLM_p last">Murine liver microsomes (1 mg/mL), a NADPH-regenerating system (5 mM glucose-6-phosphate, 5 U/mL glucose-6-phosphate-dehydrogenase, and 1 mM NADP<sup>+</sup>), and 4 mM MgCl<sub>2</sub> in 0.1 M Tris-buffer (pH = 7.4) were preincubated for 5 min at 37 °C. The reaction was started by the addition of the analyte (100 μM) and incubation was continued at 37 °C. At defined time points, 50 μL aliquots were quenched by the addition of a precooled solution of 100 μL of internal standard (100 μM) in MeCN. The samples were vortexed, sonicated for 30 min, and centrifugated. The supernatant was directly used for quantitative determination via LC–MS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> HWB Stability</h3><div class="NLM_p last">Determination of human whole blood stability was carried out following a similar procedure described previously by Thorarensen et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Fresh human whole blood (EDTA) from two healthy male subjects were incubated at 37 °C followed by the addition of the analytes to a final concentration of 1 μM. Incubation was continued at 37 °C, and 100 μL aliquots were quenched at defined time points by the addition to a precooled solution of internal standard (100 μM) in MeCN. The samples were vortexed, sonicated for 30 min, and centrifugated. The supernatant was directly used for quantitative determination via LC–MS.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Solubility Determination</h3><div class="NLM_p last">The solubility of compounds <b>23</b> and <b>28</b> were determined via standard HPLC techniques. A linear calibration curve was determined in MeOH from seven different concentrations starting from 1.0 mg/mL with 2-fold serial dilution steps. AUCs from HPLC runs using the same method as described below were plotted against the concentration, and the calibration curve was set up via linear regression. Samples of <b>23</b> and <b>28</b> were prepared by stirring an excess of solid material in 0.05 M PBS buffer pH 7.4 overnight at ambient temperature. The samples were centrifuged, and the supernatant was analyzed by HPLC. With the obtained AUC, the aqueous solubility was calculated using the compound specific calibration curve.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General</h3><div class="NLM_p last">Reagents, starting materials, and solvents were of commercial quality and were used without further purification unless otherwise stated. HWE reagents and hydroxybenzaldehydes were synthesized as reported earlier.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> For the preparation of cyanoacetamides and compounds <b>29</b> and <b>30</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Supporting Information</a>. TLC analysis was carried out on Merck 60 F254 silica gel plates and visualized under UV light at 254 and 365 nm. Preparative column chromatography was carried out on Grace Davison Davisil LC60A 20–45 μm or Merck Geduran Si60 63–200 μm silica using a Interchim PuriFlash 430 automated flash chromatography system. The purity of final compounds was determined via RP-HPLC on a Hewlett-Packard 1090 Series II LC or an Agilent 1100 Series LC with Phenomenex Luna C8 columns (150 × 4.6 mm, 5 μm), and detection was performed with a UV DAD at 254 and 230 nm wavelength. Elution was carried out with the following gradient: 0.01 M KH<sub>2</sub>PO<sub>4</sub>, pH 2.30 (solvent A), MeOH (solvent B), 40% B to 85% B in 8 min, 85% B for 5 min, 85% to 40% B in 1 min, 40% B for 2 min, stop time 16 min, flow 1.5 mL/min. NMR spectra were recorded on a Bruker Avance 200 or Bruker Avance 400 NMR spectrometer. Chemical shifts are reported in ppm relative to TMS, and the spectra were calibrated against the residual proton peak of the used deuterated solvent. Standard mass spectra were obtained either as ESI-MS (pos. and/or neg. mode) from a Advion DCMS interface, (settings as follows: ESI voltage 3.50 kV, capillary voltage 187 V, source voltage 44 V, capillary temperature 250 °C, desolvation gas temperature 250 °C, gas flow 5 L/min) or as FAB-MS (pos. and/or neg. mode) measured by the mass spectrometry department, Institute of Organic Chemistry, Eberhard-Karls-University Tuebingen. HRMS for final compounds was measured by the mass spectrometry department, Institute of Organic Chemistry, Eberhard-Karls-University Tuebingen on a Bruker maXis 4G ESI-TOF from Daltonik/Bremen. The instrument was run in ESI+ Mode, and settings were as follows: nebulizer gas 1.2 bar, gas flow, 6.0 L/min, source temperature 200 °C, capillary voltage +4500 V, end plate offset −500 V. The <i>m</i>/<i>z</i> range was from 80 to 1000 <i>m</i>/<i>z</i>. All final compounds show ≥95% purity according to analytical HPLC. The biologically active compounds were screened for known patterns of assay interference compounds using the ZINC15 database.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> This analysis revealed interference potential for the structural element of the arylidene dinitriles (compounds <b>25</b>–<b>27</b>). The issue of the high intrinsic electrophilicity of these compounds was already discussed above, and the evident JAK3 selectivity of the representative compound <b>27</b> in different biochemical and cellular assays demonstrates that the biological activity of this compound class is not only an artifact.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure A for HWE-Reaction to Acrylamides <b>3</b>–<b>8</b></h3><div class="NLM_p">To a suspension of LiCl (1.5 equiv) in dry MeCN (0.2 M) was added appropriate HWE-reagent (1.5 equiv) and DBU (1.5 equiv). The mixture was stirred for 10 min at ambient temperature before <b>41</b>, <b>42</b>, or <b>43</b> was added as suspension in dry chloroform (ca. 0.8 M). The reaction was monitored via TLC and quenched with sat. NH<sub>4</sub>Cl after complete conversion. After extractive workup with DCM (5×), the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The crude product was purified via flash chromatography unless otherwise stated.</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>E</i>)-3-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)acrylamide (<b>3</b>)</h4><div class="NLM_p last">Obtained from 200 mg of <b>41</b> and 170 mg of diethyl (2-amino-2-oxoethyl)phosphonate following general procedure D but with alternative workup procedure. The product precipitated out of solution and showed bad solubility in common organic solvents like DCM and EtOAc. The crude product was isolated by filtration and was subjected to column chromatography with DCM/MeOH (8–20%), which resulted in a bad elution. The combined product fractions still contained considerable amounts of HWE-reagent, which were removed by washing with water. Yield: 120 mg (54%) of <b>3</b> as yellowish solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.98 (br s, 1H), 8.64 (s, 1H), 7.75 (dd, <i>J</i> = 19.6, 8.3 Hz, 4H), 7.63 (br s, 1H), 7.57–7.48 (m, 2H), 7.21 (br s, 1H), 6.82–6.78 (m, 1H), 6.75 (d, <i>J</i> = 15.9 Hz, 1H), 4.47–4.35 (m, 1H), 2.45–2.30 (m, 2H), 1.98–1.86 (m, 4H), 1.77–1.68 (m, 1H), 1.50–1.29 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 166.4, 151.0, 144.4, 138.2, 136.0, 135.8, 134.8, 132.5, 131.6, 130.0, 127.7, 123.9, 123.7, 104.2, 100.0, 56.0, 30.3, 25.1, 24.3. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O: 386.19754, found 386.19758; HPLC <i>t</i><sub>ret</sub> = 6.730 min.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>E</i>)-3-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)acrylamide (<b>4</b>)</h4><div class="NLM_p last">Obtained from 55 mg of <b>42</b> and 22 mg of diethyl (2-amino-2-oxoethyl)phosphonate following general procedure D with a reaction time of 2 h at ambient temperature. Flash purification with DCM/MeOH (8–16%). Yield: 22 mg (78%) of <b>4</b> as off-white solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 11.97 (br s, 1H), 8.65 (s, 1H), 7.87 (s, 1H), 7.82–7.45 (m, 6H), 7.18 (s, 1H), 6.86–6.68 (m, 2H), 4.52–4.26 (m, 1H), 2.44–2.22 (m, 2H), 2.07–1.64 (m, 5H), 1.53–1.25 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 166.5, 151.1, 144.5, 138.4, 135.8, 135.4, 134.8, 132.4, 131.6, 130.2, 129.4, 128.7, 128.5, 124.0, 123.5, 104.3, 100.0, 56.1, 30.3, 25.2, 24.3. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O: 386.19754, found 386.19788; HPLC t<sub>ret</sub> = 6.341 min.</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i>)-3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)acrylamide (<b>5</b>)</h4><div class="NLM_p last">Obtained from 120 mg of <b>43</b> and 105 mg of diethyl (2-amino-2-oxoethyl)phosphonate following general procedure A with a reaction time of 2 h at ambient temperature. Extraction was performed with EtOAc instead of DCM. Flash purification with DCM/MeOH (4–18%). Yield: 105 mg (78%) of <b>5</b> as yellowish solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 12.04 (br s, 1H), 8.66 (s, 1H), 7.73 (br s, 1H), 7.59–7.50 (m, 1H), 7.36 (d, <i>J</i> = 15.7 Hz, 1H), 7.25–7.13 (m, <i>J</i> = 3.6 Hz, 2H), 7.04 (d, <i>J</i> = 3.7 Hz, 1H), 6.85–6.76 (m, 1H), 6.56 (d, <i>J</i> = 15.7 Hz, 1H), 4.97–4.71 (m, 1H), 2.47–2.19 (m, 2H), 2.06–1.84 (m, 4H), 1.83–1.68 (m, 1H), 1.63–1.37 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 166.2, 152.1, 145.3, 144.6, 141.4, 136.1, 134.8, 132.7, 126.1, 124.1, 121.1, 115.4, 115.0, 104.2, 99.9, 56.4, 30.3, 25.3, 24.4. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O<sub>2</sub>: 376.17680, found 376.17721; HPLC <i>t</i><sub>ret</sub> = 6.741 min.</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>E</i>)-3-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)-<i>N</i>,<i>N</i>-dimethylacrylamide (<b>6</b>)</h4><div class="NLM_p last">Obtained from 50 mg of <b>41</b> and 49 mg of diethyl (2-(dimethylamino)-2-oxoethyl)phosphonate following general procedure A with a reaction time of 4 h at ambient temperature. Flash purification with DCM/MeOH (4–10%). Yield: 42 mg (70%) of <b>6</b> as white solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub> + MeOD) δ 8.77 (s, 1H), 7.80–7.59 (m, 5H), 7.41 (d, <i>J</i> = 3.6 Hz, 1H), 6.99 (d, <i>J</i> = 15.5 Hz, 1H), 6.84 (d, <i>J</i> = 3.6 Hz, 1H), 4.47 (tt, <i>J</i> = 12.3, 4.3 Hz, 1H), 3.13 (d, <i>J</i> = 24.8 Hz, 6H), 2.63–2.40 (m, 2H), 2.06–1.74 (m, 5H), 1.55–1.30 (m, 3H). Indole NH was exchanged by MeOD, but a residual peak was visible with 0.2 protons. <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub> + MeOD) δ 167.2, 152.7, 144.9, 141.9, 137.2, 136.6, 135.7, 134.1, 132.3, 130.4, 128.5, 123.6, 119.2, 105.5, 101.2, 56.7, 37.4, 35.9, 30.7, 25.4, 24.5. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>25</sub>H<sub>27</sub>N<sub>5</sub>O: 414.22884, found 414.22919; HPLC <i>t</i><sub>ret</sub> = 6.938 min.</div></div><div id="sec5_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>E</i>)-3-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)-<i>N</i>,<i>N</i>-dimethylacrylamide (<b>7</b>)</h4><div class="NLM_p last">Obtained from 26 mg of <b>42</b> and 25 mg of (2-(dimethylamino)-2-oxoethyl)phosphonate following general procedure A with a reaction time of 2 h at ambient temperature. Flash purification with DCM/MeOH (3–10%). Yield: 23 mg (74%) of <b>7</b> as off-white solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 11.70 (br s, 1H), 8.89 (s, 1H), 7.89 (s, 1H), 7.81–7.43 (m, 5H), 7.00 (d, <i>J</i> = 15.5 Hz, 1H), 6.88 (d, <i>J</i> = 3.3 Hz, 1H), 4.61–4.36 (m, 1H), 3.12 (d, <i>J</i> = 19.3 Hz, 6H), 2.62–2.35 (m, 2H), 2.08–1.71 (m, 5H), 1.62–1.32 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 166.5, 152.4, 144.5, 141.4, 136.3, 136.0, 135.4, 133.9, 131.8, 130.3, 129.6, 129.3, 128.6, 123.4, 119.0, 105.5, 101.1, 56.9, 37.6, 36.1, 31.1, 25.8, 24.9. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>25</sub>H<sub>27</sub>N<sub>5</sub>O: 414.22884, found 414.22874; HPLC <i>t</i><sub>ret</sub> = 6.636 min.</div></div><div id="sec5_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>E</i>)-3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)-<i>N</i>,<i>N</i>-dimethylacrylamide (<b>8</b>)</h4><div class="NLM_p last">Obtained from 40 mg of <b>43</b> and 41 mg of (2-(dimethylamino)-2-oxoethyl)phosphonate following general procedure A with a reaction time of 2 h at ambient temperature. Flash purification with DCM/MeOH (4–10%). Yield: 42 mg (88%) of <b>8</b> as slightly yellowish solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 11.92 (br s, 1H), 8.88 (s, 1H), 7.55 (d, <i>J</i> = 15.2 Hz, 1H), 7.49 (d, <i>J</i> = 3.5 Hz, 1H), 7.10 (d, <i>J</i> = 3.6 Hz, 1H), 6.94 (d, <i>J</i> = 15.2 Hz, 1H), 6.86 (d, <i>J</i> = 3.5 Hz, 1H), 6.75 (d, <i>J</i> = 3.6 Hz, 1H), 5.09–4.84 (m, 1H), 3.12 (d, <i>J</i> = 17.1 Hz, 6H), 2.67–2.35 (m, 2H), 2.18–1.78 (m, 5H), 1.64–1.37 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 166.8, 153.5, 146.6, 145.4, 143.1, 136.9, 136.0, 134.4, 129.1, 123.7, 116.7, 115.7, 115.4, 105.4, 101.0, 57.2, 37.2, 35.9, 30.6, 25.7, 24.7. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>: 404.20810, found 404.20835; HPLC <i>t</i><sub>ret</sub> = 7.148 min.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure B for Dehydration to Nitriles <b>9</b>–<b>11</b> and <b>18</b>–<b>20</b></h3><div class="NLM_p">Cyanuric chloride (1 equiv) was dissolved in ice-cooled dry DMF and stirred for 10 min before primary amide (<b>3</b>, <b>4</b>, <b>5</b>, <b>12</b>, <b>13</b>, or <b>14</b>) was added dropwise as a solution or suspension in dry DMF. After complete addition, the mixture was stirred at the stated temperature until TLC indicated full consumption of starting material. Then the reaction was quenched with sat. NaHCO<sub>3</sub> and extracted with EtOAc (4×). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified via flash chromatography.</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>)-3-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)acrylonitrile (<b>9</b>)</h4><div class="NLM_p last">Obtained from 45 mg of <b>3</b> as suspension in 3 mL of DMF and 22 mg of cyanuric chloride in 1 mL of DMF following general procedure B with a reaction time of 30 min under ice-cooling. Flash purification with DCM/MeOH (4–10%). Yield: 34 mg (81%) of <b>9</b> as white solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.02 (br s, 1H), 8.66 (s, 1H), 7.87 (d, <i>J</i> = 8.2 Hz, 2H), 7.83–7.72 (m, 3H), 7.55 (t, <i>J</i> = 2.9 Hz, 1H), 6.83–6.77 (m, 1H), 6.62 (d, <i>J</i> = 16.7 Hz, 1H), 4.45–4.32 (m, 1H), 2.43–2.29 (m, 2H), 2.00–1.85 (m, 4H), 1.76–1.67 (m, 1H), 1.51–1.28 (m, 3H); <sup>13</sup>C NMR (100 MHz, DMSO) δ 150.7, 149.7, 144.3, 135.7, 134.7, 134.7, 133.0, 132.5, 130.0, 127.9, 124.0, 118.6, 104.2, 100.0, 98.1, 56.1, 30.2, 25.0, 24.2. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>21</sub>N<sub>5</sub>: 368.18697, found 368.18720; HPLC <i>t</i><sub>ret</sub> = 7.888 min.</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>E</i>)-3-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)acrylonitrile (<b>10</b>)</h4><div class="NLM_p last">Obtained from 40 mg of <b>4</b> as suspension in 1 mL of DMF and 22 mg of cyanuric chloride in 1 mL of DMF following general procedure B with a reaction time of 40 min under ice-cooling. Flash purification with DCM/MeOH (4–10%). Yield: 30 mg (79%) of <b>10</b> as yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.84 (br s, 1H), 8.88 (s, 1H), 7.84 (s, 1H), 7.71–7.58 (m, 3H), 7.53 (d, <i>J</i> = 3.1 Hz, 1H), 7.47 (d, <i>J</i> = 16.7 Hz, 1H), 6.90 (d, <i>J</i> = 3.1 Hz, 1H), 6.00 (d, <i>J</i> = 16.7 Hz, 1H), 4.52–4.39 (m, 1H), 2.60–2.43 (m, 2H), 2.08–1.93 (m, 4H), 1.89–1.78 (m, 1H), 1.56–1.35 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 149.6, 143.8, 135.4, 135.3, 134.5, 134.4, 132.3, 131.8, 129.6, 128.8, 128.7, 123.8, 117.8, 105.7, 101.2, 98.2, 57.2, 31.1, 25.8, 24.9. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>21</sub>N<sub>5</sub>: 368.18697, found 368.18717; HPLC <i>t</i><sub>ret</sub> = 7.879 min.</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>E</i>)-3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)acrylonitrile (<b>11</b>)</h4><div class="NLM_p last">Obtained from 38 mg of <b>5</b> as suspension in 2 mL of DMF and 19 mg of cyanuric chloride in 1 mL of DMF following general procedure B with a reaction time of 30 min under ice-cooling. Flash purification with EtOAc/MeOH (0–15%). Yield: 24 mg (66%) of <b>11</b> as yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.06 (br s, 1H), 8.66 (s, 1H), 7.65 (d, <i>J</i> = 16.4 Hz, 1H), 7.58–7.52 (m, 1H), 7.26 (d, <i>J</i> = 3.6 Hz, 1H), 7.18 (d, <i>J</i> = 3.6 Hz, 1H), 6.84–6.78 (m, 1H), 6.09 (d, <i>J</i> = 16.4 Hz, 1H), 4.90–4.78 (m, 1H), 2.41–2.25 (m, 2H), 2.04–1.90 (m, 4H), 1.81–1.73 (m, 1H), 1.60–1.38 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 150.7, 146.9, 144.6, 140.9, 136.3, 136.2, 134.9, 132.8, 124.1, 118.6, 117.7, 115.4, 104.1, 100.0, 94.3, 56.4, 30.3, 25.2, 24.4. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>19</sub>N<sub>5</sub>O: 358.16624, found 358.16650; HPLC <i>t</i><sub>ret</sub> = 7.960 min.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure C for Hydrogenation to Saturated Amides <b>12</b>–<b>17</b></h3><div class="NLM_p">To a solution of acrylamide (<b>3</b>–<b>8</b>) in the stated solvent mixture was added Pd/C (10 wt % Pd), and hydrogen was bubbled through the stirred solution for 5–10 min. Then the reaction was stirred under an atmosphere of hydrogen until reaction control indicated full conversion. The catalyst was filtered off, the filtrate was evaporated, and the residue was purified via flash chromatography.</div><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)propanamide (<b>12</b>)</h4><div class="NLM_p last">Obtained from 58 mg of <b>3</b> and 10 mg of Pd/C in 20 mL of DCM/MeOH (1:1) following general procedure C with stirring overnight at 40 °C oil-bath temperature. Product was sufficiently pure after filtering off the catalyst. Yield: 55 mg (95%) of <b>12</b> as greyish solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 12.28 (br s, 1H), 8.75 (s, 1H), 7.73–7.56 (m, 3H), 7.53–7.31 (m, 3H), 6.99–6.67 (m, 2H), 4.56–4.30 (m, 1H), 2.95 (t, <i>J</i> = 7.3 Hz, 2H), 2.56–2.18 (m, 4H), 2.06–1.62 (m, 5H), 1.53–1.24 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 173.7, 152.1, 144.5, 143.7, 133.6, 132.9, 132.4, 130.0, 129.1, 127.0, 125.4, 105.1, 100.7, 56.9, 36.5, 31.03, 30.4, 25.4, 24.6. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>25</sub>N<sub>5</sub>O: 388.21319, found 388.21341; HPLC <i>t</i><sub>ret</sub> = 6.661 min.</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)propanamide (<b>13</b>)</h4><div class="NLM_p last">Obtained from 14 mg of <b>4</b> and 4 mg of Pd/C in 2.5 mL of THF/MeOH (4:1) following general procedure C with a reaction time of 90 min at ambient temperature. Flash chromatography with DCM/MeOH (8–16%). Yield: 10 mg (71%) of <b>13</b> as white solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.94 (s, 1H), 8.63 (s, 1H), 7.58–7.28 (m, 6H), 6.78 (s, 2H), 4.48–4.32 (m, 1H), 2.93 (t, <i>J</i> = 7.3 Hz, 2H), 2.45 (t, <i>J</i> = 7.3 Hz, 2H), 2.41–2.29 (m, 2H), 1.99–1.86 (m, 4H), 1.79–1.67 (m, 1H), 1.54–1.28 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 173.2, 151.6, 144.4, 142.0, 135.7, 134.7, 132.3, 130.9, 129.6, 129.3, 128.6, 127.0, 123.8, 104.3, 99.9, 55.9, 36.4, 30.6, 30.3, 25.1, 24.3. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>25</sub>N<sub>5</sub>O: 388.21319, found 388.21372; HPLC <i>t</i><sub>ret</sub> = 6.300 min.</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)propanamide (<b>14</b>)</h4><div class="NLM_p last">Obtained from 50 mg of <b>5</b> and 10 mg of Pd/C in 8 mL of EtOAc/MeOH (1:1) following general procedure C with stirring overnight at 40 °C oil-bath temperature. Product was sufficiently pure after filtering off the catalyst. Yield: 45 mg (90%) of <b>14</b> as yellowish solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub> + MeOD) δ 8.63 (s, 1H), 7.35 (d, <i>J</i> = 3.4 Hz, 1H), 6.84–6.67 (m, 2H), 6.24 (d, <i>J</i> = 3.4 Hz, 1H), 4.88–4.64 (m, 1H), 3.05 (t, <i>J</i> = 7.4 Hz, 2H), 2.62 (t, <i>J</i> = 7.4 Hz, 2H), 2.52–2.26 (m, 2H), 2.09–1.71 (m, 5H), 1.56–1.34 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub> + MeOD) δ 174.9, 156.6, 143.9, 143.5, 142.4, 135.3, 134.5, 133.4, 123.3, 113.8, 108.0, 105.1, 100.6, 56.9, 33.3, 30.4, 25.6, 24.7, 24.0. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>: 378.19245, found 378.19239; HPLC <i>t</i><sub>ret</sub> = 6.572 min.</div></div><div id="sec5_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>15</b>)</h4><div class="NLM_p last">Obtained from 16 mg of <b>6</b> and 4 mg of Pd/C in 5 mL of EtOAc/MeOH (1:1) following general procedure C with a reaction time of 1 h at ambient temperature. Flash chromatography with DCM/MeOH (4–10%). Yield: 15 mg (93%) of <b>15</b> as off-white solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 11.93 (bs, 1H), 8.62 (s, 1H), 7.63–7.39 (m, 5H), 6.78 (s, 1H), 4.51–4.28 (m, 1H), 2.99–2.80 (m, 8H), 2.69 (t, <i>J</i> = 7.2 Hz, 2H), 2.35 (m, 2H), 2.00–1.65 (m, 5H), 1.52–1.26 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 171.2, 151.6, 144.4, 143.3, 135.7, 134.8, 132.4, 129.4, 128.8, 128.5, 123.9, 104.3, 100.1, 55.9, 36.7, 34.9, 33.7, 30.5, 30.3, 25.2, 24.3. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O: 416.24449, found 416.24442; HPLC <i>t</i><sub>ret</sub> = 6.920 min.</div></div><div id="sec5_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>16</b>)</h4><div class="NLM_p last">Obtained from 22 mg of <b>7</b> and 4 mg of Pd/C in 2.5 mL of THF/MeOH (4:1) following general procedure C with a reaction time of 1 h at ambient temperature. Flash chromatography with DCM/MeOH (3–10%). Yield: 21 mg (95%) of <b>16</b> as white foam. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 10.69 (br s, 1H), 8.85 (s, 1H), 7.57 (s, 1H), 7.52–7.36 (m, 4H), 6.91 (d, <i>J</i> = 3.7 Hz, 1H), 4.62–4.42 (m, 1H), 3.14–3.03 (m, 2H), 2.97 (d, <i>J</i> = 2.5 Hz, 6H), 2.75–2.64 (m, 2H), 2.58–2.37 (m, 2H), 2.07–1.77 (m, 5H), 1.51–1.35 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 172.0, 153.7, 143.4, 142.6, 135.4, 135.2, 134.4, 131.1, 130.4, 129.9, 129.0, 127.3, 123.4, 105.7, 101.6, 56.9, 37.3, 35.6, 35.1, 31.3, 31.0, 25.8, 25.0. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O: 416.24449, found 416.24448; HPLC <i>t</i><sub>ret</sub> = 7.009 min.</div></div><div id="sec5_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>17</b>)</h4><div class="NLM_p last">Obtained from 35 mg of <b>8</b> and 8 mg of Pd/C in 4 mL of EtOAc/MeOH (3:1) following general procedure C with a reaction time of 4 h at ambient temperature. Flash chromatography with DCM/MeOH (4–10%). Yield: 21 mg (60%) of <b>17</b> as white solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 11.83 (bs, 1H), 8.86 (s, 1H), 7.47 (d, <i>J</i> = 3.3 Hz, 1H), 6.92–6.80 (m, 2H), 6.28 (d, <i>J</i> = 3.3 Hz, 1H), 4.98–4.74 (m, 1H), 3.14 (t, <i>J</i> = 7.6 Hz, 2H), 2.98 (d, <i>J</i> = 6.2 Hz, 6H), 2.75 (t, <i>J</i> = 7.6 Hz, 2H), 2.58–2.32 (m, 2H), 2.14–1.80 (m, 5H), 1.64–1.37 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 171.3, 157.5, 144.8, 143.8, 143.4, 136.3, 135.5, 133.9, 123.3, 113.9, 107.9, 105.3, 100.8, 57.0, 37.2, 35.6, 31.8, 30.8, 26.0, 25.1, 24.0. ESI-HRMS [M + Na]<sup>+</sup> calculated for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>: 428.20570, found 428.20570; HPLC <i>t</i><sub>ret</sub> = 6.980 min.</div></div><div id="sec5_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)propanenitrile (<b>18</b>)</h4><div class="NLM_p last">Obtained from 48 mg of <b>12</b> as solution in 1.5 mL of DMF and 23 mg of cyanuric chloride in 1 mL of DMF following general procedure B with a reaction time of 2 h at ambient temperature. Flash purification with EtOAc/MeOH (0–20%). Yield: 27 mg (53%) of <b>18</b> as white solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 11.95 (br s, 1H), 8.63 (s, 1H), 7.78–7.39 (m, 5H), 6.90–6.67 (m, 1H), 4.72–4.05 (m, 1H), 3.09–2.82 (m, 4H), 2.45–2.22 (m, 2H), 2.01–1.64 (m, 5H), 1.52–1.25 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 151.4, 144.4, 140.5, 135.8, 134.8, 132.4, 129.6, 129.4, 128.8, 123.9, 120.2, 104.3, 100.0, 55.9, 30.3, 30.3, 25.2, 24.3, 17.8. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>: 370.20262, found 370.20293; HPLC <i>t</i><sub>ret</sub> = 7.335 min.</div></div><div id="sec5_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)propanenitrile (<b>19</b>)</h4><div class="NLM_p last">Obtained from 40 mg of <b>13</b> as solution in 1 mL of DMF and 19 mg of cyanuric chloride in 1 mL of DMF following general procedure B with a reaction time of 3 h at ambient temperature. Flash purification first with DCM/MeOH (4–10%), then EtOAc/MeOH (0–20%). Yield: 19 mg (50%) of <b>19</b> as greenish solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 11.89 (br s, 1H), 8.89 (s, 1H), 7.62 (s, 1H), 7.58–7.38 (m, 4H), 6.89 (d, <i>J</i> = 3.4 Hz, 1H), 4.63–4.40 (m, 1H), 3.07 (t, <i>J</i> = 7.3 Hz, 2H), 2.71 (t, <i>J</i> = 7.3 Hz, 2H), 2.60–2.39 (m, 2H), 2.08–1.90 (m, 4H), 1.87–1.76 (m, 1H), 1.55–1.35 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 152.4, 144.8, 138.9, 136.2, 135.5, 133.8, 131.9, 129.9, 129.8, 129.3, 128.4, 123.3, 119.0, 105.4, 101.1, 56.8, 31.6, 31.0, 25.7, 24.9, 19.3. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>: 370.20262, found 370.20270; HPLC <i>t</i><sub>ret</sub> = 7.467 min.</div></div><div id="sec5_10_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)propanenitrile (<b>20</b>)</h4><div class="NLM_p last">Obtained from 40 mg of <b>14</b> as solution in 1 mL of DMF and 20 mg of cyanuric chloride in 1 mL of DMF following general procedure B with a reaction time of 1 h at ambient temperature. Flash purification with EtOAc/MeOH (0–20%). Yield: 25 mg (66%) of <b>20</b> as off-white solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 11.98 (br s, 1H), 8.62 (s, 1H), 7.59–7.44 (m, 1H), 7.03 (d, <i>J</i> = 3.2 Hz, 1H), 6.84–6.74 (m, 1H), 6.56 (d, <i>J</i> = 3.2 Hz, 1H), 4.92–4.67 (m, 1H), 3.12 (t, <i>J</i> = 6.7 Hz, 2H), 2.94 (t, <i>J</i> = 6.7 Hz, 2H), 2.44–2.19 (m, 2H), 2.03–1.69 (m, 5H), 1.63–1.39 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 154.3, 144.6, 143.7, 142.0, 135.9, 134.7, 132.5, 124.0, 119.8, 113.8, 108.9, 104.2, 99.8, 56.1, 30.3, 25.2, 24.4, 23.6, 15.6. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O: 360.18189, found 360.18214; HPLC <i>t</i><sub>ret</sub> = 7.180 min.</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> General Procedure D for Knoevenagel Condensation to Cyanoacrylamides (<b>21</b>–<b>28</b>)</h3><div class="NLM_p">Aldehyde <b>41</b>, <b>42</b>, or <b>43</b> and corresponding cyanoacetamide or malononitrile (1.1 to 1.5 equiv) were dissolved in alcoholic solvent (MeOH, EtOH, or iPrOH). Piperidine (0.1 equiv) was added to the stirred solution, and the mixture was heated to 60–80 °C or ambient temperature until TLC or HPLC indicated complete conversion. The products were either isolated by filtration or flash purification. The compounds were usually isolated as mixture of <i>E</i>/<i>Z</i> isomers, resulting in NMR spectra of high complexity.</div><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>E</i>/<i>Z</i>)-2-Cyano-3-(4-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)-<i>N</i>,<i>N</i>-dimethylacrylamide (<b>21</b>)</h4><div class="NLM_p last">Obtained from 51 mg of <b>41</b> and 25 mg of 2-cyano-<i>N</i>,<i>N</i>-dimethylacetamide (1.5 equiv) in 2 mL of EtOH following general procedure D at 70 °C heating block temperature. The solvents were evaporated, and the residue was subjected to flash chromatography (DCM/MeOH 1–7%). Yield: 26 mg (41%) as yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.81 (br s, 1H), 9.06–8.81 (m, 1H), 8.07 (d, <i>J</i> = 8.3 Hz) and 7.73 (d, <i>J</i> = 8.3 Hz, 2H), 7.84 (s) and 7.40 (s, 1H), 7.81 (d, <i>J</i> = 8.3 Hz) and 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.51 (d, <i>J</i> = 3.3 Hz, 1H), 6.90 (d, <i>J</i> = 3.3 Hz, 1H), 4.61–4.37 (m, 1H), 3.34–2.97 (m, 6H), 2.63–2.43 (m, 2H), 2.09–1.77 (m, 5H), 1.59–1.34 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.7, 162.3, 151.5, 151.4, 150.9, 145.5, 144.8, 136.6, 135.7, 134.8, 134.1, 134.1, 134.0, 133.6, 133.4, 130.5, 130.4, 130.3, 129.6, 123.4, 115.9, 108.0, 105.4, 101.2, 101.2, 57.1, 39.2, 37.9, 36.6, 35.3, 31.1, 25.8, 24.9. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>6</sub>O: 439.22409, found 439.22423; HPLC <i>t</i><sub>ret</sub> = 6.457 and 7.190 min (<i>E</i>/<i>Z</i> mixture).</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>/<i>Z</i>)-2-Cyano-3-(3-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)-<i>N</i>,<i>N</i>-dimethylacrylamide (<b>22</b>)</h4><div class="NLM_p last">Obtained from 51 mg of <b>42</b> and 25 mg of 2-cyano-<i>N</i>,<i>N</i>-dimethylacetamide (1.5 equiv) in 2 mL of EtOH following general procedure D at 70 °C heating block temperature. The solvents were evaporated, and the residue was subjected to flash chromatography (DCM/MeOH 1–7%). Yield: 13 mg (20%) as yellow solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 11.59 (br s, 1H), 8.87 (s, 1H), 8.13 (s, 1H), 7.87–7.74 (m, 2H), 8.09 (s) and 7.72–7.58 (m, 2H), 7.50 (d, <i>J</i> = 3.1 Hz, 1H), 6.96–6.83 (m, 1H), 4.57–4.33 (m, 1H), 3.30–3.00 (m, 6H), 2.62–2.35 (m, 2H), 2.09–1.78 (m, 5H), 1.55–1.36 (m, 3H). ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>6</sub>O: 439.22409, found 439.22417; HPLC <i>t</i><sub>ret</sub> = 6.797 and 7.680 min (<i>E</i>/<i>Z</i> mixture).</div></div><div id="sec5_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>/<i>Z</i>)-2-Cyano-3-(5-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)-<i>N</i>,<i>N</i>-dimethylacrylamide (<b>23</b>)</h4><div class="NLM_p last">Obtained from 669 mg of <b>43</b> and 247 mg of 2-cyano-<i>N</i>,<i>N</i>-dimethylacetamide (1.1 equiv) in 10 mL of MeOH following general procedure D at 60 °C oil-bath temperature. After complete conversion (ca. 90 min), the reaction mixture was cooled to −20 °C for several hours. The precipitate was collected by filtration and was washed with cold MeOH, yielding the title compound with no need of purification. Yield: 755 mg (88%) as yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.05 (br s, 1H), 8.72–8.63 (m, 1H), 7.78 (s, 1H), 7.56 (s, 1H), 7.49 (d, <i>J</i> = 3.5 Hz, 1H), 7.39 (d, <i>J</i> = 3.5 Hz, 1H), 6.86–6.78 (m, 1H), 4.99–4.86 (m, 1H), 3.21–2.87 (m, 6H), 2.42–2.27 (m, 2H), 2.02 (d, <i>J</i> = 10.7 Hz, 2H), 1.95–1.84 (m, 2H), 1.80–1.70 (m, 1H), 1.66–1.42 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 162.8, 149.5, 148.4, 144.6, 140.5, 136.3, 135.4, 135.1, 132.8, 124.1, 121.9, 116.3, 115.9, 104.1, 101.9, 100.3, 56.1, 30.4, 30.0, 24.9, 24.3 ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>24</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>: 429.20335, found 429.20357; HPLC <i>t</i><sub>ret</sub> = 6.172 and 6.985 min (<i>E</i>/<i>Z</i> mixture).</div></div><div id="sec5_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>E</i>/<i>Z</i>)-2-Cyano-3-(5-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)-<i>N</i>-methylacrylamide (<b>24</b>)</h4><div class="NLM_p last">Obtained from 50 mg of <b>43</b> and 18 mg of <b>44</b> (1.2 equiv, for preparation see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">Supporting Information</a>) in 2 mL of MeOH following general procedure D at 60 °C heating block temperature. After complete conversion (2 h), the reaction mixture was cooled to −20 °C for several hours. The precipitate was collected by filtration and was washed with cold MeOH, yielding the title compound with no need of purification. Yield: 54 mg (87%) as yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.10 (br s, 1H), 8.69 (s, 1H), 8.44–8.31 (m, 1H), 8.08 (s, 1H), 7.60 (d, <i>J</i> = 3.7 Hz, 1H), 7.59–7.53 (m, 1H), 7.42 (d, <i>J</i> = 3.7 Hz, 1H), 6.89–6.79 (m, 1H), 5.03–4.89 (m, 1H), 2.77 (d, <i>J</i> = 4.3 Hz, 3H), 2.44–2.29 (m, 2H), 2.09–1.98 (m, 2H), 1.96–1.85 (m, 2H), 1.80–1.71 (m, 1H), 1.69–1.42 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 160.9, 149.5, 149.0, 144.7, 140.5, 136.3, 135.1, 135.1, 132.8, 124.1, 123.1, 116.5, 116.0, 104.1, 101.4, 100.4, 56.1, 30.0, 26.8, 24.9, 24.2. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>22</sub>N<sub>6</sub>O<sub>2</sub>: 415.18770, found 415.18817; HPLC <i>t</i><sub>ret</sub> = 6.796 and 7.573 min (<i>E</i>/<i>Z</i> mixture).</div></div><div id="sec5_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylidene)malononitrile (<b>25</b>)</h4><div class="NLM_p last">Obtained from 25 mg of <b>41</b> and 6 mg of malononitrile (1.2 equiv) in 4 mL of <i>i</i>PrOH following general procedure D at ambient temperature for 6 h. The reaction was quenched with sat. NH<sub>4</sub>Cl followed by extractive workup (5 × 10 mL EtOAc). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated, and the residue was subjected to flash chromatography (DCM/MeOH 4–10%). Yield: 18 mg (63%) as amorphous yellow solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 12.00 (bs, 1H), 8.77–8.50 (m, 2H), 8.13 (d, <i>J</i> = 6.9 Hz, 2H), 7.93 (d, <i>J</i> = 6.9 Hz, 2H), 7.56–7.45 (m, 1H), 6.86–6.70 (m, 1H), 4.49–4.23 (m, 1H), 2.41–2.20 (m, 2H), 2.05–1.75 (m, 5H), 1.48–1.24 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 160.6, 150.1, 144.5, 136.1, 136.0, 135.0, 132.7, 132.0, 130.8, 130.5, 124.1, 114.2, 113.2, 104.3, 100.2, 82.48, 56.3, 30.2, 25.1, 24.3. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>24</sub>H<sub>20</sub>N<sub>6</sub>: 393.18222, found 393.18275; HPLC <i>t</i><sub>ret</sub> = 7.826 min.</div></div><div id="sec5_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzylidene)malononitrile (<b>26</b>)</h4><div class="NLM_p last">Obtained from 25 mg of <b>42</b> and 6 mg of malononitrile (1.2 equiv) in 2 mL of <i>i</i>PrOH following general procedure D at ambient temperature for 6 h. The reaction was quenched with sat. NH<sub>4</sub>Cl followed by extractive workup (5 × 10 mL EtOAc). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated, and the residue was subjected to flash chromatography (DCM/MeOH 4–10%). Yield: 16 mg (56%) as yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.99 (bs, 1H), 8.70 (s, 1H), 8.67 (s, 1H), 8.21 (s, 1H), 8.17 (d, <i>J</i> = 7.6 Hz, 1H), 7.99 (d, <i>J</i> = 7.6 Hz, 1H), 7.85 (t, <i>J</i> = 7.6 Hz, 1H), 7.55 (s, 1H), 6.81 (s, 1H), 4.45–4.31 (m, 1H), 2.43–2.29 (m, 2H), 2.02–1.83 (m, 4H), 1.76–1.65 (m, 1H), 1.49–1.32 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 160.8, 149.9, 144.5, 135.9, 134.9, 134.8, 132.4, 132.2, 131.7, 131.4, 131.0, 130.0, 124.0 114.0, 113.0, 104.2, 100.0, 82.8, 56.1, 30.3, 25.0, 24.2. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>24</sub>H<sub>20</sub>N<sub>6</sub>: 393.18222, found 393.18238; HPLC <i>t</i><sub>ret</sub> = 8.393 min.</div></div><div id="sec5_11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-((5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)methylene)malononitrile (<b>27</b>)</h4><div class="NLM_p last">Obtained from 25 mg of <b>43</b> and 7 mg of malononitrile (1.2 equiv) in 2 mL of <i>i</i>PrOH following general procedure D at ambient temperature for 1 h. The reaction was quenched with sat. NH<sub>4</sub>Cl followed by extractive workup (5 × 10 mL DCM). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated, and the residue was subjected to flash chromatography (DCM/MeOH 4–10%). Yield: 32 mg (93%) as red solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 12.13 (bs, 1H), 8.70 (s, 1H), 8.40 (s, 1H), 7.66 (d, <i>J</i> = 3.8 Hz, 1H), 7.62–7.53 (m, 1H), 7.49 (d, <i>J</i> = 3.8 Hz, 1H), 6.83 (s, 1H), 5.08–4.81 (m, 1H), 2.45–2.20 (m, 2H), 2.10–1.83 (m, 4H), 1.80–1.43 (m, 4H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 151.2, 149.0, 144.7, 143.8, 139.9, 136.6, 135.3, 133.0, 127.0, 124.2, 117.3, 114.6, 113.3, 104.1, 100.7, 75.5, 56.1, 29.9, 24.8, 24.2. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>22</sub>H<sub>18</sub>N<sub>6</sub>O: 383.16149, found 383.16200; HPLC <i>t</i><sub>ret</sub> = 8.622 min.</div></div><div id="sec5_11_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>E</i>/<i>Z</i>)-3-(5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)-2-(4-methylpiperazine-1-carbonyl)acrylonitrile (<b>28</b>)</h4><div class="NLM_p last">Obtained from 50 mg of <b>43</b> and 30 mg of <b>45</b> (1.2 equiv, for preparation see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_001.pdf" class="ext-link">Supporting Information</a>) in 3 mL of EtOH following general procedure D at 80 °C heating block temperature. The solvents were evaporated, and the residue was subjected to flash chromatography (DCM/0.5 M NH<sub>3</sub> in MeOH 5–10%). Yield: 59 mg (81%) as orange solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.06 (br s, 1H), 8.76–8.59 (m, 1H), 7.76 (s) and 7.67 (s, 1H), 7.59–7.53 (m, 1H), 7.49 (d, <i>J</i> = 3.2 Hz) and 7.25 (d, <i>J</i> = 3.2 Hz, 1H), 7.39 (d, <i>J</i> = 3.2) and 7.21 (d, <i>J</i> = 3.2 Hz, 1H), 6.88–6.74 (m, 1H), 5.02–4.85 (m) and 4.70–4.57 (m, 1H), 3.45–3.24 (m, 4H), 2.40–2.24 (m, 5H), 2.22–2.16 (m, 3H), 2.08–1.83 (m, 5H), 1.81–1.68 (m, 1H), 1.66–1.42 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 161.8, 159.9, 149.5, 149.1, 148.4, 147.7, 144.6, 140.4, 136.2, 136.2, 135.4, 135.0, 134.8, 132.7, 131.6, 124.0, 121.8, 120.3, 117.0, 116.2, 115.8, 115.7, 104.1, 104.0, 103.7, 101.5, 100.2, 99.9, 56.2, 56.0, 54.2, 54.1, 53.9, 53.8, 53.1, 45.9, 45.3, 45.1, 45.0, 41.5, 41.2, 30.2, 29.9, 24.9, 24.8, 24.5, 24.2. ESI-HRMS [M + H]<sup>+</sup> calculated for C<sub>27</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>: 484.24555, found 484.24556; HPLC <i>t</i><sub>ret</sub> = 4.632 and 5.008 min (<i>E</i>/<i>Z</i> mixture).</div></div><div id="sec5_11_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Synthesis of <i>N</i><sup>4</sup>-Cyclohexyl-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine (<b>34</b>)</h4><div id="sec5_11_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Step 1: 4-Chloro-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>31</b>)</h5><div class="NLM_p last">In a 500 mL round bottomed flask, 9.77 g of 4-chloro-7-azaindole (64 mmol, 1.0 equiv) was dissolved in 280 mL of dry THF, and the solution was cooled with ice/water. To the stirred solution was added 3.07 g of NaH (60% disp. in mineral oil, 76.8 mmol, 1.2 equiv) portion-wise. After complete addition, stirring was continued for 15 min followed by the dropwise addition of 12.82 g of tosyl chloride (67.2 mmol, 1.05 equiv) as solution in 40 mL of dry THF. The cooling bath was removed after complete addition, and the reaction mixture was stirred for 2 h at ambient temperature. At this point, HPLC indicated full consumption of starting material. The reaction was quenched by careful addition of 10 mL of saturated NH<sub>4</sub>Cl solution. The mixture was diluted with EtOAc and transferred to a separatory funnel. The organic phase was washed twice with 100 mL of 1 M K<sub>2</sub>CO<sub>3</sub> and once with brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated under reduced pressure. The resulting solid was triturated with cold MeOH, and the solvent was decanted off, yielding 18.32 g (93%) of the title compound as brown solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 5.3 Hz, 1H), 8.06 (d, <i>J</i> = 8.4 Hz, 2H), 7.76 (d, <i>J</i> = 4.0 Hz, 1H), 7.27 (d, <i>J</i> = 8.4 Hz, 2H), 7.18 (d, <i>J</i> = 5.3 Hz, 1H), 6.68 (d, <i>J</i> = 4.0 Hz, 1H), 2.36 (s, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 147.6 145.6, 145.4, 136.8, 135.2, 129.8, 128.2, 127.0, 122.3, 119.1, 103.4, 21.7. DC-MS (ESI) <i>m</i>/<i>z</i>: 305.2 [M – H]<sup>−</sup>; HPLC <i>t</i><sub>ret</sub> = 8.47 min.</div></div><div id="sec5_11_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Step 2: 4-Chloro-5-nitro-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>32</b>)</h5><div class="NLM_p last">In a 500 mL three-necked round bottomed flask were dissolved 18.30 g of <b>31</b> (59.6 mmol, 1.0 equiv) and 10.55 g of tetramethylammonium nitrate (77.5 mmol, 1.3 equiv) in 300 mL of dry DCM, and the solution was cooled with ice/water to an internal temperature of 0–5 °C. To the stirred solution were slowly added 16.28 g of trifluoroacetic anhydride (77.5 mmol, 1.3 equiv) via syringe pump over the course of 10 h. After complete addition, the mixture was allowed to reach ambient temperature slowly, and stirring was continued overnight. HPLC indicated full conversion, and the reaction was diluted with DCM up to a total volume of ca. 500 mL. The organic phase was successively washed with water, sat. NaHCO<sub>3</sub>, sat. Na<sub>2</sub>CO<sub>3</sub>, and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure almost to dryness. The yellow suspension was taken up in a small amount of MeOH and stored at −20 °C for several hours. The solids were isolated by filtration, washed sparingly with cold MeOH, and dried in vacuo to yield 14.14 g (67%) of the title compound as beige fine needles. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1H), 8.07 (d, <i>J</i> = 8.4 Hz, 2H), 7.93 (d, <i>J</i> = 4.1 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 2H), 6.85 (d, <i>J</i> = 4.0 Hz, 1H), 2.40 (s, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 147.2, 146.6, 142.3, 140.6, 134.4, 131.3, 130.1, 130.0, 128.6, 123,0, 104.5, 21.9. DC-MS (ESI) <i>m</i>/<i>z</i>: 406.0 [M + Na + MeOH]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.82 min.</div></div><div id="sec5_11_9_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Step 3: <i>N</i>-Cyclohexyl-5-nitro-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine (<b>33</b>)</h5><div class="NLM_p last">In a 1 L round bottomed flask, 14.10 g of <b>32</b> (40 mmol, 1.0 equiv) was suspended in 180 mL of <i>i</i>PrOH. To the stirred suspension was added a mixture 7.9 mL of Et<sub>3</sub>N (56 mmol, 1.4 equiv) and 5.7 mL of cyclohexylamine (50 mmol, 1.25 equiv) at ambient temperature. The mixture was heated to reflux for 60 min. At this point, reaction control (HPLC) indicated full consumption of starting material. A mixture of 360 mL of H<sub>2</sub>O and 180 mL of sat. NH<sub>4</sub>Cl solution was added slowly to the hot reaction mixture causing the precipitation of solids. After complete addition, the suspension was stirred for 5 min at elevated temperature and was then cooled down in an ice bath under moderate stirring for another 30 min. The solids were collected by filtration, washed with water, and dried in vacuo affording 15.55 g (94%) of the title compound as an orange to red granular solid, which was carried on to the next step without further purification. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 9.20–8.95 (m, 2H), 8.05 (d, <i>J</i> = 8.4 Hz, 2H), 7.57 (d, <i>J</i> = 4.1 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 6.69 (d, <i>J</i> = 4.1 Hz, 1H), 3.94 (m, 1H), 2.38 (s, 3H), 2.19–1.99 (m, 2H), 1.93–1.58 (m, 3H), 1.57–1.31 (m, 5H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 146.41, 145.9, 144.9, 134.9, 129.8, 128.6, 126.6, 123.6, 107.6, 106.7, 52.9, 33.5, 25.4, 24.4, 21.8. DC-MS (ESI) <i>m</i>/<i>z</i>: 469.5 [M + Na + MeOH]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 10.17 min.</div></div><div id="sec5_11_9_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 4: <i>N</i><sup>4</sup>-Cyclohexyl-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine (<b>34</b>)</h5><div class="NLM_p last">In a 1 L two-necked round-bottomed flask, 15.52 g of <b>33</b> (40.4 mmol) was suspended in a mixture of 120 mL of MeOH and 360 mL of EtOAc. The stirred mixture was purged with nitrogen for 5 min, then 750 mg of Pd/C was added. Subsequently, the mixture was purged with hydrogen for 10 min, then the flask was sealed with a rubber septum and a hydrogen reservoir was attached via cannula. The reaction mixture was heated up to 60 °C oil-bath temperature and stirred for about 36 h until TLC indicated full consumption of starting material. The catalyst was removed by filtration over a Celite pad and was washed thoroughly with MeOH and EtOAc. The filtrate darkened rapidly during filtration upon contact to air oxygen. It was concentrated under reduced pressure and coevaporated with DCM to yield 14.40 g of <b>34</b> (quant.) as purple foam. The vicinal diamine <b>34</b> seems not to be suitable for long-term storage under shelf conditions and should be carried on to the next step as soon as possible. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 7.99 (d, <i>J</i> = 8.1 Hz, 2H), 7.82 (s, 1H), 7.44 (d, <i>J</i> = 4.1 Hz, 1H), 7.21 (d, <i>J</i> = 8.1 Hz, 2H), 6.53 (d, <i>J</i> = 4.1 Hz, 1H), 4.75 (bs, 1H), 3.77–3.57 (m, 1H), 2.96 (bs, 2H), 2.33 (s, 3H), 2.11–1.95 (m, 2H), 1.86–1.57 (m, 3H), 1.45–1.10 (m, 5H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 145.8, 144.8, 141.0, 137.1, 135.7, 129.6, 128.0, 123.1, 122.3, 108.0, 105.0, 52.5, 34.4, 25.7, 2.9, 21.7. DC-MS (ESI) <i>m</i>/<i>z</i>: 385.4 [M + H]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 6.97 min.</div></div></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> General Procedure E for Imidazole Ring Closure</h3><div class="NLM_p">A solution of <b>34</b> (1 equiv) and its corresponding aldehyde (1.2 equiv) in DMF (0.2 M) was stirred for 15 min at ambient temperature. Then 3% v/v water and KHSO<sub>5</sub> (0.7 equiv) were added, and stirring was continued until TLC indicated complete conversion. The reaction mixture was poured in 0.2 M K<sub>2</sub>CO<sub>3</sub> solution (2 equiv), the precipitate filtered off, dried in vacuo, and purified by column chromatography unless otherwise stated.</div><div id="sec5_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (4-(1-Cyclohexyl-6-tosyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)methanol (<b>35</b>)</h4><div class="NLM_p last">Obtained from 384 mg of <b>34</b> and 164 mg of 4-(hydroxymethyl)benzaldehyde following general procedure E with a reaction time of 2 h at ambient temperature. Crude product afforded flash purification using gradient elution (petrol ether/(EtOAc + 5% MeOH) 50–100%) to yield 343 mg (69%) of <b>35</b> as a brownish foam. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 8.94 (s, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (d, <i>J</i> = 4.1 Hz, 1H), 7.44 (q, <i>J</i> = 8.5 Hz, 4H), 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 6.97 (d, <i>J</i> = 4.1 Hz, 1H), 4.77 (s, 2H), 4.40 (tt, <i>J</i> = 12.1, 3.8 Hz, 1H), 3.76 (br s, 1H), 2.40–2.14 (m, 5H), 2.00–1.71 (m, 5H), 1.47–1.28 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 154.0, 145.3, 144.0, 142.9, 138.3, 137.0, 135.4, 133.0, 129.7, 129.5, 129.1, 128.4, 126.9, 124.7, 107.8, 105.1, 64.2, 56.8, 31.1, 25.6, 24.9, 21.7. DC-MS (ESI) <i>m</i>/<i>z</i>: 522.9 [M + Na]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.077 min.</div></div><div id="sec5_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (3-(1-Cyclohexyl-6-tosyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)methanol (<b>36</b>)</h4><div class="NLM_p last">Obtained from 264 mg of <b>34</b> and 112 mg of 3-(hydroxymethyl)benzaldehyde following general procedure E with a reaction time of 1 h at ambient temperature. Crude product afforded flash purification using gradient elution (petrol ether/(EtOAc + 5% MeOH) 30–100%) to yield 247 mg (72%) of <b>36</b> as a brownish foam. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 8.93 (s, 1H), 8.11 (d, <i>J</i> = 8.3 Hz, 2H), 7.85 (d, <i>J</i> = 4.1 Hz, 1H), 7.62 (s, 1H), 7.53–7.39 (m, 3H), 7.26 (d, <i>J</i> = 8.3 Hz, 3H), 6.97 (d, <i>J</i> = 4.1 Hz, 1H), 4.75 (s, 2H), 4.56–4.30 (m, 1H), 2.95 (bs, 1H), 2.40–2.12 (m, 5H), 2.04–1.72 (m, 5H), 1.46–1.29 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 153.9, 145.3, 142.9, 142.5, 138.2, 136.6, 135.4, 132.9, 130.3, 129.7, 128.9, 128.7, 128.4, 128.3, 128.1, 124.9, 107.8, 105.0, 64.5, 56.9, 31.1, 25.6, 24.9, 21.8. FAB-MS <i>m</i>/<i>z</i>: 501.2 [M + H]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.333 min.</div></div><div id="sec5_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (5-(1-Cyclohexyl-6-tosyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-yl)methanol (<b>37</b>)</h4><div class="NLM_p last">Obtained from 14.5 g of <b>34</b> and 5.7 g of 5-(hydroxymethyl)furfural following general procedure E with a reaction time of 2 h at ambient temperature. The crude product (ca. 17 g) was redissolved in DCM/MeOH, 34 g of Celite was added, and the solvents were stripped off again. The solids were loaded on a short plug of silica (10 cm diameter, 3 cm height) and covered with wool. The short column was conditioned with petrol ether followed by elution with 2000 mL of EtOAc + 5% MeOH. The filtrate was concentrated to a thick brown oil and was taken up in a minimal amount of warm MeOH. The dark solution was diluted with the approximately same volume of Et<sub>2</sub>O and cooled for several hours in an ice-bath. The formed precipitate was isolated by filtration, washed with Et<sub>2</sub>O, and dried in vacuo (10.5 g). For a second crop, the mother liquor and washings were evaporated and subjected to flash chromatography (petrol ether/(EtOAc + 5% MeOH) 50–100%) to yield another 2 g. Total yield: 12.5 g (68%) of <b>37</b> as pale brownish solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 8.89 (s, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (d, <i>J</i> = 4.1 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 6.92 (d, <i>J</i> = 4.1 Hz, 1H), 6.89 (d, <i>J</i> = 3.4 Hz, 1H), 6.44 (d, <i>J</i> = 3.4 Hz, 1H), 4.85–4.61 (m, 3H), 2.33 (s, 3H), 2.28–2.08 (m, 2H), 1.95–1.72 (m, 5H), 1.45–1.27 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 156.9, 145.3, 144.4, 143.6, 142.9, 138.3, 136.9, 135.4, 133.2, 129.7, 128.4, 124.8, 114.5, 109.8, 107.8, 104.7, 57.4, 57.3, 30.8, 25.8, 24.9, 21.7. DC-MS (ESI) <i>m</i>/<i>z</i>: 491.3 [M + H]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.112 min.</div></div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> General Procedure F for Dess–Martin Oxidation of Phenylmethanols <b>35</b> and <b>36</b></h3><div class="NLM_p">An ice-cooled solution of <b>35</b> or <b>36</b> in DCM (0.2 M) was treated with Dess–Martin–Periodinane (1.2 equiv). After addition, the mixture was allowed to warm up to ambient temperature, and stirring was continued until TLC indicated complete conversion. Saturated NaHCO<sub>3</sub> solution was added, and the biphasic mixture was transferred to a separatory funnel. The aqueous phase was extracted five times with DCM, and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The crude product was purified via flash chromatography.</div><div id="sec5_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(1-Cyclohexyl-6-tosyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzaldehyde (<b>38</b>)</h4><div class="NLM_p last">Obtained from 148 mg of <b>35</b> following general procedure F. Flash purification with gradient (petrol ether/(EtOAc + 5% MeOH) 30–80%). Yield 118 mg (80%) of <b>38</b> as brownish foam. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 10.10 (s, 1H), 8.94 (s, 1H), 8.17–7.95 (m, 4H), 7.84 (d, <i>J</i> = 4.0 Hz, 1H), 7.79 (d, <i>J</i> = 7.8 Hz, 2H), 7.24 (d, <i>J</i> = 7.8 Hz, 2H), 6.97 (d, <i>J</i> = 4.0 Hz, 1H), 4.53–4.28 (m, 1H), 2.41–2.17 (m, 5H), 2.05–1.75 (m, 5H), 1.55–1.28 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 191.6, 152.5, 145.3, 142.9, 138.8, 137.3, 137.2 136.4, 135.3, 133.2, 130.3, 130.0, 129.7, 128.3, 124.9, 107.8, 104.9, 57.1, 31.1, 25.6, 24.8, 21.7. DC-MS (ESI) <i>m</i>/<i>z</i>: 520.9 [M + Na]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.347 min.</div></div><div id="sec5_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-(1-Cyclohexyl-6-tosyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzaldehyde (<b>39</b>)</h4><div class="NLM_p last">Obtained from 240 mg of <b>36</b> following general procedure F. Flash purification using gradient elution (petrol ether/(EtOAc + 5% MeOH) 30–80%). Yield: 220 mg (92%) of <b>39</b> as brownish foam. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 8.93 (s, 1H), 8.11 (d, <i>J</i> = 8.3 Hz, 2H), 7.85 (d, <i>J</i> = 4.1 Hz, 1H), 7.62 (s, 1H), 7.53–7.39 (m, 3H), 7.26 (d, <i>J</i> = 8.3 Hz, 3H), 6.97 (d, <i>J</i> = 4.1 Hz, 1H), 4.75 (s, 2H), 4.56–4.30 (m, 1H), 2.95 (bs, 1H), 2.40–2.12 (m, 5H), 2.04–1.72 (m, 5H), 1.46–1.29 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 153.9, 145.3, 142.9, 142.5, 138.2, 136.6, 135.4, 132.9, 130.3, 129.7, 128.9, 128.7, 128.4, 128.3, 128.1, 124.9, 107.8, 105.0, 64.5, 56.9, 31.1, 25.6, 24.9, 21.8. FAB-MS <i>m</i>/<i>z</i>: 499.2 [M + H]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.751 min.</div></div><div id="sec5_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 5-(1-Cyclohexyl-6-tosyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-carbaldehyde (<b>40</b>)</h4><div class="NLM_p last">Obtained from 12.2 g (24.9 mmol, 1.0 equiv) of <b>37</b> and 469 mg (1.25 mmol, 0.05 equiv) of Cu(MeCN)<sub>4</sub>·OTf partially dissolved in 180 mL of MeCN in a Schlenk flask. TEMPO (1.25 mmol, 0.05 equiv), 2,2′-bipyridine (1.25 mmol, 0.05 equiv), and <i>N</i>-methylimidazole (2.5 mmol, 0.1 equiv) were added as a solution in MeCN, and the reaction mixture was stirred under a slightly positive pressure of oxygen overnight at 50 °C water-bath temperature. During the course of the reaction, starting material dissolved, and the product precipitated partially. The mixture was cooled to 0–5 °C, and the precipitate was collected by filtration. The filtrate was passed through a plug of silica and eluted with EtOAc. The volatiles were removed, and the residue together with the filtered crude product were subjected to column chromatography (PE/EtOAC + 5% MeOH (20–80%)) to yield 10.5 g (87%) of <b>40</b> as yellow to orange solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 9.77 (s, 1H), 8.93 (s, 1H), 8.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.86 (d, <i>J</i> = 4.1 Hz, 1H), 7.41 (d, <i>J</i> = 3.7 Hz, 1H), 7.32–7.22 (m, 3H), 6.98 (d, <i>J</i> = 4.1 Hz, 1H), 5.10–4.88 (m, <i>J</i> = 12.2 Hz, 1H), 2.43–2.20 (m, 5H), 2.11–1.84 (m, 5H), 1.63–1.43 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 177.4, 153.2, 149.7, 145.4, 143.2, 142.6, 139.0, 137.4, 135.4, 133.8, 129.8, 128.4, 125.0, 122.0, 115.4, 107.8, 104.6, 57.9, 31.0, 26.0, 25.0, 21.8. DC-MS (ESI) <i>m</i>/<i>z</i>: 511.3 [M + Na]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 8.520 min.</div></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> General Procedure G for Tosyl Cleavage</h3><div class="NLM_p">Aldehyde <b>38</b>, <b>39</b>, or <b>40</b> was suspended in a 1 M solution of KOH in MeOH, and the mixture was stirred until TLC indicated complete consumption of starting material. The reaction was quenched by the addition of sat. NH<sub>4</sub>Cl followed by dilution with enough EtOAc and water to get clear phases. The organic phase was washed two times with water and once with brine and then dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The residue was subjected to column chromatography.</div><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzaldehyde (<b>41</b>)</h4><div class="NLM_p last">Obtained from 362 mg of <b>38</b> following general procedure G. Flash purification with DCM/MeOH (3–10%). Yield: 188 mg (75%) of <b>41</b> as off-white solid. <sup>1</sup>H NMR (200 MHz, DMSO) δ 12.03 (br s, 1H), 10.15 (s, 1H), 8.68 (s, 1H), 8.12 (d, <i>J</i> = 7.8 Hz, 2H), 7.93 (d, <i>J</i> = 7.8 Hz, 2H), 7.61–7.50 (m, 1H), 6.84–6.76 (m, 1H), 4.55–4.24 (m, 1H), 2.46–2.23 (m, 2H), 1.88 (dd, <i>J</i> = 35.2, 24.7 Hz, 5H), 1.52–1.22 (m, 3H). <sup>13</sup>C NMR (50 MHz, DMSO) δ 192.5, 150.1, 144.2, 136.2, 136.2, 135.8, 134.7, 132.3, 130.1, 129.4, 123.8, 104.1, 100.0, 56.1, 30.3, 25.1, 24.3. DC-MS (ESI) <i>m</i>/<i>z</i>: 342.9 [M – H]<sup>−</sup>; HPLC <i>t</i><sub>ret</sub> = 6.975 min.</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzaldehyde (<b>42</b>)</h4><div class="NLM_p last">Obtained from 340 mg of <b>39</b> following general procedure G. Flash purification with DCM/MeOH (3–10%) to yield 178 mg (76%) of <b>42</b> as beige solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 11.85 (br s, 1H), 10.13 (s, 1H), 8.91 (s, 1H), 8.21 (s, 1H), 8.07 (d, <i>J</i> = 7.6 Hz, 1H), 7.96 (d, <i>J</i> = 7.6 Hz, 1H), 7.74 (t, <i>J</i> = 7.6 Hz, 1H), 7.52 (d, <i>J</i> = 3.5 Hz, 1H), 6.90 (d, <i>J</i> = 3.5 Hz, 1H), 4.57–4.34 (m, 1H), 2.53 (dd, <i>J</i> = 23.9, 12.3 Hz, 2H), 2.12–1.76 (m, 5H), 1.59–1.31 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 191.6, 151.4, 144.6, 136.9, 136.2, 135.5, 135.3, 134.0, 132.4, 131.1, 130.7, 129.7, 123.5, 105.5, 101.1, 57.2, 31.1, 25.8, 24.9. FAB-MS <i>m</i>/<i>z</i>: 345.2 [M + H]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 6.152 min.</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)furan-2-carbaldehyde (<b>43</b>)</h4><div class="NLM_p last">Obtained from 6.0 g of <b>40</b> following general procedure G. Flash purification with DCM/MeOH (3–10%) to yield 2.24 g (54%) of <b>43</b> as yellow solid. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 12.05 (br s, 1H), 9.78 (s, 1H), 8.89 (s, 1H), 7.51 (d, <i>J</i> = 3.4 Hz, 1H), 7.42 (d, <i>J</i> = 3.7 Hz, 1H), 7.30 (d, <i>J</i> = 3.7 Hz, 1H), 6.90 (d, <i>J</i> = 3.4 Hz, 1H), 5.17–4.94 (m, 1H), 2.63–2.36 (m, 2H), 2.18–1.79 (m, 5H), 1.69–1.43 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 177.5, 153.1, 150.3, 145.1, 141.4, 136.8, 135.7, 134.4, 123.6, 122.0, 114.7, 105.2, 100.9, 57.8, 30.9, 26.0, 25.0. DC-MS (ESI) <i>m</i>/<i>z</i>: 357.2 [M + Na]<sup>+</sup>; HPLC <i>t</i><sub>ret</sub> = 6.991 min.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00571" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00571" class="ext-link">10.1021/acs.jmedchem.8b00571</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Kinome selectivity data for compound <b>23</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Additional experimental procedures and data for the preparation of intermediates and compound <b>29</b> and <b>30</b>; X-ray crystallographic diffraction data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES codes of final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_001.pdf">jm8b00571_si_001.pdf (158.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf">jm8b00571_si_002.pdf (381.06 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_003.csv">jm8b00571_si_003.csv (1.85 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Cocrystal structures of JAK3 in complex with compounds <b>10</b>, <b>11</b>, and <b>20</b> are deposited in the Protein Data Bank under the accession codes 6GL9, 6GLA, and 6GLB, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00571" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan A. Laufer</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Eberhard
Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6952-1486" title="Orcid link">http://orcid.org/0000-0001-6952-1486</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cbb8bfaeadaaa5e5a7aabeadaeb98bbea5a2e6bfbeaea9a2a5acaea5e5afae"><span class="__cf_email__" data-cfemail="fc8f88999a9d92d2909d899a998ebc899295d18889999e95929b9992d29899">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Forster</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Eberhard
Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Apirat Chaikuad</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, Johann Wolfgang Goethe
University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, DE, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
for Pharmaceutical Chemistry, Johann Wolfgang
Goethe University, Max-von-Laue-Str.
9, D-60438 Frankfurt
am Main, DE, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1120-2209" title="Orcid link">http://orcid.org/0000-0003-1120-2209</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teodor Dimitrov</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Eberhard
Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Döring</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Eberhard
Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julia Holstein</span> - <span class="hlFld-Affiliation affiliation">Department
of Dermatology, University Medical Center,
Eberhard Karls University Tübingen, Liebermeisterstr. 25, 72076 Tübingen, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benedict-Tilman Berger</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, Johann Wolfgang Goethe
University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, DE, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
for Pharmaceutical Chemistry, Johann Wolfgang
Goethe University, Max-von-Laue-Str.
9, D-60438 Frankfurt
am Main, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Gehringer</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Eberhard
Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0163-3419" title="Orcid link">http://orcid.org/0000-0003-0163-3419</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kamran Ghoreschi</span> - <span class="hlFld-Affiliation affiliation">Department
of Dermatology, University Medical Center,
Eberhard Karls University Tübingen, Liebermeisterstr. 25, 72076 Tübingen, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susanne Müller</span> - <span class="hlFld-Affiliation affiliation">Institute
for Pharmaceutical Chemistry, Johann Wolfgang
Goethe University, Max-von-Laue-Str.
9, D-60438 Frankfurt
am Main, DE, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Knapp</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, Johann Wolfgang Goethe
University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, DE, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
for Pharmaceutical Chemistry, Johann Wolfgang
Goethe University, Max-von-Laue-Str.
9, D-60438 Frankfurt
am Main, DE, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">German
Cancer Consortium, DKTK, 60590 Site Frankfurt/Mainz, DE, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5995-6494" title="Orcid link">http://orcid.org/0000-0001-5995-6494</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">S.K. and A.C. are grateful for financial support by the DFG Sonderforschungsbereich SFB1177 Autophagy. K.G. and J.H. are supported by the DFG FOR 2497/TP02 (GH133/2-1). S.K., A.C., S.M., and B.T. would like to acknowledge support by the SGC, a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and the Centre of Excellence Macromolecular Complexes (CEF) at Frankfurt University. S.K. and S.L are grateful for support by the German Cancer network DKTK. M.G. gratefully acknowledges funding by the Recruitment of Excellent Junior Researchers Grant of the University of Tübingen. M.F., M.G., and T.D. thank Silke Bauer, Katharina Bauer, and Daniela Müller for biological testing of the final compounds.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS USED</td></tr><tr><td class="NLM_term">bpy</td><td class="NLM_def"><p class="first last">2,2′-bipyridyl</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess–Martin periodinane</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">HWE</td><td class="NLM_def"><p class="first last">Horner-Wadsworth–Emmons</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">janus kinase</p></td></tr><tr><td class="NLM_term">NMI</td><td class="NLM_def"><p class="first last"><i>N</i>-methylimidazole</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">TEMPO</td><td class="NLM_def"><p class="first last">2,2,6,6-tetramethylpiperidinyloxyl</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term">TYK2</td><td class="NLM_def"><p class="first last">tyrosine kinase 2</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms and consequences of JAK-STAT signaling in the immune system</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1038/ni.3691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fni.3691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=28323260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFagu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=374-384&issue=4&author=A.+V.+Villarinoauthor=Y.+Kannoauthor=J.+J.+O%E2%80%99Shea&title=Mechanisms+and+consequences+of+JAK-STAT+signaling+in+the+immune+system&doi=10.1038%2Fni.3691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms and consequences of Jak-STAT signaling in the immune system</span></div><div class="casAuthors">Villarino, Alejandro V.; Kanno, Yuka; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">374-384</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal transducer and activator of transcription') family constitute a rapid membrane-to-nucleus signaling module that affects every aspect of the mammalian immune system.  Research on this paradigmatic pathway has experienced breakneck growth in the quarter century since its discovery and has yielded a stream of basic and clin. insights that have profoundly influenced modern understanding of human health and disease, exemplified by the bench-to-bedside success of Jak inhibitors ('jakinibs') and pathway-targeting drugs.  Here we review recent advances in Jak-STAT biol., focusing on immune cell function, disease etiol. and therapeutic intervention, as well as broader principles of gene regulation and signal-dependent TFs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrUlP3emd5BrVg90H21EOLACvtfcHk0lh_ZYFju2vFIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFagu7c%253D&md5=b50a88aee2b64fcb85c9a64d4ec1724e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni.3691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3691%26sid%3Dliteratum%253Aachs%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DMechanisms%2520and%2520consequences%2520of%2520JAK-STAT%2520signaling%2520in%2520the%2520immune%2520system%26jtitle%3DNat.%2520Immunol.%26date%3D2017%26volume%3D18%26issue%3D4%26spage%3D374%26epage%3D384%26doi%3D10.1038%2Fni.3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAKs and STATs: biological implications</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&issue=1&author=W.%0AJ.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKs+and+STATs%3A+biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0lipfNjSBhvVBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKs%2520and%2520STATs%253A%2520biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26issue%3D1%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spolski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">New insights into the regulation of T cells by γc family cytokines</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1038/nri2580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnri2580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19543225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=480-490&issue=7&author=Y.+Rochmanauthor=R.+Spolskiauthor=W.+J.+Leonard&title=New+insights+into+the+regulation+of+T+cells+by+%CE%B3c+family+cytokines&doi=10.1038%2Fnri2580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the regulation of T cells by γc family cytokines</span></div><div class="casAuthors">Rochman, Yrina; Spolski, Rosanne; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Common cytokine receptor γ-chain (γc) family cytokines have crucial roles in the development, proliferation, survival and differentiation of multiple cell lineages of both the innate and adaptive immune systems.  In this Review, the authors focus on the current understanding of the distinct and overlapping effects of interleukin-2 (IL-2), IL-7, IL-9, IL-15 and IL-21, as well as the IL-7-related cytokine thymic stromal lymphopoietin (TSLP), on the survival and proliferation of conventional αβ T cells, γδ T cells and regulatory T cells.  This knowledge potentially allows for the therapeutic manipulation of immune responses for the treatment of cancer, autoimmunity, allergic diseases and immunodeficiency, as well as for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GBlSyD8_NLVg90H21EOLACvtfcHk0lipfNjSBhvVBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D&md5=a6c7285b05193002b89be7233d11f271</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2580%26sid%3Dliteratum%253Aachs%26aulast%3DRochman%26aufirst%3DY.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DNew%2520insights%2520into%2520the%2520regulation%2520of%2520T%2520cells%2520by%2520%25CE%25B3c%2520family%2520cytokines%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26issue%3D7%26spage%3D480%26epage%3D490%26doi%3D10.1038%2Fnri2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>228</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&issue=1&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lipfNjSBhvVBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26issue%3D1%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candotti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notarangelo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAK3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>203</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1111/j.0105-2896.2005.00220.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1111%2Fj.0105-2896.2005.00220.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=15661026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2005&pages=127-142&issue=1&author=M.+Pesuauthor=F.+Candottiauthor=M.+Husaauthor=S.+R.+Hofmannauthor=L.+D.+Notarangeloauthor=J.+J.+O%E2%80%99Shea&title=JAK3%2C+severe+combined+immunodeficiency%2C+and+a+new+class+of+immunosuppressive+drugs&doi=10.1111%2Fj.0105-2896.2005.00220.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span></div><div class="casAuthors">Pesu, Marko; Candotti, Fabio; Husa, Matthew; Hofmann, Sigrun R.; Notarangelo, Luigi D.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent elucidation of the multiple mol. mechanisms underlying severe combined immunodeficiency (SCID) is an impressive example of the power of mol. medicine.  Anal. of patients and the concomitant generation of animal models mimicking these disorders have quickly provided great insights into the pathophysiol. of these potentially devastating illnesses.  Here, the authors summarize the discoveries that led to the understanding of the role of cytokine receptors and a specific tyrosine kinase, Janus kinase 3 (Jak3), in the pathogenesis of SCID.  The authors discuss how the identification of mutations of Jak3 in autosomal recessive SCID has facilitated the diagnosis of these disorders, offered new insights into the biol. of this kinase, permitted new avenues for therapy, and provided the rationale for a generation of a new class of immunosuppressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYir7OTbMwFbVg90H21EOLACvtfcHk0lipfNjSBhvVBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D&md5=038b25b97798eda4b6aa1818238e45ba</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.0105-2896.2005.00220.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0105-2896.2005.00220.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DHusa%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DS.%2BR.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK3%252C%2520severe%2520combined%2520immunodeficiency%252C%2520and%2520a%2520new%2520class%2520of%2520immunosuppressive%2520drugs%26jtitle%3DImmunol.%2520Rev.%26date%3D2005%26volume%3D203%26issue%3D1%26spage%3D127%26epage%3D142%26doi%3D10.1111%2Fj.0105-2896.2005.00220.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borie, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">A new modality for immunosuppression: targeting the JAK/STAT pathway</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/nrd1441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnrd1441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=15232577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&issue=7&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+new+modality+for+immunosuppression%3A+targeting+the+JAK%2FSTAT+pathway&doi=10.1038%2Fnrd1441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A new modality for immunosuppression: targeting the JAK/STAT pathway</span></div><div class="casAuthors">O'Shea, John J.; Pesu, Marko; Borie, Dominic C.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Thousands of organs are transplanted each year and millions of people suffer from autoimmune diseases, which creates a need for an armamentarium of immunosuppressive drugs.  Unfortunately, immunosuppressants have unwanted side effects owing, in part, to the fact that they have ubiquitous mol. targets.  Cytokines have emerged as important controllers of the immune response, and work during the past decade has identified Janus kinases (JAKs) and signal transducers, and activators of transcription (STATs), as crucial intracellular elements in cytokine signalling.  Here, we discuss the potential of the JAK/STAT pathway as a target for new immunosuppressants.  In particular, the inhibition of JAK3 seems to be an excellent strategy, because of the selective expression and precise functions of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhrBmh4tsEibVg90H21EOLACvtfcHk0lhAUJdN_g8kRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D&md5=7f09261dbb7c43b4eedb750a35f8e7d5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd1441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1441%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520new%2520modality%2520for%2520immunosuppression%253A%2520targeting%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D7%26spage%3D555%26epage%3D564%26doi%3D10.1038%2Fnrd1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">843</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnrd.2017.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=29104284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=843&author=D.+M.+Schwartzauthor=Y.+Kannoauthor=A.+Villarinoauthor=M.+Wardauthor=M.+Gadinaauthor=J.+J.+O%E2%80%99Shea&title=JAK+inhibition+as+a+therapeutic+strategy+for+immune+and+inflammatory+diseases&doi=10.1038%2Fnrd.2017.201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span></div><div class="casAuthors">Schwartz, Daniella M.; Kanno, Yuka; Villarino, Alejandro; Ward, Michael; Gadina, Massimo; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">843-862</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts to target their assocd. signalling pathways.  Janus kinases (JAKs) are essential signalling mediators downstream of many pro-inflammatory cytokines, and small-mol. inhibitors of JAKs (jakinibs) have gained traction as safe and efficacious options for the treatment of inflammation-driven pathologies such as rheumatoid arthritis, psoriasis and inflammatory bowel disease.  Building on the clin. success of first-generation jakinibs, second-generation compds. that claim to be more selective are currently undergoing development and proceeding to clin. trials.  However, important questions remain about the advantages and limitations of improved JAK selectivity, optimal routes and dosing regimens and how best to identify patients who will benefit from jakinibs.  This Review discusses the biol. of jakinibs from a translational perspective, focusing on recent insights from clin. trials, the development of novel agents and the use of jakinibs in a spectrum of immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TNpGT01l8rVg90H21EOLACvtfcHk0lhAUJdN_g8kRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO&md5=4607422f83f94c0c7194935d6d460c31</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.201%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DVillarino%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520for%2520immune%2520and%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D843%26doi%3D10.1038%2Fnrd.2017.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1038/ni.1701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fni.1701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19295632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=356-360&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Selectivity+and+therapeutic+inhibition+of+kinases%3A+to+be+or+not+to+be%3F&doi=10.1038%2Fni.1701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-360</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases, which serve crit. functions in signaling pathways in all cells, are popular therapeutic targets.  At present, eight kinase inhibitors have been approved in the United States, each of which shows nanomolar potency.  Although the initial goal was to generate inhibitors with a high degree of selectivity, recent experience has revealed that many of these approved compds. target more than one kinase.  Surprisingly, this promiscuity is less problematic than one would have imagined; indeed, it opens new therapeutic opportunities.  In this Perspective, we discuss the present status of Janus kinase inhibitors-a new class of immunosuppressive drugs-and the advantages and disadvantages of selectively inhibiting this class of kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU0w6t4jgqirVg90H21EOLACvtfcHk0lhAUJdN_g8kRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D&md5=64dd47e897181d00e5dce6be3bc5db6e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fni.1701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1701%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSelectivity%2520and%2520therapeutic%2520inhibition%2520of%2520kinases%253A%2520to%2520be%2520or%2520not%2520to%2520be%253F%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26spage%3D356%26epage%3D360%26doi%3D10.1038%2Fni.1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolvering, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raulf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drückes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrmann, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">JAK1 has a dominant role over JAK3 in signal transduction through gamma-c-containing cytokine receptors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Dr%C3%BCckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=JAK1+has+a+dominant+role+over+JAK3+in+signal+transduction+through+gamma-c-containing+cytokine+receptors&doi=10.1016%2Fj.chembiol.2011.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0lgaNxRUDTPIMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJAK1%2520has%2520a%2520dominant%2520role%2520over%2520JAK3%2520in%2520signal%2520transduction%2520through%2520gamma-c-containing%2520cytokine%2520receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323%26doi%3D10.1016%2Fj.chembiol.2011.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drückes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">Selective inhibitors of the janus kinase JAK3—are they effective?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4617</span>– <span class="NLM_lpage">4621</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.bmcl.2014.08.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4617-4621&issue=19&author=G.+Thomaauthor=P.+Dr%C3%BCckesauthor=H.-G.+Zerwes&title=Selective+inhibitors+of+the+janus+kinase+JAK3%E2%80%94are+they+effective%3F&doi=10.1016%2Fj.bmcl.2014.08.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.046%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DSelective%2520inhibitors%2520of%2520the%2520janus%2520kinase%2520JAK3%25E2%2580%2594are%2520they%2520effective%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D19%26spage%3D4617%26epage%3D4621%26doi%3D10.1016%2Fj.bmcl.2014.08.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fensome, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span> <span> </span><span class="NLM_article-title">ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK kinase isoforms to cellular signaling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1552</span>– <span class="NLM_lpage">1558</span>, <span class="refDoi"> DOI: 10.1021/cb5002125</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5002125" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1552-1558&issue=7&author=A.+Thorarensenauthor=M.+E.+Bankerauthor=A.+Fensomeauthor=J.-B.+Telliezauthor=B.+Jubaauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garcia&title=ATP-mediated+kinome+selectivity%3A+the+missing+link+in+understanding+the+contribution+of+individual+JAK+kinase+isoforms+to+cellular+signaling&doi=10.1021%2Fcb5002125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fcb5002125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5002125%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26atitle%3DATP-mediated%2520kinome%2520selectivity%253A%2520the%2520missing%2520link%2520in%2520understanding%2520the%2520contribution%2520of%2520individual%2520JAK%2520kinase%2520isoforms%2520to%2520cellular%2520signaling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1552%26epage%3D1558%26doi%3D10.1021%2Fcb5002125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of janus kinase (JAK) inhibitors for inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&issue=12&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+development+of+janus+kinase+%28JAK%29+inhibitors+for+inflammatory+diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lgaNxRUDTPIMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520development%2520of%2520janus%2520kinase%2520%2528JAK%2529%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D12%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Farseeva, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span> <span> </span><span class="NLM_article-title">Selective JAK inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1439</span>– <span class="NLM_lpage">1471</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.4155%2Ffmc.14.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=25329199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1439-1471&issue=12&author=B.+W.+Dymockauthor=E.+G.+Yangauthor=Y.+Chu-Farseevaauthor=L.+Yao&title=Selective+JAK+inhibitors&doi=10.4155%2Ffmc.14.92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Selective JAK inhibitors</span></div><div class="casAuthors">Dymock, Brian W.; Yang, Eugene Guorong; Chu-Farseeva, Yuyi; Yao, Lianbin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1439-1471</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Consisting of four members, JAK1, JAK2, JAK3 and TYK2, the JAK kinases have emerged as important targets for proliferative and immune-inflammatory disorders.  Recent progress in the discovery of selective inhibitors has been significant, with selective compds. now reported for each isoform.  This article summarizes the current state-of-the-art with a discussion of the most recently described selective compds.  X-ray co-crystal structures reveal the mol. reasons for the obsd. biochem. selectivity.  A concluding anal. of JAK inhibitors in the clinic highlights increased clin. trial activity and diversity of indications.  Selective JAK inhibitors, as single agents or in combination regimens, have a very promising future in the treatment of oncol., immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6G9eFT7Ww27Vg90H21EOLACvtfcHk0lj4520ue09ShA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI&md5=343aa75228918e6e4e063adb1fed96f1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.92%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DChu-Farseeva%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DL.%26atitle%3DSelective%2520JAK%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471%26doi%3D10.4155%2Ffmc.14.92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span> <span> </span><span class="NLM_article-title">Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1107</span>, <span class="refDoi"> DOI: 10.1002/eji.201646680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1002%2Feji.201646680" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=1096-1107&issue=7&author=K.+Welschauthor=J.+Holsteinauthor=A.+Laurenceauthor=K.+Ghoreschi&title=Targeting+JAK%2FSTAT+signalling+in+inflammatory+skin+diseases+with+small+molecule+inhibitors&doi=10.1002%2Feji.201646680"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Feji.201646680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201646680%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DK.%26aulast%3DHolstein%26aufirst%3DJ.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DGhoreschi%26aufirst%3DK.%26atitle%3DTargeting%2520JAK%252FSTAT%2520signalling%2520in%2520inflammatory%2520skin%2520diseases%2520with%2520small%2520molecule%2520inhibitors%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2017%26volume%3D47%26issue%3D7%26spage%3D1096%26epage%3D1107%26doi%3D10.1002%2Feji.201646680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenkopf, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casavant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang-Poa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of CP-690’550: a potent and selective janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8468</span>– <span class="NLM_lpage">8484</span>, <span class="refDoi"> DOI: 10.1021/jm1004286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%E2%80%99550%3A+a+potent+and+selective+janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection&doi=10.1021%2Fjm1004286"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%25E2%2580%2599550%253A%2520a%2520potent%2520and%2520selective%2520janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484%26doi%3D10.1021%2Fjm1004286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuninger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchetto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangrevelinghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">Identification of a potent janus Kinase 3 Inhibitor with high selectivity within the janus kinase family</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1021/jm101157q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&issue=1&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+janus+Kinase+3+Inhibitor+with+high+selectivity+within+the+janus+kinase+family&doi=10.1021%2Fjm101157q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520janus%2520Kinase%25203%2520Inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D284%26epage%3D288%26doi%3D10.1021%2Fjm101157q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korniski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbrink, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6&doi=10.1016%2Fj.jmb.2010.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lj4520ue09ShA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433%26doi%3D10.1016%2Fj.jmb.2010.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">The cysteinome of protein kinases as a target in drug development</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4372</span>– <span class="NLM_lpage">4385</span>, <span class="refDoi"> DOI: 10.1002/anie.201707875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1002%2Fanie.201707875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=4372-4385&author=A.+Chaikuadauthor=P.+Kochauthor=S.+Lauferauthor=S.+Knapp&title=The+cysteinome+of+protein+kinases+as+a+target+in+drug+development&doi=10.1002%2Fanie.201707875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Cysteinome of Protein Kinases as a Target in Drug Development</span></div><div class="casAuthors">Chaikuad, Apirat; Koch, Pierre; Laufer, Stefan A.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4372-4385</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Drugs that function through covalent bond formation represent a considerable fraction of the authors' repository of effective medicines but safety concerns and the complexity of developing covalent inhibitors has rendered covalent targeting a less attractive strategy for rational drug design.  The recent approval of four covalent kinase inhibitors and the development of highly potent covalent kinase probes with exceptional selectivity has raised significant interest in industry and academic research and validated the concept of covalent kinase targeting for clin. applications.  The abundance of cysteines at diverse positions in and around the kinase active site suggests that a large fraction of kinases can be targeted by covalent inhibitors.  Herein, the authors review recent developments of this rapidly growing area in kinase drug development and highlight the unique opportunities and challenges of this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphHGXsIr-dpbVg90H21EOLACvtfcHk0lj9I5RE55ZpnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFGgs7c%253D&md5=311ba5ab53dc4a5dc1dc92ddd4b6d4c2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201707875%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520cysteinome%2520of%2520protein%2520kinases%2520as%2520a%2520target%2520in%2520drug%2520development%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D4372%26epage%3D4385%26doi%3D10.1002%2Fanie.201707875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Developing irreversible inhibitors of the protein kinase cysteinome</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.chembiol.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=23438744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=146-159&issue=2&author=Q.+Liuauthor=Y.+Sabnisauthor=Z.+Zhaoauthor=T.+Zhangauthor=S.+J.+Buhrlageauthor=L.+H.+Jonesauthor=N.+S.+Gray&title=Developing+irreversible+inhibitors+of+the+protein+kinase+cysteinome&doi=10.1016%2Fj.chembiol.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome</span></div><div class="casAuthors">Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng; Zhang, Tinghu; Buhrlage, Sara J.; Jones, Lyn H.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-159</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a large family of approx. 530 highly conserved enzymes that transfer a γ-phosphate group from ATP to a variety of amino acid residues, such as tyrosine, serine, and threonine, that serves as a ubiquitous mechanism for cellular signal transduction.  The clin. success of a no. of kinase-directed drugs and the frequent observation of disease causing mutations in protein kinases suggest that a large no. of kinases may represent therapeutically relevant targets.  To date, the majority of clin. and preclin. kinase inhibitors are ATP competitive, noncovalent inhibitors that achieve selectivity through recognition of unique features of particular protein kinases.  Recently, there has been renewed interest in the development of irreversible inhibitors that form covalent bonds with cysteine or other nucleophilic residues in the ATP-binding pocket.  Irreversible kinase inhibitors have a no. of potential advantages including prolonged pharmacodynamics, suitability for rational design, high potency, and ability to validate pharmacol. specificity through mutation of the reactive cysteine residue.  Here, we review recent efforts to develop cysteine-targeted irreversible protein kinase inhibitors and discuss their modes of recognizing the ATP-binding pocket and their biol. activity profiles.  In addn., we provided an informatics assessment of the potential "kinase cysteinome" and discuss strategies for the efficient development of new covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGD7TX3oIeLVg90H21EOLACvtfcHk0lj9I5RE55ZpnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D&md5=cef80823123bae88362e816a0a638133</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSabnis%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDeveloping%2520irreversible%2520inhibitors%2520of%2520the%2520protein%2520kinase%2520cysteinome%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D146%26epage%3D159%26doi%3D10.1016%2Fj.chembiol.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elwood, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesvaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraybill, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bays, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenblatt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanovska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielstorff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarthy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorosh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klappenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kariv, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slipetz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandliker, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of JAK3 biology in autoimmune disease using a highly selective, irreversible JAK3 inhibitor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.239723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1124%2Fjpet.116.239723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=28193636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2js7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=229-244&issue=2&author=F.+Elwoodauthor=D.+Witterauthor=J.+Piesvauxauthor=B.+Kraybillauthor=N.+Baysauthor=C.+Alpertauthor=P.+Goldenblattauthor=Y.+Quauthor=I.+Ivanovskaauthor=H.-H.+Leeauthor=C.-S.+Chiuauthor=H.+Tangauthor=M.+E.+Scottauthor=S.+Deshmukhauthor=M.+Zielstorffauthor=A.+Byfordauthor=K.+Chakravarthyauthor=L.+Doroshauthor=A.+Rivkinauthor=J.+Klappenbachauthor=B.-S.+Panauthor=I.+Karivauthor=C.+Dinsmoreauthor=D.+Slipetzauthor=P.+Dandliker&title=Evaluation+of+JAK3+biology+in+autoimmune+disease+using+a+highly+selective%2C+irreversible+JAK3+inhibitor&doi=10.1124%2Fjpet.116.239723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of JAK3 biology in autoimmune disease using a highly selective, irreversible JAK3 inhibitor</span></div><div class="casAuthors">Elwood, Fiona; Witter, David J.; Piesvaux, Jennifer; Kraybill, Brian; Bays, Nathan; Alpert, Carla; Goldenblatt, Peter; Qu, Yujie; Ivanovska, Irena; Lee, Hyun-Hee; Chiu, Chi-Sung; Tang, Hao; Scott, Mark E.; Deshmukh, Sujal V.; Zielstorff, Mark; Byford, Alan; Chakravarthy, Kalyan; Dorosh, Lauren; Rivkin, Alexey; Klappenbach, Joel; Pan, Bo-Sheng; Kariv, Ilona; Dinsmore, Christopher; Slipetz, Deborah; Dandliker, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-244</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reversible janus assocd. kinase (JAK) inhibitors such as tofacitinib and decernotinib block cytokine signaling and are efficacious in treating autoimmune diseases.  However, therapeutic doses are limited due to inhibition of other JAK/signal transducer and activator of transcription pathways assocd. with hematopoiesis, lipid biogenesis, infection, and immune responses.  A selective JAK3 inhibitor may have a better therapeutic index; however, until recently, no compds. have been described that maintain JAK3 selectivity in cells, as well as against the kinome, with good physicochem. properties to test the JAK3 hypothesis in vivo.  To quantify the biochem. basis for JAK isoenzyme selectivity, we detd. that the apparent Km value for each JAK isoenzyme ranged from 31.8 to 2.9 μM for JAK1 and JAK3, resp.  To confirm compd. activity in cells, we developed a novel enzyme complementation assay that read activity of single JAK isoenzymes in a cellular context.  Reversible JAK3 inhibitors cannot achieve sufficient selectivity against other isoenzymes in the cellular context due to inherent differences in enzyme ATP Km values.  Therefore, we developed irreversible JAK3 compds. that are potent and highly selective in vitro in cells and against the kinome.  Compd. 2, a potent inhibitor of JAK3 (0.15 nM) was 4300-fold selective for JAK3 over JAK1 in enzyme assays, 67-fold [interleukin (IL)-2 vs. IL-6] or 140-fold [IL-2 vs. erythropoietin or granulocyte-macrophage colony-stimulating factor (GMCSF)] selective in cellular reporter assays and >35-fold selective in human peripheral blood mononuclear cell assays (IL-7 vs. IL-6 or GMCSF).  In vivo, selective JAK3 inhibition was sufficient to block the development of inflammation in a rat model of rheumatoid arthritis, while sparing hematopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp6-yK4H1dDbVg90H21EOLACvtfcHk0lizNezKSmfIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2js7vL&md5=942ec024e9681b696dfbfeaf22f5acb2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.239723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.239723%26sid%3Dliteratum%253Aachs%26aulast%3DElwood%26aufirst%3DF.%26aulast%3DWitter%26aufirst%3DD.%26aulast%3DPiesvaux%26aufirst%3DJ.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DAlpert%26aufirst%3DC.%26aulast%3DGoldenblatt%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DIvanovska%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DH.-H.%26aulast%3DChiu%26aufirst%3DC.-S.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DM.%2BE.%26aulast%3DDeshmukh%26aufirst%3DS.%26aulast%3DZielstorff%26aufirst%3DM.%26aulast%3DByford%26aufirst%3DA.%26aulast%3DChakravarthy%26aufirst%3DK.%26aulast%3DDorosh%26aufirst%3DL.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DKlappenbach%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DKariv%26aufirst%3DI.%26aulast%3DDinsmore%26aufirst%3DC.%26aulast%3DSlipetz%26aufirst%3DD.%26aulast%3DDandliker%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520JAK3%2520biology%2520in%2520autoimmune%2520disease%2520using%2520a%2520highly%2520selective%252C%2520irreversible%2520JAK3%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26issue%3D2%26spage%3D229%26epage%3D244%26doi%3D10.1124%2Fjpet.116.239723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in JAK3 inhibition: isoform selectivity by covalent cysteine targeting</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4229</span>– <span class="NLM_lpage">4237</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.bmcl.2017.07.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=28844493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2lsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4229-4237&issue=18&author=M.+Forsterauthor=M.+Gehringerauthor=S.+A.+Laufer&title=Recent+advances+in+JAK3+inhibition%3A+isoform+selectivity+by+covalent+cysteine+targeting&doi=10.1016%2Fj.bmcl.2017.07.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting</span></div><div class="casAuthors">Forster, Michael; Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4229-4237</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are a family of four cytosolic protein kinases with a high degree of structural similarity.  Due to its very restricted role in immune regulation, JAK3 was promoted as an excellent target for immunosuppression for more than a decade, but clin. validation of this concept is still elusive.  During the last years, speculation arose that kinase activity of JAK1, which cooperates with JAK3 in cytokine receptor signaling, may have a dominant role over the one of JAK3.  Until recently, however, this issue could not be appropriately addressed due to a lack of highly isoform-selective tool compds.  With the recent resurgence of covalent drugs, targeting of a specific cysteine that distinguishes JAK3 from other JAK family members became an attractive design option.  By applying this strategy, a set of JAK3 inhibitors with excellent selectivity against other JAK isoforms and the kinome was developed during the last three years and used to decipher JAK3-dependent signaling.  The data obtained with these tool compds. demonstrates that selective JAK3 inhibition is sufficient to block downstream signaling.  Since one of these inhibitors is currently under evaluation in phase II clin. studies against several inflammatory disorders, it will soon become apparent whether selective JAK3 inhibition translates into clin. efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopN0oBBGxua7Vg90H21EOLACvtfcHk0lizNezKSmfIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2lsb3M&md5=3c6b2f86ccd3e3f3e254bbece5fa3ac5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.079%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DM.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DRecent%2520advances%2520in%2520JAK3%2520inhibition%253A%2520isoform%2520selectivity%2520by%2520covalent%2520cysteine%2520targeting%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4229%26epage%3D4237%26doi%3D10.1016%2Fj.bmcl.2017.07.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiriadi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banach, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiamengo, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihle, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J. W.</span></span> <span> </span><span class="NLM_article-title">Tricyclic covalent inhibitors selectively target JAK3 through an active site thiol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4573</span>– <span class="NLM_lpage">4589</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.595181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1074%2Fjbc.M114.595181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=4573-4589&issue=8&author=E.+R.+Goedkenauthor=M.+A.+Argiriadiauthor=D.+L.+Banachauthor=B.+A.+Fiamengoauthor=S.+E.+Foleyauthor=K.+E.+Frankauthor=J.+S.+Georgeauthor=C.+M.+Harrisauthor=A.+D.+Hobsonauthor=D.+C.+Ihleauthor=D.+Marcotteauthor=P.+J.+Mertaauthor=M.+E.+Michalakauthor=S.+E.+Murdockauthor=M.+J.+Tomlinsonauthor=J.+W.+Voss&title=Tricyclic+covalent+inhibitors+selectively+target+JAK3+through+an+active+site+thiol&doi=10.1074%2Fjbc.M114.595181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.595181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.595181%26sid%3Dliteratum%253Aachs%26aulast%3DGoedken%26aufirst%3DE.%2BR.%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DBanach%26aufirst%3DD.%2BL.%26aulast%3DFiamengo%26aufirst%3DB.%2BA.%26aulast%3DFoley%26aufirst%3DS.%2BE.%26aulast%3DFrank%26aufirst%3DK.%2BE.%26aulast%3DGeorge%26aufirst%3DJ.%2BS.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DHobson%26aufirst%3DA.%2BD.%26aulast%3DIhle%26aufirst%3DD.%2BC.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DMichalak%26aufirst%3DM.%2BE.%26aulast%3DMurdock%26aufirst%3DS.%2BE.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DVoss%26aufirst%3DJ.%2BW.%26atitle%3DTricyclic%2520covalent%2520inhibitors%2520selectively%2520target%2520JAK3%2520through%2520an%2520active%2520site%2520thiol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D8%26spage%3D4573%26epage%3D4589%26doi%3D10.1074%2Fjbc.M114.595181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimermančič, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Covalent docking of large libraries for the discovery of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnchembio.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=25344815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1066-1072&issue=12&author=N.+Londonauthor=R.+M.+Millerauthor=S.+Krishnanauthor=K.+Uchidaauthor=J.+J.+Irwinauthor=O.+Eidamauthor=L.+Giboldauthor=P.+Cimerman%C4%8Di%C4%8Dauthor=R.+Bonnetauthor=B.+K.+Shoichetauthor=J.+Taunton&title=Covalent+docking+of+large+libraries+for+the+discovery+of+chemical+probes&doi=10.1038%2Fnchembio.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent docking of large libraries for the discovery of chemical probes</span></div><div class="casAuthors">London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biol. studies.  Despite these advantages, protein-reactive compds. are usually avoided in high-throughput screening campaigns.  Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small mols.  We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC β-lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases.  We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3.  Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization.  As covalent virtual screening may have broad utility for the rapid discovery of chem. probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngQdIYqslNLVg90H21EOLACvtfcHk0lifCRUo8xpUaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE&md5=4e5fbeb8f67cb82d464d57069ba0c93a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1666%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DEidam%26aufirst%3DO.%26aulast%3DGibold%26aufirst%3DL.%26aulast%3DCimerman%25C4%258Di%25C4%258D%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DCovalent%2520docking%2520of%2520large%2520libraries%2520for%2520the%2520discovery%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D12%26spage%3D1066%26epage%3D1072%26doi%3D10.1038%2Fnchembio.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnchembio.2056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=27018889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=373-379&issue=5&author=G.+A.+Smithauthor=K.+Uchidaauthor=A.+Weissauthor=J.+Taunton&title=Essential+biphasic+role+for+JAK3+catalytic+activity+in+IL-2+receptor+signaling&doi=10.1038%2Fnchembio.2056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span></div><div class="casAuthors">Smith, Geoffrey A.; Uchida, Kenji; Weiss, Arthur; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-379</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To drive lymphocyte proliferation and differentiation, common γ-chain (γc) cytokine receptors require hours to days of sustained stimulation.  JAK1 and JAK3 kinases are found together in all γc-receptor complexes, but how their resp. catalytic activities contribute to signaling over time is not known.  Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i).  By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4+ T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave.  Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase.  An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice.  Our chem. genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2-driven T cell proliferation and will find broad utility in studies of γc-receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfXNNV1cRJbVg90H21EOLACvtfcHk0lifCRUo8xpUaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D&md5=573d99767ce37cf58a8f71e9e01102b5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2056%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DEssential%2520biphasic%2520role%2520for%2520JAK3%2520catalytic%2520activity%2520in%2520IL-2%2520receptor%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26issue%3D5%26spage%3D373%26epage%3D379%26doi%3D10.1038%2Fnchembio.2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyskens, K. M. S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herter-Sprie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Development of selective covalent janus kinase 3 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6589</span>– <span class="NLM_lpage">6606</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00710</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00710" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6589-6606&issue=16&author=L.+Tanauthor=K.+Akahaneauthor=R.+McNallyauthor=K.+M.+S.+E.+Reyskensauthor=S.+B.+Ficarroauthor=S.+Liuauthor=G.+S.+Herter-Sprieauthor=S.+Koyamaauthor=M.+J.+Pattisonauthor=K.+Labellaauthor=L.+Johannessenauthor=E.+A.+Akbayauthor=K.-K.+Wongauthor=D.+A.+Frankauthor=J.+A.+Martoauthor=T.+A.+Lookauthor=J.+S.+C.+Arthurauthor=M.+J.+Eckauthor=N.+S.+Gray&title=Development+of+selective+covalent+janus+kinase+3+inhibitors&doi=10.1021%2Facs.jmedchem.5b00710"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00710%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DMcNally%26aufirst%3DR.%26aulast%3DReyskens%26aufirst%3DK.%2BM.%2BS.%2BE.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHerter-Sprie%26aufirst%3DG.%2BS.%26aulast%3DKoyama%26aufirst%3DS.%26aulast%3DPattison%26aufirst%3DM.%2BJ.%26aulast%3DLabella%26aufirst%3DK.%26aulast%3DJohannessen%26aufirst%3DL.%26aulast%3DAkbay%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DLook%26aufirst%3DT.%2BA.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDevelopment%2520of%2520selective%2520covalent%2520janus%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D16%26spage%3D6589%26epage%3D6606%26doi%3D10.1021%2Facs.jmedchem.5b00710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Design of a janus kinase 3 (JAK3) specific inhibitor 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1971-1993&issue=5&author=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+E.+Bankerauthor=B.+Jubaauthor=J.+Jussifauthor=T.+Linauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garciaauthor=R.+Unwallaauthor=J.+I.+Trujilloauthor=S.+Liangauthor=P.+Balboauthor=Y.+Cheauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=L.+Leungauthor=X.+Yangauthor=S.+Soucyauthor=M.+Hegenauthor=J.+Coeauthor=J.+Langilleauthor=F.+Vajdosauthor=J.+Chrencikauthor=J.-B.+Telliez&title=Design+of+a+janus+kinase+3+%28JAK3%29+specific+inhibitor+1-%28%282S%2C5R%29-5-%28%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29-2-methylpiperidin-1-yl%29prop-2-en-1-one+%28PF-06651600%29+allowing+for+the+interrogation+of+JAK3+signaling+in+humans&doi=10.1021%2Facs.jmedchem.6b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans</span></div><div class="casAuthors">Thorarensen, Atli; Dowty, Martin E.; Banker, Mary Ellen; Juba, Brian; Jussif, Jason; Lin, Tsung; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin; Unwalla, Ray; Trujillo, John I.; Liang, Sidney; Balbo, Paul; Che, Ye; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Leung, Louis; Yang, Xin; Soucy, Sarah; Hegen, Martin; Coe, Jotham; Langille, Jonathan; Vajdos, Felix; Chrencik, Jill; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1971-1993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in several compds. entering clin. development and two FDA approved NMEs.  However, despite significant effort during the past two decades, identification of highly selective JAK3 inhibitors has eluded the scientific community.  A significant effort within the research organization has resulted in the identification of the first orally active JAK3 specific inhibitor, which achieves JAK isoform specificity through covalent interaction with a unique JAK3 residue Cys-909.  The relatively rapid resynthesis rate of the JAK3 enzyme presented a unique challenge in the design of covalent inhibitors with appropriate pharmacodynamics properties coupled with limited unwanted off-target reactivity.  This effort resulted in the identification of PF-06651600 I, a potent and low clearance compd. with demonstrated in vivo efficacy.  The favorable efficacy and safety profile of this specific JAK3 inhibitor I led to its evaluation in several human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodS6VFIL07nrVg90H21EOLACvtfcHk0lgQs2z274XbsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D&md5=d1ab749203fae07f89463f97518e3db8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSoucy%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDesign%2520of%2520a%2520janus%2520kinase%25203%2520%2528JAK3%2529%2520specific%2520inhibitor%25201-%2528%25282S%252C5R%2529-5-%2528%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529-2-methylpiperidin-1-yl%2529prop-2-en-1-one%2520%2528PF-06651600%2529%2520allowing%2520for%2520the%2520interrogation%2520of%2520JAK3%2520signaling%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D1971%26epage%3D1993%26doi%3D10.1021%2Facs.jmedchem.6b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corona, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Selective JAK3 inhibitors with a covalent reversible binding mode targeting a new induced fit binding pocket</span>. <i>Cell Chemical Biology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2016.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.chembiol.2016.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1335-1340&issue=11&author=M.+Forsterauthor=A.+Chaikuadauthor=S.+M.+Bauerauthor=J.+Holsteinauthor=M.+B.+Robersauthor=C.+R.+Coronaauthor=M.+Gehringerauthor=E.+Pfaffenrotauthor=K.+Ghoreschiauthor=S.+Knappauthor=S.+A.+Laufer&title=Selective+JAK3+inhibitors+with+a+covalent+reversible+binding+mode+targeting+a+new+induced+fit+binding+pocket&doi=10.1016%2Fj.chembiol.2016.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DHolstein%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DCorona%26aufirst%3DC.%2BR.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSelective%2520JAK3%2520inhibitors%2520with%2520a%2520covalent%2520reversible%2520binding%2520mode%2520targeting%2520a%2520new%2520induced%2520fit%2520binding%2520pocket%26jtitle%3DCell%2520Chemical%2520Biology%26date%3D2016%26volume%3D23%26issue%3D11%26spage%3D1335%26epage%3D1340%26doi%3D10.1016%2Fj.chembiol.2016.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>The Structural
Genomics Consortium. <span> </span><span class="NLM_article-title">FM-381 a chemical probe for JAK3</span>. <a href="http://www.thesgc.org/chemical-probes/FM-381" class="extLink">http://www.thesgc.org/chemical-probes/FM-381</a> (accessed 05.01.<span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Structural%0AGenomics+Consortium.+FM-381+a+chemical+probe+for+JAK3.+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FFM-381+%28accessed+05.01.2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DFM-381%2520a%2520chemical%2520probe%2520for%2520JAK3%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span>The Chemical
Probes Portal. <span> </span><span class="NLM_article-title">FM-381</span>. <a href="http://www.chemicalprobes.org/fm-381" class="extLink">http://www.chemicalprobes.org/fm-381</a> (accessed 05.01.<span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Chemical%0AProbes+Portal.+FM-381.+http%3A%2F%2Fwww.chemicalprobes.org%2Ffm-381+%28accessed+05.01.2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DFM-381%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of janus kinase 3 (JAK3) inhibitors</span>. <i>Anal. Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8817</span>– <span class="NLM_lpage">8822</span>, <span class="refDoi"> DOI: 10.1039/C4AY01589D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1039%2FC4AY01589D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KktLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=8817-8822&issue=21&author=S.+M.+Bauerauthor=M.+Gehringerauthor=S.+A.+Laufer&title=A+direct+enzyme-linked+immunosorbent+assay+%28ELISA%29+for+the+quantitative+evaluation+of+janus+kinase+3+%28JAK3%29+inhibitors&doi=10.1039%2FC4AY01589D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of Janus Kinase 3 (JAK3) inhibitors</span></div><div class="casAuthors">Bauer, Silke M.; Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8817-8822</span>CODEN:
                <span class="NLM_cas:coden">AMNEGX</span>;
        ISSN:<span class="NLM_cas:issn">1759-9679</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The availability of a robust, precise and cost-efficient test system is the prerequisite for the performance of any medicinal chem. program, esp. in an academic environment.  For the identification of novel Janus Kinase 3 inhibitors and detn. of structure-activity relationships, a direct ELISA was developed.  Being applicable in a std. lab., the main advantage over existing methods is the basic equipment requirement as this assay does not need special handling originating from the use of cell cultures or radiometric readout.  In contrast to earlier methods relying on two-step procedures, our assay uses a single peroxidase conjugated antibody to quantify and detect substrate phosphorylation.  This optimized assay features a limit of detection of 0.032 μg mL-1, a wide dynamic range of 0.638 OD units and an appropriate Z' factor of 0.66.  The detd. IC50 value for Tofacitinib was 3.5 ± 0.6 nM (n = 18).  A detailed assay protocol custom-tailored for the JAK3 kinase domain and a step-by-step manual for optimizing specific assay conditions are presented.  This ELISA primarily addresses researchers within the academic setting facing the task to identify lead structures and explore structure-activity relationships of JAK3 inhibitors at reasonable costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4PXaxHHwvLbVg90H21EOLACvtfcHk0lgQs2z274XbsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KktLnN&md5=0ec4f079c1bf1552cde1a15d08534453</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2FC4AY01589D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4AY01589D%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DA%2520direct%2520enzyme-linked%2520immunosorbent%2520assay%2520%2528ELISA%2529%2520for%2520the%2520quantitative%2520evaluation%2520of%2520janus%2520kinase%25203%2520%2528JAK3%2529%2520inhibitors%26jtitle%3DAnal.%2520Methods%26date%3D2014%26volume%3D6%26issue%3D21%26spage%3D8817%26epage%3D8822%26doi%3D10.1039%2FC4AY01589D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafimova, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pufall, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maglathlin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frödin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1038/nchembio.925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnchembio.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=22466421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=471-476&issue=5&author=I.+M.+Serafimovaauthor=M.+A.+Pufallauthor=S.+Krishnanauthor=K.+Dudaauthor=M.+S.+Cohenauthor=R.+L.+Maglathlinauthor=J.+M.+McFarlandauthor=R.+M.+Millerauthor=M.+Fr%C3%B6dinauthor=J.+Taunton&title=Reversible+targeting+of+noncatalytic+cysteines+with+chemically+tuned+electrophiles&doi=10.1038%2Fnchembio.925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span></div><div class="casAuthors">Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Froedin, Morten; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacol. potency and selectivity.  Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies.  Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner.  Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts.  Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissocg., covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2.  A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine.  Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond.  Our results establish a chem.-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcv3GjPOB6rVg90H21EOLACvtfcHk0ljsVIsGJmq4wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D&md5=6455a9a029714beb317286f71ac1326b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.925%26sid%3Dliteratum%253Aachs%26aulast%3DSerafimova%26aufirst%3DI.%2BM.%26aulast%3DPufall%26aufirst%3DM.%2BA.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DDuda%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DMaglathlin%26aufirst%3DR.%2BL.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFr%25C3%25B6din%26aufirst%3DM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DReversible%2520targeting%2520of%2520noncatalytic%2520cysteines%2520with%2520chemically%2520tuned%2520electrophiles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26issue%3D5%26spage%3D471%26epage%3D476%26doi%3D10.1038%2Fnchembio.925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span> <span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0ljsVIsGJmq4wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodroofe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimprich, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupcho, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartnett, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niles, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">Target engagement and drug residence time can be observed in living cells with BRET</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10091</span>, <span class="refDoi"> DOI: 10.1038/ncomms10091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fncomms10091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=26631872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10091&author=M.+B.+Robersauthor=M.+L.+Dartauthor=C.+C.+Woodroofeauthor=C.+A.+Zimprichauthor=T.+A.+Kirklandauthor=T.+Machleidtauthor=K.+R.+Kupchoauthor=S.+Levinauthor=J.+R.+Hartnettauthor=K.+Zimmermanauthor=A.+L.+Nilesauthor=R.+F.+Ohanaauthor=D.+L.+Danielsauthor=M.+Slaterauthor=M.+G.+Woodauthor=M.+Congauthor=Y.-Q.+Chengauthor=K.+V.+Wood&title=Target+engagement+and+drug+residence+time+can+be+observed+in+living+cells+with+BRET&doi=10.1038%2Fncomms10091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Target engagement and drug residence time can be observed in living cells with BRET</span></div><div class="casAuthors">Robers, Matthew B.; Dart, Melanie L.; Woodroofe, Carolyn C.; Zimprich, Chad A.; Kirkland, Thomas A.; Machleidt, Thomas; Kupcho, Kevin R.; Levin, Sergiy; Hartnett, James R.; Zimmerman, Kristopher; Niles, Andrew L.; Ohana, Rachel Friedman; Daniels, Danette L.; Slater, Michael; Wood, Monika G.; Cong, Mei; Cheng, Yi-Qiang; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10091</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The therapeutic action of drugs is predicated on their phys. engagement with cellular targets.  Here we describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reveal the binding characteristics of a drug with selected targets within intact cells.  Cell-permeable fluorescent tracers are used in a competitive binding format to quantify drug engagement with the target proteins fused to Nanoluc luciferase.  The approach enabled us to profile isoenzyme-specific engagement and binding kinetics for a panel of histone deacetylase (HDAC) inhibitors.  Our anal. was directed particularly to the clin. approved prodrug FK228 (Istodax/Romidepsin) because of its unique and largely unexplained mechanism of sustained intracellular action.  Anal. of the binding kinetics by BRET revealed remarkably long intracellular residence times for FK228 at HDAC1, explaining the protracted intracellular behavior of this prodrug.  Our results demonstrate a novel application of BRET for assessing target engagement within the complex milieu of the intracellular environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFFk0LNiL_LVg90H21EOLACvtfcHk0ljsVIsGJmq4wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO&md5=723cc5dd7d229b1115da4c2c9d75c913</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fncomms10091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10091%26sid%3Dliteratum%253Aachs%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DDart%26aufirst%3DM.%2BL.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DZimprich%26aufirst%3DC.%2BA.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DKupcho%26aufirst%3DK.%2BR.%26aulast%3DLevin%26aufirst%3DS.%26aulast%3DHartnett%26aufirst%3DJ.%2BR.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DNiles%26aufirst%3DA.%2BL.%26aulast%3DOhana%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DM.%2BG.%26aulast%3DCong%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DY.-Q.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DTarget%2520engagement%2520and%2520drug%2520residence%2520time%2520can%2520be%2520observed%2520in%2520living%2520cells%2520with%2520BRET%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10091%26doi%3D10.1038%2Fncomms10091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsup, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward-Tharp, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnerly, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radi, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4234</span>– <span class="NLM_lpage">4243</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1003668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.4049%2Fjimmunol.1003668" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=4234-4243&issue=7&author=K.+Ghoreschiauthor=M.+I.+Jessonauthor=X.+Liauthor=J.+L.+Leeauthor=S.+Ghoshauthor=J.+W.+Alsupauthor=J.+D.+Warnerauthor=M.+Tanakaauthor=S.+M.+Steward-Tharpauthor=M.+Gadinaauthor=C.+J.+Thomasauthor=J.+C.+Minnerlyauthor=C.+E.+Storerauthor=T.+P.+LaBrancheauthor=Z.+A.+Radiauthor=M.+E.+Dowtyauthor=R.+D.+Headauthor=D.+M.+Meyerauthor=N.+Kishoreauthor=J.+J.+O%E2%80%99Shea&title=Modulation+of+innate+and+adaptive+immune+responses+by+tofacitinib+%28CP-690%2C550%29&doi=10.4049%2Fjimmunol.1003668"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1003668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1003668%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BL.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DAlsup%26aufirst%3DJ.%2BW.%26aulast%3DWarner%26aufirst%3DJ.%2BD.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSteward-Tharp%26aufirst%3DS.%2BM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DMinnerly%26aufirst%3DJ.%2BC.%26aulast%3DStorer%26aufirst%3DC.%2BE.%26aulast%3DLaBranche%26aufirst%3DT.%2BP.%26aulast%3DRadi%26aufirst%3DZ.%2BA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DHead%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DModulation%2520of%2520innate%2520and%2520adaptive%2520immune%2520responses%2520by%2520tofacitinib%2520%2528CP-690%252C550%2529%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26issue%3D7%26spage%3D4234%26epage%3D4243%26doi%3D10.4049%2Fjimmunol.1003668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haché, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Moos, E.</span></span> <span> </span><span class="NLM_article-title">A practical Oxone®-mediated, high-throughput, solution-phase synthesis of benzimidazoles from 1,2-phenylenediamines and aldehydes and its application to preparative scale synthesis</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2003</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1683</span>– <span class="NLM_lpage">1692</span>, <span class="refDoi"> DOI: 10.1055/s-2003-40888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1055%2Fs-2003-40888" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=1683-1692&issue=11&author=P.+L.+Beaulieuauthor=B.+Hach%C3%A9author=E.+von+Moos&title=A+practical+Oxone%C2%AE-mediated%2C+high-throughput%2C+solution-phase+synthesis+of+benzimidazoles+from+1%2C2-phenylenediamines+and+aldehydes+and+its+application+to+preparative+scale+synthesis&doi=10.1055%2Fs-2003-40888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-40888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-40888%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DHach%25C3%25A9%26aufirst%3DB.%26aulast%3Dvon%2BMoos%26aufirst%3DE.%26atitle%3DA%2520practical%2520Oxone%25C2%25AE-mediated%252C%2520high-throughput%252C%2520solution-phase%2520synthesis%2520of%2520benzimidazoles%2520from%25201%252C2-phenylenediamines%2520and%2520aldehydes%2520and%2520its%2520application%2520to%2520preparative%2520scale%2520synthesis%26jtitle%3DSynthesis%26date%3D2003%26volume%3D2003%26issue%3D11%26spage%3D1683%26epage%3D1692%26doi%3D10.1055%2Fs-2003-40888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dess, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. C.</span></span> <span> </span><span class="NLM_article-title">Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4156</span>, <span class="refDoi"> DOI: 10.1021/jo00170a070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00170a070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=4155-4156&issue=22&author=D.+B.+Dessauthor=J.+C.+Martin&title=Readily+accessible+12-I-5+oxidant+for+the+conversion+of+primary+and+secondary+alcohols+to+aldehydes+and+ketones&doi=10.1021%2Fjo00170a070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones</span></div><div class="casAuthors">Dess, D. B.; Martin, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4155-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Oxidn. of 2-IC6H4CO2H with KBrO3 in aq. H2SO4, followed by treatment of the oxidn. product with Ac2O gave 87% periodinane I, a 10-I-5 species (i.e., 10 valence electrons are formally involved in binding 5 ligands to the central iodine atom).  I reacted rapidly with primary or secondary alcs. at room temp. to give the corresponding aldehydes or ketones in high yield.  Excess I does not further oxidize the aldehyde or ketone under the reaction conditions.  The reaction is strongly catalyzed by excess alc. or strong acid, but is unaffected by pyridine.  I oxidizes benzylic alcs. selectively in the presence of satd. alcs.  Procedures for sepg. the carbonyl product from the reaction mixt. are mild and simple.  Cryst. I is stable at room temp. in the absence of moisture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAtQbosBW467Vg90H21EOLACvtfcHk0ljdNcS0lbDoCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D&md5=31b4835cd94c04773221d921e76231d1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00170a070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00170a070%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DReadily%2520accessible%252012-I-5%2520oxidant%2520for%2520the%2520conversion%2520of%2520primary%2520and%2520secondary%2520alcohols%2520to%2520aldehydes%2520and%2520ketones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26issue%3D22%26spage%3D4155%26epage%3D4156%26doi%3D10.1021%2Fjo00170a070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S. S.</span></span> <span> </span><span class="NLM_article-title">Highly practical copper(I)/TEMPO catalyst system for chemoselective aerobic oxidation of primary alcohols</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">16901</span>– <span class="NLM_lpage">16910</span>, <span class="refDoi"> DOI: 10.1021/ja206230h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja206230h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GitLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=16901-16910&issue=42&author=J.+M.+Hooverauthor=S.+S.+Stahl&title=Highly+practical+copper%28I%29%2FTEMPO+catalyst+system+for+chemoselective+aerobic+oxidation+of+primary+alcohols&doi=10.1021%2Fja206230h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Practical Copper(I)/TEMPO Catalyst System for Chemoselective Aerobic Oxidation of Primary Alcohols</span></div><div class="casAuthors">Hoover, Jessica M.; Stahl, Shannon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16901-16910</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aerobic oxidn. reactions have been the focus of considerable attention, but their use in mainstream org. chem. has been constrained by limitations in their synthetic scope and by practical factors, such as the use of pure O2 as the oxidant or complex catalyst synthesis.  Here, we report a new (bpy)CuI/TEMPO catalyst system that enables efficient and selective aerobic oxidn. of a broad range of primary alcs., including allylic, benzylic, and aliph. derivs., to the corresponding aldehydes, e.g. benzaldehyde, cinnamaldehyde, cyclohexanecarboxaldehyde, N-Boc-L-prolinal, using readily available reagents, at room temp. with ambient air as the oxidant.  The catalyst system is compatible with a wide range of functional groups and the high selectivity for 1° alcs. enables selective oxidn. of diols that lack protecting groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY-aJRI5siPbVg90H21EOLACvtfcHk0ljdNcS0lbDoCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GitLzK&md5=6f0bc378de72a715d623b0dcdc69b210</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja206230h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206230h%26sid%3Dliteratum%253Aachs%26aulast%3DHoover%26aufirst%3DJ.%2BM.%26aulast%3DStahl%26aufirst%3DS.%2BS.%26atitle%3DHighly%2520practical%2520copper%2528I%2529%252FTEMPO%2520catalyst%2520system%2520for%2520chemoselective%2520aerobic%2520oxidation%2520of%2520primary%2520alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26issue%3D42%26spage%3D16901%26epage%3D16910%26doi%3D10.1021%2Fja206230h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanchette, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essenfeld, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masamune, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Horner-Wadsworth-Emmons reaction: use of lithium chloride and an amine for base-sensitive compounds</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2183</span>– <span class="NLM_lpage">2186</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)80205-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2FS0040-4039%2801%2980205-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1984&pages=2183-2186&issue=21&author=M.+A.+Blanchetteauthor=W.+Choyauthor=J.+T.+Davisauthor=A.+P.+Essenfeldauthor=S.+Masamuneauthor=W.+R.+Roushauthor=T.+Sakai&title=Horner-Wadsworth-Emmons+reaction%3A+use+of+lithium+chloride+and+an+amine+for+base-sensitive+compounds&doi=10.1016%2FS0040-4039%2801%2980205-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2980205-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252980205-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchette%26aufirst%3DM.%2BA.%26aulast%3DChoy%26aufirst%3DW.%26aulast%3DDavis%26aufirst%3DJ.%2BT.%26aulast%3DEssenfeld%26aufirst%3DA.%2BP.%26aulast%3DMasamune%26aufirst%3DS.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DHorner-Wadsworth-Emmons%2520reaction%253A%2520use%2520of%2520lithium%2520chloride%2520and%2520an%2520amine%2520for%2520base-sensitive%2520compounds%26jtitle%3DTetrahedron%2520Lett.%26date%3D1984%26volume%3D25%26issue%3D21%26spage%3D2183%26epage%3D2186%26doi%3D10.1016%2FS0040-4039%2801%2980205-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maetz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span> <span> </span><span class="NLM_article-title">A simple preparation of N-protected chiral α-aminonitriles from N-protected α-amino acid amides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">4221</span>– <span class="NLM_lpage">4222</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(97)00895-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2FS0040-4039%2897%2900895-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=4221-4222&issue=24&author=P.+Maetzauthor=M.+Rodriguez&title=A+simple+preparation+of+N-protected+chiral+%CE%B1-aminonitriles+from+N-protected+%CE%B1-amino+acid+amides&doi=10.1016%2FS0040-4039%2897%2900895-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2897%2900895-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252897%252900895-2%26sid%3Dliteratum%253Aachs%26aulast%3DMaetz%26aufirst%3DP.%26aulast%3DRodriguez%26aufirst%3DM.%26atitle%3DA%2520simple%2520preparation%2520of%2520N-protected%2520chiral%2520%25CE%25B1-aminonitriles%2520from%2520N-protected%2520%25CE%25B1-amino%2520acid%2520amides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26issue%3D24%26spage%3D4221%26epage%3D4222%26doi%3D10.1016%2FS0040-4039%2897%2900895-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hett, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a JAK3-selective inhibitor: functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3442</span>– <span class="NLM_lpage">3451</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00677</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00677" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3442-3451&issue=12&author=J.-B.+Telliezauthor=M.+E.+Dowtyauthor=L.+Wangauthor=J.+Jussifauthor=T.+Linauthor=L.+Liauthor=E.+Moyauthor=P.+Balboauthor=W.+Liauthor=Y.+Zhaoauthor=K.+Crouseauthor=C.+Dickinsonauthor=P.+Symanowiczauthor=M.+Hegenauthor=M.+E.+Bankerauthor=F.+Vincentauthor=R.+Unwallaauthor=S.+Liangauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=X.+Yangauthor=J.+Baumanauthor=J.+I.+Trujilloauthor=A.+Casimiro-Garciaauthor=F.+F.+Vajdosauthor=L.+Leungauthor=K.+F.+Geogheganauthor=A.+Quaziauthor=D.+Xuanauthor=L.+Jonesauthor=E.+Hettauthor=K.+Wrightauthor=J.+D.+Clarkauthor=A.+Thorarensen&title=Discovery+of+a+JAK3-selective+inhibitor%3A+functional+differentiation+of+JAK3-selective+inhibition+over+pan-JAK+or+JAK1-selective+inhibition&doi=10.1021%2Facschembio.6b00677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00677%26sid%3Dliteratum%253Aachs%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMoy%26aufirst%3DE.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DCrouse%26aufirst%3DK.%26aulast%3DDickinson%26aufirst%3DC.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DQuazi%26aufirst%3DA.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DHett%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520JAK3-selective%2520inhibitor%253A%2520functional%2520differentiation%2520of%2520JAK3-selective%2520inhibition%2520over%2520pan-JAK%2520or%2520JAK1-selective%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D3442%26epage%3D3451%26doi%3D10.1021%2Facschembio.6b00677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P.</span></span> <span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&issue=1&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lj7QRsc2mMMLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26issue%3D1%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Processing of X-ray snapshots from crystals in random orientations</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2204</span>– <span class="NLM_lpage">2216</span>, <span class="refDoi"> DOI: 10.1107/S1399004714013534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS1399004714013534" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=2204-2216&issue=8&author=W.+Kabsch&title=Processing+of+X-ray+snapshots+from+crystals+in+random+orientations&doi=10.1107%2FS1399004714013534"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS1399004714013534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004714013534%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520snapshots%2520from%2520crystals%2520in%2520random%2520orientations%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2014%26volume%3D70%26issue%3D8%26spage%3D2204%26epage%3D2216%26doi%3D10.1107%2FS1399004714013534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">Pt 4</span>),  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&issue=Pt+4&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lh6PZLPHPsg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26issue%3DPt%25204%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lh6PZLPHPsg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&issue=4&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lh6PZLPHPsg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3D4%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&issue=1&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0ljx98eAusXxRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D1%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span> <i>PyMol. Molecular Graphics System</i>, version 0.99rc6; <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=W.+L.+DeLano&title=PyMol.+Molecular+Graphics+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26jtitle%3DPyMol.%2520Molecular%2520Graphics%2520System%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>ZINC15. <a href="http://zinc15.docking.org/patterns/home/" class="extLink">http://zinc15.docking.org/patterns/home/</a> (accessed 20.03.<span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ZINC15.+http%3A%2F%2Fzinc15.docking.org%2Fpatterns%2Fhome%2F+%28accessed+20.03.2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maria Galvez-Llompart, Riccardo Ocello, Laura Rullo, Serena Stamatakos, Irene Alessandrini, Riccardo Zanni, Iñaki Tuñón, Andrea Cavalli, Sanzio Candeletti, Matteo Masetti, Patrizia Romualdi, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Recanatini</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the JAK/STAT Pathway: A Combined Ligand- and Target-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (6)
                                     , 3091-3108. <a href="https://doi.org/10.1021/acs.jcim.0c01468" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01468%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DTargeting%252Bthe%252BJAK%25252FSTAT%252BPathway%25253A%252BA%252BCombined%252BLigand-%252Band%252BTarget-Based%252BApproach%26aulast%3DGalvez-Llompart%26aufirst%3DMaria%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22122020%26date%3D17052021%26volume%3D61%26issue%3D6%26spage%3D3091%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Han Zhang, Wenjuan Jiang, Payal Chatterjee, <span class="NLM_string-name hlFld-ContribAuthor">Yun Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (5)
                                     , 2093-2102. <a href="https://doi.org/10.1021/acs.jcim.8b00959" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00959%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26volume%3D139%26spage%3D17945%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DRanking%252BReversible%252BCovalent%252BDrugs%25253A%252BFrom%252BFree%252BEnergy%252BPerturbation%252Bto%252BFragment%252BDocking%26aulast%3DZhang%26aufirst%3DHan%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D25122018%26date%3D27022019%26date%3D14022019%26volume%3D59%26issue%3D5%26spage%3D2093%26epage%3D2102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judit  Remenyi</span>, <span class="hlFld-ContribAuthor ">Rangeetha Jayaprakash  Naik</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Momchil  Razsolkov</span>, <span class="hlFld-ContribAuthor ">Alyssa  Verano</span>, <span class="hlFld-ContribAuthor ">Quan  Cai</span>, <span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Rachel  Toth</span>, <span class="hlFld-ContribAuthor ">Samantha  Raggett</span>, <span class="hlFld-ContribAuthor ">Carla  Baillie</span>, <span class="hlFld-ContribAuthor ">Ryan  Traynor</span>, <span class="hlFld-ContribAuthor ">C. James  Hastie</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">J. Simon C.  Arthur</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of a chemical genetic model for JAK3. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-89356-4" title="DOI URL">https://doi.org/10.1038/s41598-021-89356-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-89356-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-89356-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DGeneration%252Bof%252Ba%252Bchemical%252Bgenetic%252Bmodel%252Bfor%252BJAK3%26aulast%3DRemenyi%26aufirst%3DJudit%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Amy C.  Hart</span>, <span class="hlFld-ContribAuthor ">Ryan  Moslin</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>. </span><span class="cited-content_cbyCitation_article-title">JAK
              Family Inhibitors for Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-86. <a href="https://doi.org/10.1002/0471266949.bmc279" title="DOI URL">https://doi.org/10.1002/0471266949.bmc279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc279%26sid%3Dliteratum%253Aachs%26atitle%3DJAK%252BFamily%252BInhibitors%252Bfor%252BAutoimmune%252BDiseases%26aulast%3DBorzilleri%26aufirst%3DRobert%2BM.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D86%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaurav  Raina</span>, <span class="hlFld-ContribAuthor ">Prakash  Kannaboina</span>, <span class="hlFld-ContribAuthor ">Qazi Naveed  Ahmed</span>, <span class="hlFld-ContribAuthor ">Krishanu  Mondal</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Barluenga‐Valdes Type Cross‐Coupling Reaction: Alkenylation of 7‐Azaindole
              s. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 251-256. <a href="https://doi.org/10.1002/ajoc.202000516" title="DOI URL">https://doi.org/10.1002/ajoc.202000516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000516%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BBarluenga%2525E2%252580%252590Valdes%252BType%252BCross%2525E2%252580%252590Coupling%252BReaction%25253A%252BAlkenylation%252Bof%252B7%2525E2%252580%252590Azaindole%252Bs%26aulast%3DRaina%26aufirst%3DGaurav%26date%3D2021%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D251%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Xiaojun Julia  Liang</span>, <span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Stefan  Gerstenecker</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9269. <a href="https://doi.org/10.3390/ijms21239269" title="DOI URL">https://doi.org/10.3390/ijms21239269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239269%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BClass%252Bof%252BCovalent%252BDual%252BInhibitors%252BTargeting%252Bthe%252BProtein%252BKinases%252BBMX%252Band%252BBTK%26aulast%3DForster%26aufirst%3DMichael%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Urvashi</span>, <span class="hlFld-ContribAuthor ">Mohammad Ovais  Dar</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>, <span class="hlFld-ContribAuthor ">Shrikant  Kukreti</span>, <span class="hlFld-ContribAuthor ">Vibha  Tandon</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(II)-catalyzed sulfonylation of 7-azaindoles using DABSO as SO2-Source and its mechanistic study. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (28-29)
                                     , 131337. <a href="https://doi.org/10.1016/j.tet.2020.131337" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131337%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCu%252528II%252529-catalyzed%252Bsulfonylation%252Bof%252B7-azaindoles%252Busing%252BDABSO%252Bas%252BSO2-Source%252Band%252Bits%252Bmechanistic%252Bstudy%26aulast%3DUrvashi%26date%3D2020%26volume%3D76%26issue%3D28-29%26spage%3D131337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors: An Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 43-94. <a href="https://doi.org/10.1007/7355_2020_103" title="DOI URL">https://doi.org/10.1007/7355_2020_103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_103%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%25253A%252BAn%252BOverview%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D43%26epage%3D94%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Janus Kinase 3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-256. <a href="https://doi.org/10.1007/7355_2020_96" title="DOI URL">https://doi.org/10.1007/7355_2020_96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_96%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BJanus%252BKinase%252B3%252BInhibitors%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D256%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihai  Ke</span>, <span class="hlFld-ContribAuthor ">Ying-Yeung  Yeung</span>. </span><span class="cited-content_cbyCitation_article-title">Furans and Their Benzo Derivatives: Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14770-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14770-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14770-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14770-5%26sid%3Dliteratum%253Aachs%26atitle%3DFurans%252Band%252BTheir%252BBenzo%252BDerivatives%25253A%252BApplications%26aulast%3DKe%26aufirst%3DZhihai%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-Heon  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Three Heterocyclic Rings Fused (5-6-5). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14899-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14899-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14899-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14899-1%26sid%3Dliteratum%253Aachs%26atitle%3DThree%252BHeterocyclic%252BRings%252BFused%252B%2525285-6-5%252529%26aulast%3DSong%26aufirst%3DYang-Heon%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farzan  Solimani</span>, <span class="hlFld-ContribAuthor ">Katharina  Meier</span>, <span class="hlFld-ContribAuthor ">Kamran  Ghoreschi</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Topical and Systemic JAK Inhibitors in Dermatology. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.02847" title="DOI URL">https://doi.org/10.3389/fimmu.2019.02847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.02847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.02847%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DEmerging%252BTopical%252Band%252BSystemic%252BJAK%252BInhibitors%252Bin%252BDermatology%26aulast%3DSolimani%26aufirst%3DFarzan%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.  Solimani</span>, <span class="hlFld-ContribAuthor ">F. J.  Hilke</span>, <span class="hlFld-ContribAuthor ">K.  Ghoreschi</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmakologie der Januskinaseinhibitoren. </span><span class="cited-content_cbyCitation_journal-name">Der Hautarzt</span><span> <strong>2019,</strong> <em>70 </em>
                                    (12)
                                     , 934-941. <a href="https://doi.org/10.1007/s00105-019-04509-x" title="DOI URL">https://doi.org/10.1007/s00105-019-04509-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00105-019-04509-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00105-019-04509-x%26sid%3Dliteratum%253Aachs%26jtitle%3DDer%2520Hautarzt%26atitle%3DPharmakologie%252Bder%252BJanuskinaseinhibitoren%26aulast%3DSolimani%26aufirst%3DF.%26date%3D2019%26date%3D2019%26volume%3D70%26issue%3D12%26spage%3D934%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Dai</span>, <span class="hlFld-ContribAuthor ">LiXi  Yang</span>, <span class="hlFld-ContribAuthor ">Glynn  Addison</span>. </span><span class="cited-content_cbyCitation_article-title">Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (18)
                                     , 1531-1543. <a href="https://doi.org/10.2174/1389557519666190617152011" title="DOI URL">https://doi.org/10.2174/1389557519666190617152011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666190617152011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666190617152011%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252BStatus%252Bin%252Bthe%252BDiscovery%252Bof%252BCovalent%252BJanus%252BKinase%252B3%252B%252528JAK3%252529%252BInhibitors%26aulast%3DDai%26aufirst%3DJun%26date%3D2019%26volume%3D19%26issue%3D18%26spage%3D1531%26epage%3D1543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weigang  Fan</span>, <span class="hlFld-ContribAuthor ">Charlie  Verrier</span>, <span class="hlFld-ContribAuthor ">Yves  Queneau</span>, <span class="hlFld-ContribAuthor ">Florence  Popowycz</span>. </span><span class="cited-content_cbyCitation_article-title">5-Hydroxymethylfurfural (HMF) in Organic Synthesis: A Review of its Recent Applications Towards Fine Chemicals. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (4)
                                     , 583-614. <a href="https://doi.org/10.2174/1570179416666190412164738" title="DOI URL">https://doi.org/10.2174/1570179416666190412164738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190412164738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190412164738%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3D5-Hydroxymethylfurfural%252B%252528HMF%252529%252Bin%252BOrganic%252BSynthesis%25253A%252BA%252BReview%252Bof%252Bits%252BRecent%252BApplications%252BTowards%252BFine%252BChemicals%26aulast%3DFan%26aufirst%3DWeigang%26date%3D2019%26volume%3D16%26issue%3D4%26spage%3D583%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anja  Dullius</span>, <span class="hlFld-ContribAuthor ">Claudia Monfroni  Rocha</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Claucia Fernanda Volken  de Souza</span>, <span class="hlFld-ContribAuthor ">Márcia Inês  Goettert</span>. </span><span class="cited-content_cbyCitation_article-title">Are peptides a solution for the treatment of hyperactivated JAK3 pathways?. </span><span class="cited-content_cbyCitation_journal-name">Inflammopharmacology</span><span> <strong>2019,</strong> <em>27 </em>
                                    (3)
                                     , 433-452. <a href="https://doi.org/10.1007/s10787-019-00589-2" title="DOI URL">https://doi.org/10.1007/s10787-019-00589-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10787-019-00589-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10787-019-00589-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInflammopharmacology%26atitle%3DAre%252Bpeptides%252Ba%252Bsolution%252Bfor%252Bthe%252Btreatment%252Bof%252Bhyperactivated%252BJAK3%252Bpathways%25253F%26aulast%3DDullius%26aufirst%3DAnja%26date%3D2019%26date%3D2019%26volume%3D27%26issue%3D3%26spage%3D433%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria J.  Matos</span>, <span class="hlFld-ContribAuthor ">Claudio D.  Navo</span>, <span class="hlFld-ContribAuthor ">Tuuli  Hakala</span>, <span class="hlFld-ContribAuthor ">Xhenti  Ferhati</span>, <span class="hlFld-ContribAuthor ">Ana  Guerreiro</span>, <span class="hlFld-ContribAuthor ">David  Hartmann</span>, <span class="hlFld-ContribAuthor ">Barbara  Bernardim</span>, <span class="hlFld-ContribAuthor ">Kadi L.  Saar</span>, <span class="hlFld-ContribAuthor ">Ismael  Compañón</span>, <span class="hlFld-ContribAuthor ">Francisco  Corzana</span>, <span class="hlFld-ContribAuthor ">Tuomas P. J.  Knowles</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Jiménez‐Osés</span>, <span class="hlFld-ContribAuthor ">Gonçalo J. L.  Bernardes</span>. </span><span class="cited-content_cbyCitation_article-title">Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (20)
                                     , 6712-6716. <a href="https://doi.org/10.1002/ange.201901405" title="DOI URL">https://doi.org/10.1002/ange.201901405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201901405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201901405%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DQuaternization%252Bof%252BVinyl%25252FAlkynyl%252BPyridine%252BEnables%252BUltrafast%252BCysteine%2525E2%252580%252590Selective%252BProtein%252BModification%252Band%252BCharge%252BModulation%26aulast%3DMatos%26aufirst%3DMaria%2BJ.%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D20%26spage%3D6712%26epage%3D6716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria J.  Matos</span>, <span class="hlFld-ContribAuthor ">Claudio D.  Navo</span>, <span class="hlFld-ContribAuthor ">Tuuli  Hakala</span>, <span class="hlFld-ContribAuthor ">Xhenti  Ferhati</span>, <span class="hlFld-ContribAuthor ">Ana  Guerreiro</span>, <span class="hlFld-ContribAuthor ">David  Hartmann</span>, <span class="hlFld-ContribAuthor ">Barbara  Bernardim</span>, <span class="hlFld-ContribAuthor ">Kadi L.  Saar</span>, <span class="hlFld-ContribAuthor ">Ismael  Compañón</span>, <span class="hlFld-ContribAuthor ">Francisco  Corzana</span>, <span class="hlFld-ContribAuthor ">Tuomas P. J.  Knowles</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Jiménez‐Osés</span>, <span class="hlFld-ContribAuthor ">Gonçalo J. L.  Bernardes</span>. </span><span class="cited-content_cbyCitation_article-title">Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (20)
                                     , 6640-6644. <a href="https://doi.org/10.1002/anie.201901405" title="DOI URL">https://doi.org/10.1002/anie.201901405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201901405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201901405%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DQuaternization%252Bof%252BVinyl%25252FAlkynyl%252BPyridine%252BEnables%252BUltrafast%252BCysteine%2525E2%252580%252590Selective%252BProtein%252BModification%252Band%252BCharge%252BModulation%26aulast%3DMatos%26aufirst%3DMaria%2BJ.%26date%3D2019%26volume%3D58%26issue%3D20%26spage%3D6640%26epage%3D6644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanxun  Wang</span>, <span class="hlFld-ContribAuthor ">Yunfei  Du</span>, <span class="hlFld-ContribAuthor ">Niu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">A survey of the role of nitrile groups in protein–ligand interactions. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (23)
                                     , 2713-2728. <a href="https://doi.org/10.4155/fmc-2018-0252" title="DOI URL">https://doi.org/10.4155/fmc-2018-0252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0252%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DA%252Bsurvey%252Bof%252Bthe%252Brole%252Bof%252Bnitrile%252Bgroups%252Bin%252Bprotein%2525E2%252580%252593ligand%252Binteractions%26aulast%3DWang%26aufirst%3DYuanxun%26date%3D2018%26volume%3D10%26issue%3D23%26spage%3D2713%26epage%3D2728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of known reference JAK inhibitors discussed in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Compound <b>23</b> bound to JAK3 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWM">5LWM</a>). (b) Compound <b>1</b> bound to JAK3 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>). Comparison of the protein surfaces surrounding C909 (illustrated as ball/stick) shows that <b>23</b> induces a distinct binding pocket by interaction of the nitrile substituent and R911. The cavity is generated by significant rearrangement of the side chains of R911 and R953.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Compound <b>10</b> bound to JAK3 (PDB: 6GL9). (b) Compound <b>11</b> bound to JAK3 (PDB: 6GLA). (c) Compound <b>20</b> bound to JAK3 (PDB: 6GLB). Acrylonitriles <b>10</b> and <b>11</b> induce the arginine pocket as observed in the JAK3 complex with compound <b>23</b>. Saturated alkylnitrile <b>20</b> was not able to induce this cavity, and R911 and R953 shared similar conformation as observed in the crystal structure of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures and inhibition data of compounds <b>29</b> and <b>30</b>. IC<sub>50</sub> values are calculated from the results of an ELISA<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> as average ± SEM (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative BRET data measured on JAK3 kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of cytokine-induced STAT-phosphorylation of selected compounds. Human CD4<sup>+</sup> T-cells were incubated with the indicated concentrations of <b>1</b>, <b>2</b>, <b>11</b>, <b>23</b>, <b>27</b>, or <b>28</b> for 1 h followed by 30 min stimulation with single cytokines. The cells were lysed, and the pSTAT levels were determined via immunoblotting. Actin was coblotted to ensure equal loadings. IL-2 activates JAK1/3-dependent STAT5 phosphorylation (A), IL-4 activates JAK1/3-dependent STAT6 phosphorylation (B), IL-6 activates JAK1/JAK2/TYK2-dependent STAT3 phosphorylation (C), and IFN-α activates JAK1/TYK2-dependent STAT1 phosphorylation (D). The cellular assays/immunoblots for <b>1</b> and <b>23</b> were performed in a separate experiment as published previously<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> than the tests/blots for <b>2</b>, <b>11</b>, <b>27</b>, and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/medium/jm-2018-005717_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of JAK Inhibitors <b>3</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00571/20180622/images/large/jm-2018-005717_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00571&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) NaH, TsCl, THF, 0 °C to rt, 93%; (ii) Me<sub>4</sub>N·NO<sub>3</sub>, TFAA, DCM, 0–5 °C, 67%; (iii) cyclohexylamine, Et<sub>3</sub>N, <i>i</i>PrOH, reflux, 94%; (iv) Pd/C, H<sub>2</sub>, MeOH/EtOAc, 50 °C, quant; (v) corresponding aldehyde, KHSO<sub>5</sub>, DMF/H<sub>2</sub>O, rt, 68–72%; (vi) DMP, DCM, rt, 80–92%; (vii) Cu(MeCN)<sub>4</sub>·OTf, TEMPO, bpy, NMI, O<sub>2</sub>, MeCN, 50 °C, 87%; (viii) KOH, MeOH, rt, 54–75%; (ix) corresponding HWE-reagent, LiCl, DBU, MeCN/CHCl<sub>3</sub>, 54–88%; (x) Pd/C, H<sub>2</sub>, MeOH/EtOAc, rt, 60–95%; (xi) corresponding cyanoacetamide or malononitrile, piperidine, MeOH, 60 °C, 20–93%; (xii) cyanuric chloride, DMF, rt, 50–81%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms and consequences of JAK-STAT signaling in the immune system</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1038/ni.3691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fni.3691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=28323260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFagu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=374-384&issue=4&author=A.+V.+Villarinoauthor=Y.+Kannoauthor=J.+J.+O%E2%80%99Shea&title=Mechanisms+and+consequences+of+JAK-STAT+signaling+in+the+immune+system&doi=10.1038%2Fni.3691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms and consequences of Jak-STAT signaling in the immune system</span></div><div class="casAuthors">Villarino, Alejandro V.; Kanno, Yuka; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">374-384</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal transducer and activator of transcription') family constitute a rapid membrane-to-nucleus signaling module that affects every aspect of the mammalian immune system.  Research on this paradigmatic pathway has experienced breakneck growth in the quarter century since its discovery and has yielded a stream of basic and clin. insights that have profoundly influenced modern understanding of human health and disease, exemplified by the bench-to-bedside success of Jak inhibitors ('jakinibs') and pathway-targeting drugs.  Here we review recent advances in Jak-STAT biol., focusing on immune cell function, disease etiol. and therapeutic intervention, as well as broader principles of gene regulation and signal-dependent TFs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrUlP3emd5BrVg90H21EOLACvtfcHk0lixHrBOy2-rYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFagu7c%253D&md5=b50a88aee2b64fcb85c9a64d4ec1724e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni.3691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3691%26sid%3Dliteratum%253Aachs%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DMechanisms%2520and%2520consequences%2520of%2520JAK-STAT%2520signaling%2520in%2520the%2520immune%2520system%26jtitle%3DNat.%2520Immunol.%26date%3D2017%26volume%3D18%26issue%3D4%26spage%3D374%26epage%3D384%26doi%3D10.1038%2Fni.3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAKs and STATs: biological implications</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&issue=1&author=W.%0AJ.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKs+and+STATs%3A+biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0lixHrBOy2-rYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKs%2520and%2520STATs%253A%2520biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26issue%3D1%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spolski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">New insights into the regulation of T cells by γc family cytokines</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1038/nri2580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnri2580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19543225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=480-490&issue=7&author=Y.+Rochmanauthor=R.+Spolskiauthor=W.+J.+Leonard&title=New+insights+into+the+regulation+of+T+cells+by+%CE%B3c+family+cytokines&doi=10.1038%2Fnri2580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the regulation of T cells by γc family cytokines</span></div><div class="casAuthors">Rochman, Yrina; Spolski, Rosanne; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Common cytokine receptor γ-chain (γc) family cytokines have crucial roles in the development, proliferation, survival and differentiation of multiple cell lineages of both the innate and adaptive immune systems.  In this Review, the authors focus on the current understanding of the distinct and overlapping effects of interleukin-2 (IL-2), IL-7, IL-9, IL-15 and IL-21, as well as the IL-7-related cytokine thymic stromal lymphopoietin (TSLP), on the survival and proliferation of conventional αβ T cells, γδ T cells and regulatory T cells.  This knowledge potentially allows for the therapeutic manipulation of immune responses for the treatment of cancer, autoimmunity, allergic diseases and immunodeficiency, as well as for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GBlSyD8_NLVg90H21EOLACvtfcHk0lixHrBOy2-rYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D&md5=a6c7285b05193002b89be7233d11f271</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2580%26sid%3Dliteratum%253Aachs%26aulast%3DRochman%26aufirst%3DY.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DNew%2520insights%2520into%2520the%2520regulation%2520of%2520T%2520cells%2520by%2520%25CE%25B3c%2520family%2520cytokines%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26issue%3D7%26spage%3D480%26epage%3D490%26doi%3D10.1038%2Fnri2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>228</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&issue=1&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lgQvILaJhzKVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26issue%3D1%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candotti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notarangelo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAK3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>203</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1111/j.0105-2896.2005.00220.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1111%2Fj.0105-2896.2005.00220.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=15661026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2005&pages=127-142&issue=1&author=M.+Pesuauthor=F.+Candottiauthor=M.+Husaauthor=S.+R.+Hofmannauthor=L.+D.+Notarangeloauthor=J.+J.+O%E2%80%99Shea&title=JAK3%2C+severe+combined+immunodeficiency%2C+and+a+new+class+of+immunosuppressive+drugs&doi=10.1111%2Fj.0105-2896.2005.00220.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span></div><div class="casAuthors">Pesu, Marko; Candotti, Fabio; Husa, Matthew; Hofmann, Sigrun R.; Notarangelo, Luigi D.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent elucidation of the multiple mol. mechanisms underlying severe combined immunodeficiency (SCID) is an impressive example of the power of mol. medicine.  Anal. of patients and the concomitant generation of animal models mimicking these disorders have quickly provided great insights into the pathophysiol. of these potentially devastating illnesses.  Here, the authors summarize the discoveries that led to the understanding of the role of cytokine receptors and a specific tyrosine kinase, Janus kinase 3 (Jak3), in the pathogenesis of SCID.  The authors discuss how the identification of mutations of Jak3 in autosomal recessive SCID has facilitated the diagnosis of these disorders, offered new insights into the biol. of this kinase, permitted new avenues for therapy, and provided the rationale for a generation of a new class of immunosuppressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYir7OTbMwFbVg90H21EOLACvtfcHk0lgQvILaJhzKVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D&md5=038b25b97798eda4b6aa1818238e45ba</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.0105-2896.2005.00220.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0105-2896.2005.00220.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DHusa%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DS.%2BR.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK3%252C%2520severe%2520combined%2520immunodeficiency%252C%2520and%2520a%2520new%2520class%2520of%2520immunosuppressive%2520drugs%26jtitle%3DImmunol.%2520Rev.%26date%3D2005%26volume%3D203%26issue%3D1%26spage%3D127%26epage%3D142%26doi%3D10.1111%2Fj.0105-2896.2005.00220.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borie, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">A new modality for immunosuppression: targeting the JAK/STAT pathway</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/nrd1441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnrd1441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=15232577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&issue=7&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+new+modality+for+immunosuppression%3A+targeting+the+JAK%2FSTAT+pathway&doi=10.1038%2Fnrd1441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A new modality for immunosuppression: targeting the JAK/STAT pathway</span></div><div class="casAuthors">O'Shea, John J.; Pesu, Marko; Borie, Dominic C.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Thousands of organs are transplanted each year and millions of people suffer from autoimmune diseases, which creates a need for an armamentarium of immunosuppressive drugs.  Unfortunately, immunosuppressants have unwanted side effects owing, in part, to the fact that they have ubiquitous mol. targets.  Cytokines have emerged as important controllers of the immune response, and work during the past decade has identified Janus kinases (JAKs) and signal transducers, and activators of transcription (STATs), as crucial intracellular elements in cytokine signalling.  Here, we discuss the potential of the JAK/STAT pathway as a target for new immunosuppressants.  In particular, the inhibition of JAK3 seems to be an excellent strategy, because of the selective expression and precise functions of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhrBmh4tsEibVg90H21EOLACvtfcHk0lgQvILaJhzKVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D&md5=7f09261dbb7c43b4eedb750a35f8e7d5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd1441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1441%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520new%2520modality%2520for%2520immunosuppression%253A%2520targeting%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D7%26spage%3D555%26epage%3D564%26doi%3D10.1038%2Fnrd1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">843</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnrd.2017.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=29104284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=843&author=D.+M.+Schwartzauthor=Y.+Kannoauthor=A.+Villarinoauthor=M.+Wardauthor=M.+Gadinaauthor=J.+J.+O%E2%80%99Shea&title=JAK+inhibition+as+a+therapeutic+strategy+for+immune+and+inflammatory+diseases&doi=10.1038%2Fnrd.2017.201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span></div><div class="casAuthors">Schwartz, Daniella M.; Kanno, Yuka; Villarino, Alejandro; Ward, Michael; Gadina, Massimo; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">843-862</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts to target their assocd. signalling pathways.  Janus kinases (JAKs) are essential signalling mediators downstream of many pro-inflammatory cytokines, and small-mol. inhibitors of JAKs (jakinibs) have gained traction as safe and efficacious options for the treatment of inflammation-driven pathologies such as rheumatoid arthritis, psoriasis and inflammatory bowel disease.  Building on the clin. success of first-generation jakinibs, second-generation compds. that claim to be more selective are currently undergoing development and proceeding to clin. trials.  However, important questions remain about the advantages and limitations of improved JAK selectivity, optimal routes and dosing regimens and how best to identify patients who will benefit from jakinibs.  This Review discusses the biol. of jakinibs from a translational perspective, focusing on recent insights from clin. trials, the development of novel agents and the use of jakinibs in a spectrum of immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TNpGT01l8rVg90H21EOLACvtfcHk0li3LFqFLYsbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO&md5=4607422f83f94c0c7194935d6d460c31</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.201%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DVillarino%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520for%2520immune%2520and%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D843%26doi%3D10.1038%2Fnrd.2017.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1038/ni.1701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fni.1701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19295632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=356-360&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Selectivity+and+therapeutic+inhibition+of+kinases%3A+to+be+or+not+to+be%3F&doi=10.1038%2Fni.1701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-360</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases, which serve crit. functions in signaling pathways in all cells, are popular therapeutic targets.  At present, eight kinase inhibitors have been approved in the United States, each of which shows nanomolar potency.  Although the initial goal was to generate inhibitors with a high degree of selectivity, recent experience has revealed that many of these approved compds. target more than one kinase.  Surprisingly, this promiscuity is less problematic than one would have imagined; indeed, it opens new therapeutic opportunities.  In this Perspective, we discuss the present status of Janus kinase inhibitors-a new class of immunosuppressive drugs-and the advantages and disadvantages of selectively inhibiting this class of kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU0w6t4jgqirVg90H21EOLACvtfcHk0li3LFqFLYsbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D&md5=64dd47e897181d00e5dce6be3bc5db6e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fni.1701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1701%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSelectivity%2520and%2520therapeutic%2520inhibition%2520of%2520kinases%253A%2520to%2520be%2520or%2520not%2520to%2520be%253F%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26spage%3D356%26epage%3D360%26doi%3D10.1038%2Fni.1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolvering, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raulf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drückes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrmann, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">JAK1 has a dominant role over JAK3 in signal transduction through gamma-c-containing cytokine receptors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Dr%C3%BCckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=JAK1+has+a+dominant+role+over+JAK3+in+signal+transduction+through+gamma-c-containing+cytokine+receptors&doi=10.1016%2Fj.chembiol.2011.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0li3LFqFLYsbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJAK1%2520has%2520a%2520dominant%2520role%2520over%2520JAK3%2520in%2520signal%2520transduction%2520through%2520gamma-c-containing%2520cytokine%2520receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323%26doi%3D10.1016%2Fj.chembiol.2011.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drückes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">Selective inhibitors of the janus kinase JAK3—are they effective?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4617</span>– <span class="NLM_lpage">4621</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.bmcl.2014.08.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4617-4621&issue=19&author=G.+Thomaauthor=P.+Dr%C3%BCckesauthor=H.-G.+Zerwes&title=Selective+inhibitors+of+the+janus+kinase+JAK3%E2%80%94are+they+effective%3F&doi=10.1016%2Fj.bmcl.2014.08.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.046%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DSelective%2520inhibitors%2520of%2520the%2520janus%2520kinase%2520JAK3%25E2%2580%2594are%2520they%2520effective%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D19%26spage%3D4617%26epage%3D4621%26doi%3D10.1016%2Fj.bmcl.2014.08.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fensome, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span> <span> </span><span class="NLM_article-title">ATP-mediated kinome selectivity: the missing link in understanding the contribution of individual JAK kinase isoforms to cellular signaling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1552</span>– <span class="NLM_lpage">1558</span>, <span class="refDoi"> DOI: 10.1021/cb5002125</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5002125" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1552-1558&issue=7&author=A.+Thorarensenauthor=M.+E.+Bankerauthor=A.+Fensomeauthor=J.-B.+Telliezauthor=B.+Jubaauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garcia&title=ATP-mediated+kinome+selectivity%3A+the+missing+link+in+understanding+the+contribution+of+individual+JAK+kinase+isoforms+to+cellular+signaling&doi=10.1021%2Fcb5002125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fcb5002125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5002125%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26atitle%3DATP-mediated%2520kinome%2520selectivity%253A%2520the%2520missing%2520link%2520in%2520understanding%2520the%2520contribution%2520of%2520individual%2520JAK%2520kinase%2520isoforms%2520to%2520cellular%2520signaling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1552%26epage%3D1558%26doi%3D10.1021%2Fcb5002125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of janus kinase (JAK) inhibitors for inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&issue=12&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+development+of+janus+kinase+%28JAK%29+inhibitors+for+inflammatory+diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lj0lg-nP5gYlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520development%2520of%2520janus%2520kinase%2520%2528JAK%2529%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D12%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Farseeva, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span> <span> </span><span class="NLM_article-title">Selective JAK inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1439</span>– <span class="NLM_lpage">1471</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.4155%2Ffmc.14.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=25329199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1439-1471&issue=12&author=B.+W.+Dymockauthor=E.+G.+Yangauthor=Y.+Chu-Farseevaauthor=L.+Yao&title=Selective+JAK+inhibitors&doi=10.4155%2Ffmc.14.92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Selective JAK inhibitors</span></div><div class="casAuthors">Dymock, Brian W.; Yang, Eugene Guorong; Chu-Farseeva, Yuyi; Yao, Lianbin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1439-1471</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Consisting of four members, JAK1, JAK2, JAK3 and TYK2, the JAK kinases have emerged as important targets for proliferative and immune-inflammatory disorders.  Recent progress in the discovery of selective inhibitors has been significant, with selective compds. now reported for each isoform.  This article summarizes the current state-of-the-art with a discussion of the most recently described selective compds.  X-ray co-crystal structures reveal the mol. reasons for the obsd. biochem. selectivity.  A concluding anal. of JAK inhibitors in the clinic highlights increased clin. trial activity and diversity of indications.  Selective JAK inhibitors, as single agents or in combination regimens, have a very promising future in the treatment of oncol., immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6G9eFT7Ww27Vg90H21EOLACvtfcHk0lj0lg-nP5gYlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI&md5=343aa75228918e6e4e063adb1fed96f1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.92%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DChu-Farseeva%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DL.%26atitle%3DSelective%2520JAK%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471%26doi%3D10.4155%2Ffmc.14.92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span> <span> </span><span class="NLM_article-title">Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1107</span>, <span class="refDoi"> DOI: 10.1002/eji.201646680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1002%2Feji.201646680" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=1096-1107&issue=7&author=K.+Welschauthor=J.+Holsteinauthor=A.+Laurenceauthor=K.+Ghoreschi&title=Targeting+JAK%2FSTAT+signalling+in+inflammatory+skin+diseases+with+small+molecule+inhibitors&doi=10.1002%2Feji.201646680"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Feji.201646680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201646680%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DK.%26aulast%3DHolstein%26aufirst%3DJ.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DGhoreschi%26aufirst%3DK.%26atitle%3DTargeting%2520JAK%252FSTAT%2520signalling%2520in%2520inflammatory%2520skin%2520diseases%2520with%2520small%2520molecule%2520inhibitors%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2017%26volume%3D47%26issue%3D7%26spage%3D1096%26epage%3D1107%26doi%3D10.1002%2Feji.201646680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenkopf, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casavant, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang-Poa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doty, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whipple, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of CP-690’550: a potent and selective janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8468</span>– <span class="NLM_lpage">8484</span>, <span class="refDoi"> DOI: 10.1021/jm1004286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%E2%80%99550%3A+a+potent+and+selective+janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection&doi=10.1021%2Fjm1004286"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%25E2%2580%2599550%253A%2520a%2520potent%2520and%2520selective%2520janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484%26doi%3D10.1021%2Fjm1004286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuninger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchetto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangrevelinghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerwes, H.-G.</span></span> <span> </span><span class="NLM_article-title">Identification of a potent janus Kinase 3 Inhibitor with high selectivity within the janus kinase family</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1021/jm101157q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&issue=1&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+janus+Kinase+3+Inhibitor+with+high+selectivity+within+the+janus+kinase+family&doi=10.1021%2Fjm101157q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520janus%2520Kinase%25203%2520Inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D284%26epage%3D288%26doi%3D10.1021%2Fjm101157q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korniski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbrink, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6&doi=10.1016%2Fj.jmb.2010.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lhOpZttuXFwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433%26doi%3D10.1016%2Fj.jmb.2010.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">The cysteinome of protein kinases as a target in drug development</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4372</span>– <span class="NLM_lpage">4385</span>, <span class="refDoi"> DOI: 10.1002/anie.201707875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1002%2Fanie.201707875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=4372-4385&author=A.+Chaikuadauthor=P.+Kochauthor=S.+Lauferauthor=S.+Knapp&title=The+cysteinome+of+protein+kinases+as+a+target+in+drug+development&doi=10.1002%2Fanie.201707875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Cysteinome of Protein Kinases as a Target in Drug Development</span></div><div class="casAuthors">Chaikuad, Apirat; Koch, Pierre; Laufer, Stefan A.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4372-4385</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Drugs that function through covalent bond formation represent a considerable fraction of the authors' repository of effective medicines but safety concerns and the complexity of developing covalent inhibitors has rendered covalent targeting a less attractive strategy for rational drug design.  The recent approval of four covalent kinase inhibitors and the development of highly potent covalent kinase probes with exceptional selectivity has raised significant interest in industry and academic research and validated the concept of covalent kinase targeting for clin. applications.  The abundance of cysteines at diverse positions in and around the kinase active site suggests that a large fraction of kinases can be targeted by covalent inhibitors.  Herein, the authors review recent developments of this rapidly growing area in kinase drug development and highlight the unique opportunities and challenges of this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphHGXsIr-dpbVg90H21EOLACvtfcHk0lglM3jSYx-ozQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFGgs7c%253D&md5=311ba5ab53dc4a5dc1dc92ddd4b6d4c2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201707875%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520cysteinome%2520of%2520protein%2520kinases%2520as%2520a%2520target%2520in%2520drug%2520development%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D4372%26epage%3D4385%26doi%3D10.1002%2Fanie.201707875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Developing irreversible inhibitors of the protein kinase cysteinome</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.chembiol.2012.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=23438744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=146-159&issue=2&author=Q.+Liuauthor=Y.+Sabnisauthor=Z.+Zhaoauthor=T.+Zhangauthor=S.+J.+Buhrlageauthor=L.+H.+Jonesauthor=N.+S.+Gray&title=Developing+irreversible+inhibitors+of+the+protein+kinase+cysteinome&doi=10.1016%2Fj.chembiol.2012.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Irreversible Inhibitors of the Protein Kinase Cysteinome</span></div><div class="casAuthors">Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng; Zhang, Tinghu; Buhrlage, Sara J.; Jones, Lyn H.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-159</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a large family of approx. 530 highly conserved enzymes that transfer a γ-phosphate group from ATP to a variety of amino acid residues, such as tyrosine, serine, and threonine, that serves as a ubiquitous mechanism for cellular signal transduction.  The clin. success of a no. of kinase-directed drugs and the frequent observation of disease causing mutations in protein kinases suggest that a large no. of kinases may represent therapeutically relevant targets.  To date, the majority of clin. and preclin. kinase inhibitors are ATP competitive, noncovalent inhibitors that achieve selectivity through recognition of unique features of particular protein kinases.  Recently, there has been renewed interest in the development of irreversible inhibitors that form covalent bonds with cysteine or other nucleophilic residues in the ATP-binding pocket.  Irreversible kinase inhibitors have a no. of potential advantages including prolonged pharmacodynamics, suitability for rational design, high potency, and ability to validate pharmacol. specificity through mutation of the reactive cysteine residue.  Here, we review recent efforts to develop cysteine-targeted irreversible protein kinase inhibitors and discuss their modes of recognizing the ATP-binding pocket and their biol. activity profiles.  In addn., we provided an informatics assessment of the potential "kinase cysteinome" and discuss strategies for the efficient development of new covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGD7TX3oIeLVg90H21EOLACvtfcHk0lglM3jSYx-ozQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWitbs%253D&md5=cef80823123bae88362e816a0a638133</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSabnis%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDeveloping%2520irreversible%2520inhibitors%2520of%2520the%2520protein%2520kinase%2520cysteinome%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D146%26epage%3D159%26doi%3D10.1016%2Fj.chembiol.2012.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elwood, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesvaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraybill, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bays, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenblatt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanovska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielstorff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarthy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorosh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klappenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kariv, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slipetz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandliker, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of JAK3 biology in autoimmune disease using a highly selective, irreversible JAK3 inhibitor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.239723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1124%2Fjpet.116.239723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=28193636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2js7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=229-244&issue=2&author=F.+Elwoodauthor=D.+Witterauthor=J.+Piesvauxauthor=B.+Kraybillauthor=N.+Baysauthor=C.+Alpertauthor=P.+Goldenblattauthor=Y.+Quauthor=I.+Ivanovskaauthor=H.-H.+Leeauthor=C.-S.+Chiuauthor=H.+Tangauthor=M.+E.+Scottauthor=S.+Deshmukhauthor=M.+Zielstorffauthor=A.+Byfordauthor=K.+Chakravarthyauthor=L.+Doroshauthor=A.+Rivkinauthor=J.+Klappenbachauthor=B.-S.+Panauthor=I.+Karivauthor=C.+Dinsmoreauthor=D.+Slipetzauthor=P.+Dandliker&title=Evaluation+of+JAK3+biology+in+autoimmune+disease+using+a+highly+selective%2C+irreversible+JAK3+inhibitor&doi=10.1124%2Fjpet.116.239723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of JAK3 biology in autoimmune disease using a highly selective, irreversible JAK3 inhibitor</span></div><div class="casAuthors">Elwood, Fiona; Witter, David J.; Piesvaux, Jennifer; Kraybill, Brian; Bays, Nathan; Alpert, Carla; Goldenblatt, Peter; Qu, Yujie; Ivanovska, Irena; Lee, Hyun-Hee; Chiu, Chi-Sung; Tang, Hao; Scott, Mark E.; Deshmukh, Sujal V.; Zielstorff, Mark; Byford, Alan; Chakravarthy, Kalyan; Dorosh, Lauren; Rivkin, Alexey; Klappenbach, Joel; Pan, Bo-Sheng; Kariv, Ilona; Dinsmore, Christopher; Slipetz, Deborah; Dandliker, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-244</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reversible janus assocd. kinase (JAK) inhibitors such as tofacitinib and decernotinib block cytokine signaling and are efficacious in treating autoimmune diseases.  However, therapeutic doses are limited due to inhibition of other JAK/signal transducer and activator of transcription pathways assocd. with hematopoiesis, lipid biogenesis, infection, and immune responses.  A selective JAK3 inhibitor may have a better therapeutic index; however, until recently, no compds. have been described that maintain JAK3 selectivity in cells, as well as against the kinome, with good physicochem. properties to test the JAK3 hypothesis in vivo.  To quantify the biochem. basis for JAK isoenzyme selectivity, we detd. that the apparent Km value for each JAK isoenzyme ranged from 31.8 to 2.9 μM for JAK1 and JAK3, resp.  To confirm compd. activity in cells, we developed a novel enzyme complementation assay that read activity of single JAK isoenzymes in a cellular context.  Reversible JAK3 inhibitors cannot achieve sufficient selectivity against other isoenzymes in the cellular context due to inherent differences in enzyme ATP Km values.  Therefore, we developed irreversible JAK3 compds. that are potent and highly selective in vitro in cells and against the kinome.  Compd. 2, a potent inhibitor of JAK3 (0.15 nM) was 4300-fold selective for JAK3 over JAK1 in enzyme assays, 67-fold [interleukin (IL)-2 vs. IL-6] or 140-fold [IL-2 vs. erythropoietin or granulocyte-macrophage colony-stimulating factor (GMCSF)] selective in cellular reporter assays and >35-fold selective in human peripheral blood mononuclear cell assays (IL-7 vs. IL-6 or GMCSF).  In vivo, selective JAK3 inhibition was sufficient to block the development of inflammation in a rat model of rheumatoid arthritis, while sparing hematopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp6-yK4H1dDbVg90H21EOLACvtfcHk0lhYuQQ5Ib4KVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2js7vL&md5=942ec024e9681b696dfbfeaf22f5acb2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.239723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.239723%26sid%3Dliteratum%253Aachs%26aulast%3DElwood%26aufirst%3DF.%26aulast%3DWitter%26aufirst%3DD.%26aulast%3DPiesvaux%26aufirst%3DJ.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DAlpert%26aufirst%3DC.%26aulast%3DGoldenblatt%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DIvanovska%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DH.-H.%26aulast%3DChiu%26aufirst%3DC.-S.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DM.%2BE.%26aulast%3DDeshmukh%26aufirst%3DS.%26aulast%3DZielstorff%26aufirst%3DM.%26aulast%3DByford%26aufirst%3DA.%26aulast%3DChakravarthy%26aufirst%3DK.%26aulast%3DDorosh%26aufirst%3DL.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DKlappenbach%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DKariv%26aufirst%3DI.%26aulast%3DDinsmore%26aufirst%3DC.%26aulast%3DSlipetz%26aufirst%3DD.%26aulast%3DDandliker%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520JAK3%2520biology%2520in%2520autoimmune%2520disease%2520using%2520a%2520highly%2520selective%252C%2520irreversible%2520JAK3%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26issue%3D2%26spage%3D229%26epage%3D244%26doi%3D10.1124%2Fjpet.116.239723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in JAK3 inhibition: isoform selectivity by covalent cysteine targeting</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4229</span>– <span class="NLM_lpage">4237</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.bmcl.2017.07.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=28844493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2lsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4229-4237&issue=18&author=M.+Forsterauthor=M.+Gehringerauthor=S.+A.+Laufer&title=Recent+advances+in+JAK3+inhibition%3A+isoform+selectivity+by+covalent+cysteine+targeting&doi=10.1016%2Fj.bmcl.2017.07.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting</span></div><div class="casAuthors">Forster, Michael; Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4229-4237</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are a family of four cytosolic protein kinases with a high degree of structural similarity.  Due to its very restricted role in immune regulation, JAK3 was promoted as an excellent target for immunosuppression for more than a decade, but clin. validation of this concept is still elusive.  During the last years, speculation arose that kinase activity of JAK1, which cooperates with JAK3 in cytokine receptor signaling, may have a dominant role over the one of JAK3.  Until recently, however, this issue could not be appropriately addressed due to a lack of highly isoform-selective tool compds.  With the recent resurgence of covalent drugs, targeting of a specific cysteine that distinguishes JAK3 from other JAK family members became an attractive design option.  By applying this strategy, a set of JAK3 inhibitors with excellent selectivity against other JAK isoforms and the kinome was developed during the last three years and used to decipher JAK3-dependent signaling.  The data obtained with these tool compds. demonstrates that selective JAK3 inhibition is sufficient to block downstream signaling.  Since one of these inhibitors is currently under evaluation in phase II clin. studies against several inflammatory disorders, it will soon become apparent whether selective JAK3 inhibition translates into clin. efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopN0oBBGxua7Vg90H21EOLACvtfcHk0lhYuQQ5Ib4KVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2lsb3M&md5=3c6b2f86ccd3e3f3e254bbece5fa3ac5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.079%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DM.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DRecent%2520advances%2520in%2520JAK3%2520inhibition%253A%2520isoform%2520selectivity%2520by%2520covalent%2520cysteine%2520targeting%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4229%26epage%3D4237%26doi%3D10.1016%2Fj.bmcl.2017.07.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiriadi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banach, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiamengo, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihle, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J. W.</span></span> <span> </span><span class="NLM_article-title">Tricyclic covalent inhibitors selectively target JAK3 through an active site thiol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4573</span>– <span class="NLM_lpage">4589</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.595181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1074%2Fjbc.M114.595181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=4573-4589&issue=8&author=E.+R.+Goedkenauthor=M.+A.+Argiriadiauthor=D.+L.+Banachauthor=B.+A.+Fiamengoauthor=S.+E.+Foleyauthor=K.+E.+Frankauthor=J.+S.+Georgeauthor=C.+M.+Harrisauthor=A.+D.+Hobsonauthor=D.+C.+Ihleauthor=D.+Marcotteauthor=P.+J.+Mertaauthor=M.+E.+Michalakauthor=S.+E.+Murdockauthor=M.+J.+Tomlinsonauthor=J.+W.+Voss&title=Tricyclic+covalent+inhibitors+selectively+target+JAK3+through+an+active+site+thiol&doi=10.1074%2Fjbc.M114.595181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.595181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.595181%26sid%3Dliteratum%253Aachs%26aulast%3DGoedken%26aufirst%3DE.%2BR.%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26aulast%3DBanach%26aufirst%3DD.%2BL.%26aulast%3DFiamengo%26aufirst%3DB.%2BA.%26aulast%3DFoley%26aufirst%3DS.%2BE.%26aulast%3DFrank%26aufirst%3DK.%2BE.%26aulast%3DGeorge%26aufirst%3DJ.%2BS.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DHobson%26aufirst%3DA.%2BD.%26aulast%3DIhle%26aufirst%3DD.%2BC.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DMichalak%26aufirst%3DM.%2BE.%26aulast%3DMurdock%26aufirst%3DS.%2BE.%26aulast%3DTomlinson%26aufirst%3DM.%2BJ.%26aulast%3DVoss%26aufirst%3DJ.%2BW.%26atitle%3DTricyclic%2520covalent%2520inhibitors%2520selectively%2520target%2520JAK3%2520through%2520an%2520active%2520site%2520thiol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D8%26spage%3D4573%26epage%3D4589%26doi%3D10.1074%2Fjbc.M114.595181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimermančič, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Covalent docking of large libraries for the discovery of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnchembio.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=25344815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1066-1072&issue=12&author=N.+Londonauthor=R.+M.+Millerauthor=S.+Krishnanauthor=K.+Uchidaauthor=J.+J.+Irwinauthor=O.+Eidamauthor=L.+Giboldauthor=P.+Cimerman%C4%8Di%C4%8Dauthor=R.+Bonnetauthor=B.+K.+Shoichetauthor=J.+Taunton&title=Covalent+docking+of+large+libraries+for+the+discovery+of+chemical+probes&doi=10.1038%2Fnchembio.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent docking of large libraries for the discovery of chemical probes</span></div><div class="casAuthors">London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1066-1072</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biol. studies.  Despite these advantages, protein-reactive compds. are usually avoided in high-throughput screening campaigns.  Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small mols.  We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC β-lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases.  We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3.  Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization.  As covalent virtual screening may have broad utility for the rapid discovery of chem. probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngQdIYqslNLVg90H21EOLACvtfcHk0liLHeNE9B8XyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsbjE&md5=4e5fbeb8f67cb82d464d57069ba0c93a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1666%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DEidam%26aufirst%3DO.%26aulast%3DGibold%26aufirst%3DL.%26aulast%3DCimerman%25C4%258Di%25C4%258D%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DCovalent%2520docking%2520of%2520large%2520libraries%2520for%2520the%2520discovery%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D12%26spage%3D1066%26epage%3D1072%26doi%3D10.1038%2Fnchembio.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnchembio.2056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=27018889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=373-379&issue=5&author=G.+A.+Smithauthor=K.+Uchidaauthor=A.+Weissauthor=J.+Taunton&title=Essential+biphasic+role+for+JAK3+catalytic+activity+in+IL-2+receptor+signaling&doi=10.1038%2Fnchembio.2056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling</span></div><div class="casAuthors">Smith, Geoffrey A.; Uchida, Kenji; Weiss, Arthur; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-379</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To drive lymphocyte proliferation and differentiation, common γ-chain (γc) cytokine receptors require hours to days of sustained stimulation.  JAK1 and JAK3 kinases are found together in all γc-receptor complexes, but how their resp. catalytic activities contribute to signaling over time is not known.  Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i).  By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4+ T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave.  Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase.  An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice.  Our chem. genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2-driven T cell proliferation and will find broad utility in studies of γc-receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfXNNV1cRJbVg90H21EOLACvtfcHk0liLHeNE9B8XyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCru74%253D&md5=573d99767ce37cf58a8f71e9e01102b5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2056%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DEssential%2520biphasic%2520role%2520for%2520JAK3%2520catalytic%2520activity%2520in%2520IL-2%2520receptor%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26issue%3D5%26spage%3D373%26epage%3D379%26doi%3D10.1038%2Fnchembio.2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akahane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyskens, K. M. S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herter-Sprie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattison, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbay, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Development of selective covalent janus kinase 3 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6589</span>– <span class="NLM_lpage">6606</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00710</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00710" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6589-6606&issue=16&author=L.+Tanauthor=K.+Akahaneauthor=R.+McNallyauthor=K.+M.+S.+E.+Reyskensauthor=S.+B.+Ficarroauthor=S.+Liuauthor=G.+S.+Herter-Sprieauthor=S.+Koyamaauthor=M.+J.+Pattisonauthor=K.+Labellaauthor=L.+Johannessenauthor=E.+A.+Akbayauthor=K.-K.+Wongauthor=D.+A.+Frankauthor=J.+A.+Martoauthor=T.+A.+Lookauthor=J.+S.+C.+Arthurauthor=M.+J.+Eckauthor=N.+S.+Gray&title=Development+of+selective+covalent+janus+kinase+3+inhibitors&doi=10.1021%2Facs.jmedchem.5b00710"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00710%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DAkahane%26aufirst%3DK.%26aulast%3DMcNally%26aufirst%3DR.%26aulast%3DReyskens%26aufirst%3DK.%2BM.%2BS.%2BE.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHerter-Sprie%26aufirst%3DG.%2BS.%26aulast%3DKoyama%26aufirst%3DS.%26aulast%3DPattison%26aufirst%3DM.%2BJ.%26aulast%3DLabella%26aufirst%3DK.%26aulast%3DJohannessen%26aufirst%3DL.%26aulast%3DAkbay%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DLook%26aufirst%3DT.%2BA.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDevelopment%2520of%2520selective%2520covalent%2520janus%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D16%26spage%3D6589%26epage%3D6606%26doi%3D10.1021%2Facs.jmedchem.5b00710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Design of a janus kinase 3 (JAK3) specific inhibitor 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1971-1993&issue=5&author=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+E.+Bankerauthor=B.+Jubaauthor=J.+Jussifauthor=T.+Linauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garciaauthor=R.+Unwallaauthor=J.+I.+Trujilloauthor=S.+Liangauthor=P.+Balboauthor=Y.+Cheauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=L.+Leungauthor=X.+Yangauthor=S.+Soucyauthor=M.+Hegenauthor=J.+Coeauthor=J.+Langilleauthor=F.+Vajdosauthor=J.+Chrencikauthor=J.-B.+Telliez&title=Design+of+a+janus+kinase+3+%28JAK3%29+specific+inhibitor+1-%28%282S%2C5R%29-5-%28%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29-2-methylpiperidin-1-yl%29prop-2-en-1-one+%28PF-06651600%29+allowing+for+the+interrogation+of+JAK3+signaling+in+humans&doi=10.1021%2Facs.jmedchem.6b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans</span></div><div class="casAuthors">Thorarensen, Atli; Dowty, Martin E.; Banker, Mary Ellen; Juba, Brian; Jussif, Jason; Lin, Tsung; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin; Unwalla, Ray; Trujillo, John I.; Liang, Sidney; Balbo, Paul; Che, Ye; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Leung, Louis; Yang, Xin; Soucy, Sarah; Hegen, Martin; Coe, Jotham; Langille, Jonathan; Vajdos, Felix; Chrencik, Jill; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1971-1993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in several compds. entering clin. development and two FDA approved NMEs.  However, despite significant effort during the past two decades, identification of highly selective JAK3 inhibitors has eluded the scientific community.  A significant effort within the research organization has resulted in the identification of the first orally active JAK3 specific inhibitor, which achieves JAK isoform specificity through covalent interaction with a unique JAK3 residue Cys-909.  The relatively rapid resynthesis rate of the JAK3 enzyme presented a unique challenge in the design of covalent inhibitors with appropriate pharmacodynamics properties coupled with limited unwanted off-target reactivity.  This effort resulted in the identification of PF-06651600 I, a potent and low clearance compd. with demonstrated in vivo efficacy.  The favorable efficacy and safety profile of this specific JAK3 inhibitor I led to its evaluation in several human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodS6VFIL07nrVg90H21EOLACvtfcHk0lhb-7JyAira1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D&md5=d1ab749203fae07f89463f97518e3db8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSoucy%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDesign%2520of%2520a%2520janus%2520kinase%25203%2520%2528JAK3%2529%2520specific%2520inhibitor%25201-%2528%25282S%252C5R%2529-5-%2528%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529-2-methylpiperidin-1-yl%2529prop-2-en-1-one%2520%2528PF-06651600%2529%2520allowing%2520for%2520the%2520interrogation%2520of%2520JAK3%2520signaling%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D1971%26epage%3D1993%26doi%3D10.1021%2Facs.jmedchem.6b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corona, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Selective JAK3 inhibitors with a covalent reversible binding mode targeting a new induced fit binding pocket</span>. <i>Cell Chemical Biology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2016.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2Fj.chembiol.2016.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1335-1340&issue=11&author=M.+Forsterauthor=A.+Chaikuadauthor=S.+M.+Bauerauthor=J.+Holsteinauthor=M.+B.+Robersauthor=C.+R.+Coronaauthor=M.+Gehringerauthor=E.+Pfaffenrotauthor=K.+Ghoreschiauthor=S.+Knappauthor=S.+A.+Laufer&title=Selective+JAK3+inhibitors+with+a+covalent+reversible+binding+mode+targeting+a+new+induced+fit+binding+pocket&doi=10.1016%2Fj.chembiol.2016.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DHolstein%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DCorona%26aufirst%3DC.%2BR.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSelective%2520JAK3%2520inhibitors%2520with%2520a%2520covalent%2520reversible%2520binding%2520mode%2520targeting%2520a%2520new%2520induced%2520fit%2520binding%2520pocket%26jtitle%3DCell%2520Chemical%2520Biology%26date%3D2016%26volume%3D23%26issue%3D11%26spage%3D1335%26epage%3D1340%26doi%3D10.1016%2Fj.chembiol.2016.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>The Structural
Genomics Consortium. <span> </span><span class="NLM_article-title">FM-381 a chemical probe for JAK3</span>. <a href="http://www.thesgc.org/chemical-probes/FM-381" class="extLink">http://www.thesgc.org/chemical-probes/FM-381</a> (accessed 05.01.<span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Structural%0AGenomics+Consortium.+FM-381+a+chemical+probe+for+JAK3.+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FFM-381+%28accessed+05.01.2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DFM-381%2520a%2520chemical%2520probe%2520for%2520JAK3%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span>The Chemical
Probes Portal. <span> </span><span class="NLM_article-title">FM-381</span>. <a href="http://www.chemicalprobes.org/fm-381" class="extLink">http://www.chemicalprobes.org/fm-381</a> (accessed 05.01.<span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Chemical%0AProbes+Portal.+FM-381.+http%3A%2F%2Fwww.chemicalprobes.org%2Ffm-381+%28accessed+05.01.2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DFM-381%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of janus kinase 3 (JAK3) inhibitors</span>. <i>Anal. Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8817</span>– <span class="NLM_lpage">8822</span>, <span class="refDoi"> DOI: 10.1039/C4AY01589D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1039%2FC4AY01589D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KktLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=8817-8822&issue=21&author=S.+M.+Bauerauthor=M.+Gehringerauthor=S.+A.+Laufer&title=A+direct+enzyme-linked+immunosorbent+assay+%28ELISA%29+for+the+quantitative+evaluation+of+janus+kinase+3+%28JAK3%29+inhibitors&doi=10.1039%2FC4AY01589D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of Janus Kinase 3 (JAK3) inhibitors</span></div><div class="casAuthors">Bauer, Silke M.; Gehringer, Matthias; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8817-8822</span>CODEN:
                <span class="NLM_cas:coden">AMNEGX</span>;
        ISSN:<span class="NLM_cas:issn">1759-9679</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The availability of a robust, precise and cost-efficient test system is the prerequisite for the performance of any medicinal chem. program, esp. in an academic environment.  For the identification of novel Janus Kinase 3 inhibitors and detn. of structure-activity relationships, a direct ELISA was developed.  Being applicable in a std. lab., the main advantage over existing methods is the basic equipment requirement as this assay does not need special handling originating from the use of cell cultures or radiometric readout.  In contrast to earlier methods relying on two-step procedures, our assay uses a single peroxidase conjugated antibody to quantify and detect substrate phosphorylation.  This optimized assay features a limit of detection of 0.032 μg mL-1, a wide dynamic range of 0.638 OD units and an appropriate Z' factor of 0.66.  The detd. IC50 value for Tofacitinib was 3.5 ± 0.6 nM (n = 18).  A detailed assay protocol custom-tailored for the JAK3 kinase domain and a step-by-step manual for optimizing specific assay conditions are presented.  This ELISA primarily addresses researchers within the academic setting facing the task to identify lead structures and explore structure-activity relationships of JAK3 inhibitors at reasonable costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4PXaxHHwvLbVg90H21EOLACvtfcHk0lhPRNELJ0nU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KktLnN&md5=0ec4f079c1bf1552cde1a15d08534453</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2FC4AY01589D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4AY01589D%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DA%2520direct%2520enzyme-linked%2520immunosorbent%2520assay%2520%2528ELISA%2529%2520for%2520the%2520quantitative%2520evaluation%2520of%2520janus%2520kinase%25203%2520%2528JAK3%2529%2520inhibitors%26jtitle%3DAnal.%2520Methods%26date%3D2014%26volume%3D6%26issue%3D21%26spage%3D8817%26epage%3D8822%26doi%3D10.1039%2FC4AY01589D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafimova, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pufall, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maglathlin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frödin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1038/nchembio.925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnchembio.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=22466421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=471-476&issue=5&author=I.+M.+Serafimovaauthor=M.+A.+Pufallauthor=S.+Krishnanauthor=K.+Dudaauthor=M.+S.+Cohenauthor=R.+L.+Maglathlinauthor=J.+M.+McFarlandauthor=R.+M.+Millerauthor=M.+Fr%C3%B6dinauthor=J.+Taunton&title=Reversible+targeting+of+noncatalytic+cysteines+with+chemically+tuned+electrophiles&doi=10.1038%2Fnchembio.925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span></div><div class="casAuthors">Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Froedin, Morten; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacol. potency and selectivity.  Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies.  Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner.  Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts.  Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissocg., covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2.  A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine.  Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond.  Our results establish a chem.-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcv3GjPOB6rVg90H21EOLACvtfcHk0lhPRNELJ0nU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D&md5=6455a9a029714beb317286f71ac1326b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.925%26sid%3Dliteratum%253Aachs%26aulast%3DSerafimova%26aufirst%3DI.%2BM.%26aulast%3DPufall%26aufirst%3DM.%2BA.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DDuda%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DMaglathlin%26aufirst%3DR.%2BL.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFr%25C3%25B6din%26aufirst%3DM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DReversible%2520targeting%2520of%2520noncatalytic%2520cysteines%2520with%2520chemically%2520tuned%2520electrophiles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26issue%3D5%26spage%3D471%26epage%3D476%26doi%3D10.1038%2Fnchembio.925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span> <span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lhPRNELJ0nU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodroofe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimprich, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupcho, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartnett, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niles, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">Target engagement and drug residence time can be observed in living cells with BRET</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10091</span>, <span class="refDoi"> DOI: 10.1038/ncomms10091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1038%2Fncomms10091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=26631872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10091&author=M.+B.+Robersauthor=M.+L.+Dartauthor=C.+C.+Woodroofeauthor=C.+A.+Zimprichauthor=T.+A.+Kirklandauthor=T.+Machleidtauthor=K.+R.+Kupchoauthor=S.+Levinauthor=J.+R.+Hartnettauthor=K.+Zimmermanauthor=A.+L.+Nilesauthor=R.+F.+Ohanaauthor=D.+L.+Danielsauthor=M.+Slaterauthor=M.+G.+Woodauthor=M.+Congauthor=Y.-Q.+Chengauthor=K.+V.+Wood&title=Target+engagement+and+drug+residence+time+can+be+observed+in+living+cells+with+BRET&doi=10.1038%2Fncomms10091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Target engagement and drug residence time can be observed in living cells with BRET</span></div><div class="casAuthors">Robers, Matthew B.; Dart, Melanie L.; Woodroofe, Carolyn C.; Zimprich, Chad A.; Kirkland, Thomas A.; Machleidt, Thomas; Kupcho, Kevin R.; Levin, Sergiy; Hartnett, James R.; Zimmerman, Kristopher; Niles, Andrew L.; Ohana, Rachel Friedman; Daniels, Danette L.; Slater, Michael; Wood, Monika G.; Cong, Mei; Cheng, Yi-Qiang; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10091</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The therapeutic action of drugs is predicated on their phys. engagement with cellular targets.  Here we describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reveal the binding characteristics of a drug with selected targets within intact cells.  Cell-permeable fluorescent tracers are used in a competitive binding format to quantify drug engagement with the target proteins fused to Nanoluc luciferase.  The approach enabled us to profile isoenzyme-specific engagement and binding kinetics for a panel of histone deacetylase (HDAC) inhibitors.  Our anal. was directed particularly to the clin. approved prodrug FK228 (Istodax/Romidepsin) because of its unique and largely unexplained mechanism of sustained intracellular action.  Anal. of the binding kinetics by BRET revealed remarkably long intracellular residence times for FK228 at HDAC1, explaining the protracted intracellular behavior of this prodrug.  Our results demonstrate a novel application of BRET for assessing target engagement within the complex milieu of the intracellular environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFFk0LNiL_LVg90H21EOLACvtfcHk0lgYWKu36Ijpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO&md5=723cc5dd7d229b1115da4c2c9d75c913</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fncomms10091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10091%26sid%3Dliteratum%253Aachs%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DDart%26aufirst%3DM.%2BL.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DZimprich%26aufirst%3DC.%2BA.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DKupcho%26aufirst%3DK.%2BR.%26aulast%3DLevin%26aufirst%3DS.%26aulast%3DHartnett%26aufirst%3DJ.%2BR.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DNiles%26aufirst%3DA.%2BL.%26aulast%3DOhana%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DM.%2BG.%26aulast%3DCong%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DY.-Q.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DTarget%2520engagement%2520and%2520drug%2520residence%2520time%2520can%2520be%2520observed%2520in%2520living%2520cells%2520with%2520BRET%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10091%26doi%3D10.1038%2Fncomms10091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsup, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward-Tharp, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnerly, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radi, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">4234</span>– <span class="NLM_lpage">4243</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1003668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.4049%2Fjimmunol.1003668" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=4234-4243&issue=7&author=K.+Ghoreschiauthor=M.+I.+Jessonauthor=X.+Liauthor=J.+L.+Leeauthor=S.+Ghoshauthor=J.+W.+Alsupauthor=J.+D.+Warnerauthor=M.+Tanakaauthor=S.+M.+Steward-Tharpauthor=M.+Gadinaauthor=C.+J.+Thomasauthor=J.+C.+Minnerlyauthor=C.+E.+Storerauthor=T.+P.+LaBrancheauthor=Z.+A.+Radiauthor=M.+E.+Dowtyauthor=R.+D.+Headauthor=D.+M.+Meyerauthor=N.+Kishoreauthor=J.+J.+O%E2%80%99Shea&title=Modulation+of+innate+and+adaptive+immune+responses+by+tofacitinib+%28CP-690%2C550%29&doi=10.4049%2Fjimmunol.1003668"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1003668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1003668%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BL.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DAlsup%26aufirst%3DJ.%2BW.%26aulast%3DWarner%26aufirst%3DJ.%2BD.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSteward-Tharp%26aufirst%3DS.%2BM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DMinnerly%26aufirst%3DJ.%2BC.%26aulast%3DStorer%26aufirst%3DC.%2BE.%26aulast%3DLaBranche%26aufirst%3DT.%2BP.%26aulast%3DRadi%26aufirst%3DZ.%2BA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DHead%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DModulation%2520of%2520innate%2520and%2520adaptive%2520immune%2520responses%2520by%2520tofacitinib%2520%2528CP-690%252C550%2529%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26issue%3D7%26spage%3D4234%26epage%3D4243%26doi%3D10.4049%2Fjimmunol.1003668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haché, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Moos, E.</span></span> <span> </span><span class="NLM_article-title">A practical Oxone®-mediated, high-throughput, solution-phase synthesis of benzimidazoles from 1,2-phenylenediamines and aldehydes and its application to preparative scale synthesis</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2003</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1683</span>– <span class="NLM_lpage">1692</span>, <span class="refDoi"> DOI: 10.1055/s-2003-40888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1055%2Fs-2003-40888" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=1683-1692&issue=11&author=P.+L.+Beaulieuauthor=B.+Hach%C3%A9author=E.+von+Moos&title=A+practical+Oxone%C2%AE-mediated%2C+high-throughput%2C+solution-phase+synthesis+of+benzimidazoles+from+1%2C2-phenylenediamines+and+aldehydes+and+its+application+to+preparative+scale+synthesis&doi=10.1055%2Fs-2003-40888"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-40888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-40888%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DHach%25C3%25A9%26aufirst%3DB.%26aulast%3Dvon%2BMoos%26aufirst%3DE.%26atitle%3DA%2520practical%2520Oxone%25C2%25AE-mediated%252C%2520high-throughput%252C%2520solution-phase%2520synthesis%2520of%2520benzimidazoles%2520from%25201%252C2-phenylenediamines%2520and%2520aldehydes%2520and%2520its%2520application%2520to%2520preparative%2520scale%2520synthesis%26jtitle%3DSynthesis%26date%3D2003%26volume%3D2003%26issue%3D11%26spage%3D1683%26epage%3D1692%26doi%3D10.1055%2Fs-2003-40888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dess, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. C.</span></span> <span> </span><span class="NLM_article-title">Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4156</span>, <span class="refDoi"> DOI: 10.1021/jo00170a070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00170a070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=4155-4156&issue=22&author=D.+B.+Dessauthor=J.+C.+Martin&title=Readily+accessible+12-I-5+oxidant+for+the+conversion+of+primary+and+secondary+alcohols+to+aldehydes+and+ketones&doi=10.1021%2Fjo00170a070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones</span></div><div class="casAuthors">Dess, D. B.; Martin, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4155-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Oxidn. of 2-IC6H4CO2H with KBrO3 in aq. H2SO4, followed by treatment of the oxidn. product with Ac2O gave 87% periodinane I, a 10-I-5 species (i.e., 10 valence electrons are formally involved in binding 5 ligands to the central iodine atom).  I reacted rapidly with primary or secondary alcs. at room temp. to give the corresponding aldehydes or ketones in high yield.  Excess I does not further oxidize the aldehyde or ketone under the reaction conditions.  The reaction is strongly catalyzed by excess alc. or strong acid, but is unaffected by pyridine.  I oxidizes benzylic alcs. selectively in the presence of satd. alcs.  Procedures for sepg. the carbonyl product from the reaction mixt. are mild and simple.  Cryst. I is stable at room temp. in the absence of moisture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAtQbosBW467Vg90H21EOLACvtfcHk0lik2aOea47k4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D&md5=31b4835cd94c04773221d921e76231d1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00170a070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00170a070%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DReadily%2520accessible%252012-I-5%2520oxidant%2520for%2520the%2520conversion%2520of%2520primary%2520and%2520secondary%2520alcohols%2520to%2520aldehydes%2520and%2520ketones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26issue%3D22%26spage%3D4155%26epage%3D4156%26doi%3D10.1021%2Fjo00170a070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S. S.</span></span> <span> </span><span class="NLM_article-title">Highly practical copper(I)/TEMPO catalyst system for chemoselective aerobic oxidation of primary alcohols</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">16901</span>– <span class="NLM_lpage">16910</span>, <span class="refDoi"> DOI: 10.1021/ja206230h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja206230h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GitLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=16901-16910&issue=42&author=J.+M.+Hooverauthor=S.+S.+Stahl&title=Highly+practical+copper%28I%29%2FTEMPO+catalyst+system+for+chemoselective+aerobic+oxidation+of+primary+alcohols&doi=10.1021%2Fja206230h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Practical Copper(I)/TEMPO Catalyst System for Chemoselective Aerobic Oxidation of Primary Alcohols</span></div><div class="casAuthors">Hoover, Jessica M.; Stahl, Shannon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16901-16910</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aerobic oxidn. reactions have been the focus of considerable attention, but their use in mainstream org. chem. has been constrained by limitations in their synthetic scope and by practical factors, such as the use of pure O2 as the oxidant or complex catalyst synthesis.  Here, we report a new (bpy)CuI/TEMPO catalyst system that enables efficient and selective aerobic oxidn. of a broad range of primary alcs., including allylic, benzylic, and aliph. derivs., to the corresponding aldehydes, e.g. benzaldehyde, cinnamaldehyde, cyclohexanecarboxaldehyde, N-Boc-L-prolinal, using readily available reagents, at room temp. with ambient air as the oxidant.  The catalyst system is compatible with a wide range of functional groups and the high selectivity for 1° alcs. enables selective oxidn. of diols that lack protecting groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY-aJRI5siPbVg90H21EOLACvtfcHk0lik2aOea47k4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GitLzK&md5=6f0bc378de72a715d623b0dcdc69b210</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja206230h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206230h%26sid%3Dliteratum%253Aachs%26aulast%3DHoover%26aufirst%3DJ.%2BM.%26aulast%3DStahl%26aufirst%3DS.%2BS.%26atitle%3DHighly%2520practical%2520copper%2528I%2529%252FTEMPO%2520catalyst%2520system%2520for%2520chemoselective%2520aerobic%2520oxidation%2520of%2520primary%2520alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26issue%3D42%26spage%3D16901%26epage%3D16910%26doi%3D10.1021%2Fja206230h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanchette, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essenfeld, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masamune, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Horner-Wadsworth-Emmons reaction: use of lithium chloride and an amine for base-sensitive compounds</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2183</span>– <span class="NLM_lpage">2186</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)80205-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2FS0040-4039%2801%2980205-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1984&pages=2183-2186&issue=21&author=M.+A.+Blanchetteauthor=W.+Choyauthor=J.+T.+Davisauthor=A.+P.+Essenfeldauthor=S.+Masamuneauthor=W.+R.+Roushauthor=T.+Sakai&title=Horner-Wadsworth-Emmons+reaction%3A+use+of+lithium+chloride+and+an+amine+for+base-sensitive+compounds&doi=10.1016%2FS0040-4039%2801%2980205-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2980205-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252980205-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchette%26aufirst%3DM.%2BA.%26aulast%3DChoy%26aufirst%3DW.%26aulast%3DDavis%26aufirst%3DJ.%2BT.%26aulast%3DEssenfeld%26aufirst%3DA.%2BP.%26aulast%3DMasamune%26aufirst%3DS.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DHorner-Wadsworth-Emmons%2520reaction%253A%2520use%2520of%2520lithium%2520chloride%2520and%2520an%2520amine%2520for%2520base-sensitive%2520compounds%26jtitle%3DTetrahedron%2520Lett.%26date%3D1984%26volume%3D25%26issue%3D21%26spage%3D2183%26epage%3D2186%26doi%3D10.1016%2FS0040-4039%2801%2980205-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maetz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span> <span> </span><span class="NLM_article-title">A simple preparation of N-protected chiral α-aminonitriles from N-protected α-amino acid amides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">4221</span>– <span class="NLM_lpage">4222</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(97)00895-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1016%2FS0040-4039%2897%2900895-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=4221-4222&issue=24&author=P.+Maetzauthor=M.+Rodriguez&title=A+simple+preparation+of+N-protected+chiral+%CE%B1-aminonitriles+from+N-protected+%CE%B1-amino+acid+amides&doi=10.1016%2FS0040-4039%2897%2900895-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2897%2900895-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252897%252900895-2%26sid%3Dliteratum%253Aachs%26aulast%3DMaetz%26aufirst%3DP.%26aulast%3DRodriguez%26aufirst%3DM.%26atitle%3DA%2520simple%2520preparation%2520of%2520N-protected%2520chiral%2520%25CE%25B1-aminonitriles%2520from%2520N-protected%2520%25CE%25B1-amino%2520acid%2520amides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26issue%3D24%26spage%3D4221%26epage%3D4222%26doi%3D10.1016%2FS0040-4039%2897%2900895-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hett, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a JAK3-selective inhibitor: functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3442</span>– <span class="NLM_lpage">3451</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00677</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00677" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3442-3451&issue=12&author=J.-B.+Telliezauthor=M.+E.+Dowtyauthor=L.+Wangauthor=J.+Jussifauthor=T.+Linauthor=L.+Liauthor=E.+Moyauthor=P.+Balboauthor=W.+Liauthor=Y.+Zhaoauthor=K.+Crouseauthor=C.+Dickinsonauthor=P.+Symanowiczauthor=M.+Hegenauthor=M.+E.+Bankerauthor=F.+Vincentauthor=R.+Unwallaauthor=S.+Liangauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=X.+Yangauthor=J.+Baumanauthor=J.+I.+Trujilloauthor=A.+Casimiro-Garciaauthor=F.+F.+Vajdosauthor=L.+Leungauthor=K.+F.+Geogheganauthor=A.+Quaziauthor=D.+Xuanauthor=L.+Jonesauthor=E.+Hettauthor=K.+Wrightauthor=J.+D.+Clarkauthor=A.+Thorarensen&title=Discovery+of+a+JAK3-selective+inhibitor%3A+functional+differentiation+of+JAK3-selective+inhibition+over+pan-JAK+or+JAK1-selective+inhibition&doi=10.1021%2Facschembio.6b00677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00677%26sid%3Dliteratum%253Aachs%26aulast%3DTelliez%26aufirst%3DJ.-B.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMoy%26aufirst%3DE.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DCrouse%26aufirst%3DK.%26aulast%3DDickinson%26aufirst%3DC.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DQuazi%26aufirst%3DA.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DHett%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520JAK3-selective%2520inhibitor%253A%2520functional%2520differentiation%2520of%2520JAK3-selective%2520inhibition%2520over%2520pan-JAK%2520or%2520JAK1-selective%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D3442%26epage%3D3451%26doi%3D10.1021%2Facschembio.6b00677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P.</span></span> <span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&issue=1&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lh0md54aykyRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26issue%3D1%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Processing of X-ray snapshots from crystals in random orientations</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2204</span>– <span class="NLM_lpage">2216</span>, <span class="refDoi"> DOI: 10.1107/S1399004714013534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS1399004714013534" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=2204-2216&issue=8&author=W.+Kabsch&title=Processing+of+X-ray+snapshots+from+crystals+in+random+orientations&doi=10.1107%2FS1399004714013534"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS1399004714013534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004714013534%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520snapshots%2520from%2520crystals%2520in%2520random%2520orientations%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2014%26volume%3D70%26issue%3D8%26spage%3D2204%26epage%3D2216%26doi%3D10.1107%2FS1399004714013534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">Pt 4</span>),  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&issue=Pt+4&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljJZ8_dHDijaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26issue%3DPt%25204%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljJZ8_dHDijaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&issue=4&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljJZ8_dHDijaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3D4%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&issue=1&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lg88R4UMcjpmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D1%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span> <i>PyMol. Molecular Graphics System</i>, version 0.99rc6; <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=W.+L.+DeLano&title=PyMol.+Molecular+Graphics+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26jtitle%3DPyMol.%2520Molecular%2520Graphics%2520System%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>ZINC15. <a href="http://zinc15.docking.org/patterns/home/" class="extLink">http://zinc15.docking.org/patterns/home/</a> (accessed 20.03.<span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ZINC15.+http%3A%2F%2Fzinc15.docking.org%2Fpatterns%2Fhome%2F+%28accessed+20.03.2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWM','PDB','5LWM'); return false;">PDB: 5LWM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWN','PDB','5LWN'); return false;">PDB: 5LWN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK','PDB','3LXK'); return false;">PDB: 3LXK</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00571">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_43558"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00571">10.1021/acs.jmedchem.8b00571</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Kinome selectivity data for compound <b>23</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Additional experimental procedures and data for the preparation of intermediates and compound <b>29</b> and <b>30</b>; X-ray crystallographic diffraction data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf">PDF</a>)</p></li><li><p class="inline">SMILES codes of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_001.pdf">jm8b00571_si_001.pdf (158.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_002.pdf">jm8b00571_si_002.pdf (381.06 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00571/suppl_file/jm8b00571_si_003.csv">jm8b00571_si_003.csv (1.85 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Cocrystal structures of JAK3 in complex with compounds <b>10</b>, <b>11</b>, and <b>20</b> are deposited in the Protein Data Bank under the accession codes 6GL9, 6GLA, and 6GLB, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00571&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00571%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00571" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797fe40989194f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
